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Abstract 
DNA ligases are essential enzymes across all three domains of life. Their role is to bind nicked 
DNA or DNA ends and re-join broken nucleic acid strands. In bacteria, there are two key 
pathways that DNA ligases are involved in: DNA replication during cell division and DNA 
repair for breaks in DNA that occur as a result of damage. In E.coli, there are two genes for 
DNA ligases: LigA, whose structure has been published and LigB as a second ligase (unknown 
in structure) that has a different DNA, and therefore protein, sequence. 
The overall aim of this work was first to clone, express, purify and test the kinetic and 
binding reactions of LigA and LigB as native proteins (not fusion-tagged versions, which most 
previous studies have used). This has not been reported before and the characterisation of the 
kinetics of LigA and LigB are very sparse in the literature. In this study we attempted to cover 
the lack of kinetic data on native LigA and LigB by studying how its functioning is affected by 
varying [DNA], [NAD+], reaction temperature, [NMN] and [NH4SO4]. The aim was to find the 
Vmax (maximal theoretical rate), Km (Michaelis equilibrium constant) and kcat (turnover 
number) for the nick-sealing reaction with each different variable. 
We found that the Km values for LigA and LigB (how tightly they bound the nicked 
DNA) for singly-nicked DNA substrate were 12.22±6.42 and 3.50±1.34 nM, respectively. 
Therefore, native LigA was 6.4-fold tighter than native LigB. The Km values for varying NAD+
cofactor concentration were sharply different (1.55±0.33 vs. 0.16±0.03 µM), and show that 
LigB bound NAD+ 9.6 times tighter than LigA. However, the Vmax values showed that LigA 
was 4-fold faster than LigB. Both native enzymes had a similar optimum temperature for 
activity. For LigA this was ~20ºC, and for LigB approximately ~16ºC. The remaining two 
parameters, [NMN] and [NH4SO4], were only studied for LigA. The interesting result for NMN 
was that it inhibited the reaction of LigA with an IC50 of 31.34±1.58 µM. This shows that one 
of the ligation products (NMN) acts as a feedback inhibitor. The Km for the ammonium sulphate 
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concentration experiment on LigA was 37.64±40.64 µM, and that [NH4SO4] stimulated the 
LigA reaction when present about 1.6 fold. 
The results from these characterisation studies allowed the development of a three-part 
molecular screening method (in silico to in vitro to in vivo) to build towards potential future 
studies that could then explore small molecule compounds that affect these basic kinetic 
parameters and find new ligase inhibitors. Therefore the second aim of the work was to explore 
the potential of DNA ligases (LigA in particular) as possible antibiotic targets. These involved 
the use of a molecular docking programme called Molecular Operating Environment (MOE). 
This software (in silico) was used to identify eight chemical compounds from a large 
library of possible small molecular inhibitors. The key question in this work was to see if these 
compounds could inhibit the E.coli DNA LigA in vitro (by denaturing gel experiments) and in 
vivo (by Kirby-Bauer bacterial surface-inhibition experiments). We found that four out of the 
eight compounds (5-Azacytidine, Geneticin (G418), Chlorhexidine and Imidazolidinyl Urea) 
did inhibit the activity of LigA in vitro with IC50 values of 10.34±4.14, 45.31±13.81, 
20.66±6.11 and 7.56±14.48 µM, respectively. Three of the eight compounds: Geneticin 
(G418), Chlorhexidine and Imidazolidinyl, did inhibit the growth of the bacteria (in vivo) with 
IC50 values of 0.63± 0.17, 0.17±0.03 and 233.25±143.35 mM, respectively. They had success 
in all three areas of study (in silico, in vitro and in vivo) and make them suitable candidates for 
future drug development studies as a promising chemical leads to target bacteria. 
In conclusion, this thesis provides important kinetic and binding data on LigA and LigB 
that will help explain how they work in E.coli. This thesis also provides clear evidence for at 
least three new ligase inhibitors of E.coli. 
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Chapter 1: Introduction 
This opening chapter starts with an overview of the importance of ligases and where they are 
found across the three domains of life. This is followed by details on E.coli LigA and LigB, 
their structure and mechanism. The final part describes the problem of antibiotic resistance, 
ligases as potential drug targets, techniques used and the purpose of this work. 
1.1. The Importance of DNA Ligases. 
DNA ligases are essential cellular enzymes that repair breaks in DNA that occur as a result of 
damage or DNA metabolism. DNA ligases are indispensable enzymes that play a critical role 
in all DNA processes, including replication, repair and DNA recombination (Lehman, 1974; 
Mills et al., 2011). These enzymes are labelled as NAD+ or ATP dependent based on the 
respective cofactor specificities (Srivastava et al., 2005). The hydrolysis of an ATP or NAD+
cofactor provides the free-energy that is essential to push the reaction forward (Singleton et al., 
1999). DNA ligases are cornerstone tools for catalysing the formation of a phosphodiester bond 
between a 5-phosphorylated DNA termini and 3-OH of DNA (Lohman et al., 2011). 
Therefore, DNA ligases are absolutely necessary for genome integrity and are attractive drug 
targets (Horiuchi et al., 1975).  
For example, in DNA replication, DNA ligase is responsible for joining Okazaki 
fragments on the lagging strand of a replication fork in vivo. In DNA repair pathways, they 
restore continuity of the DNA backbone as the final step in nucleotide excision and base 
excision repair (Weiss & Richardson, 1967). Ligases are also crucial chemical components in 
the development of DNA biotechnology, including, cloning, molecular diagnostics and 
sequencing methods (Shuman, 2009). The discovery of Escherichia coli DNA ligases just over 
50 years ago (1967) was reported by the Lehman laboratory and four other groups in 1967, and 
this was a key event in molecular biology and biotechnology (Olivera et al., 1967; Gefter et 
al., 1967; Gellert, 1967; Zimmerman et al, 1967). Many other DNA ligases have been 
discovered since and they are present in all domains of life (prokaryotes, eukaryotes, archaea 
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and viruses) (Le et al., 2008). NAD+-dependent DNA ligases are found exclusively in bacteria, 
some archaea and a few eukaryotic viruses. ATP-dependent DNA ligases are found mainly in 
eukaryotes, archaea and bacteriophages (Tomkinson et al., 2006).  
Many studies have shown that the NAD+- dependent DNA ligases are an essential 
enzyme in several bacteria for their viability, via knockout of its gene (Rychta et al., 2007). 
Breaks (nicks) in the DNA sugar-phosphate backbone can result from external factors such 
as UV radiation or chemical damage, or from internal factors such as oxidative damage. Nicks 
are also included during the normal processes of DNA replication, recombination and repair. 
Subsequently, in humans this can cause thousands of molecular lesions per day (Jackson & 
Bartek, 2009). Therefore, if these lesions in critical genes are left unresolved, they can lead to 
cancer development and tissue atrophy (Branzei & Foiani, 2008). So DNA ligases are 
substantial enzymes for preserving genomic integrity in all cells 
1.2. Ligases across the Domains of Life. 
NAD+-dependent ligases are found mainly in bacteria and some eukaryotic viruses, whereas 
ATP-dependent DNA ligases are found mainly in eukaryotes (animals and plants) and in some 
bacteria, bacteriophage viruses and archaea (Edgell & Doolittle, 1997; Kletzin, 1992). The 
following are some examples of ligases across the three domains of life: 
  All DNA ligases in archaea characterized to date have ATP-dependent 
adenylyltransferase and nick-joining activities (Keppetipola & Shuman, 2005). However, 
Thermococcus fumicolans and Pyrococcus abyssi are one type of archaeal DNA ligases that 
can use multiple cofactors like ATP or ADP (Chambers & Patrick, 2015). In 2006, Nishida and 
his group identified the structure of DNA ligase from the archaeal species Pyrococcus furiosus 
(Ellenberger & Tomkinson, 2008). Its structure is comprised of a middle adenylation domain, 
N-terminal DNA-binding domain and an OB-fold domain. The architecture of each domain 
looked like those of human DNA ligase I, however the domain arrangements completely 
different between the two enzymes (Nishida et al., 2006). There are three families of ATP-
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dependent that are present in eukaryotes: these are called LigI, LigIII and LigIV.  LigI and 
LigIV families are found in all eukaryotes, whereas the members of the Lig III family are only 
found in vertebrates. These ligases share common catalytic regions which are the NTase 
domain, the DNA-binding domain and OB-fold domain. The catalytic region encircles nicked 
DNA with each of the domains contacting the DNA duplex (Ellenberger & Tomkinson, 2008).    
1.3. Types of DNA Ligases.
All DNA ligases follow the same reaction mechanism for fixing a DNA nick. Depending on 
the cofactor used by the enzyme, DNA ligases can be divided into two classes: those that 
require NAD+ and those requiring ATP (Zhu & Shuman, 2005; Doherty & Suh, 2000). This 
requires an AMP group to be covalently donated from the cofactor onto the ligase enzyme. The 
AMP can come from either adenosine triphosphate (ATP) or from oxidised nicotinamide 
adenine dinucleotide (NAD+). In evolutionary terms, organisms can be divided into three 
domains: the Eukarya (eukaryotes), Archaea and Prokaryotes (Bacteria). ATP-dependent DNA 
ligases are found in archaea and eukaryotes, whereas the NAD+-dependent enzymes are present 
only in Eubacteria and entomopox viruses (Sriskanda et al, 2001).  
All known bacterial species encode at least one highly conserved NAD+-dependent 
DNA ligase (Weinstock et al., 1979). Since all eubacteria contain NAD+-dependent DNA 
ligases, the uniqueness of these enzymes to bacteria makes them attractive targets for novel 
antibiotics (Wilkinson & Bowater, 2001). Additionally, NAD+-dependent DNA LigA is also 
not present in human and therefore is very potent attractive drug target (Srivastava et al., 2005; 
Gong et al., 2004). Some bacteria encode additional NAD+-dependent or ATP-dependent 
ligase enzymes (Petit & Ehrlich, 2000; Gong et al., 2004). A number of bacteria have been 
stated that ATP is the cofactor used and Haemophilus influenzae is ATP-dependant, which 
improve this (Cheng, 1997; Wilkinson et al., 2001).  
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Together NAD+- and ATP-dependent DNA ligases are extremely modular proteins with 
distinct domain architectures (Cheng & Shuman, 1997; Wilkinson et al., 2001). The differences 
in substrate specificity and structural exclusivity of the bacterial enzymes have enticed many 
to exploit this target for the discovery of novel antibacterial agents. The selectivity inhibition 
of bacterial DNA ligases with no inhibition of human DNA ligase have been stimulated by the 
identification of NAD+-competitive ligands with antibacterial activity (Mills et al., 2011; 
Sassetti et al., 2003; Miesel et al., 2003). 
Because NAD+-dependent DNA ligase is essential for DNA replication and repair, it 
has attracted interest as a prospective broad-spectrum antibacterial target, in bacteria NAD+-
dependent DNA ligases has a highly conserved phylogenetic and distinctly different from the 
eukaryotic DNA ligases (Benson, 2004; Sheraz et al., 2004; Chen et al., 2002). Therefore, 
NAD+-dependent ligases present a promising drug target for antimicrobial therapy (Brötz-
Oesterhelt et al., 2003). According to the tight phylogenetic distribution and comparing the 
different structures of LigA compared to ATP-dependent in human, researchers are strongly 
interested in the NAD+ ligase family as target for the development of new broad-spectrum 
antibiotics (Nandakumar et al., 2007). 
1.3.1. EcoLigA. 
The prototype of the NAD+-dependent class of DNA ligase is E.coli Ligase A (LigA). A LigA 
can be found in every bacterial species (Sriskanda & Shuman, 2001a). The main function of 
DNA ligase LigA is to form a phosphodiester bond at single-strand breaks between adjacent 
3′-hydroxyl and 5′-phosphate termini in double-stranded DNA (Lehman, 1979; Lahiri et al.,
2012; Shuman, 2009). In 2001, Kaczmarek stated that the deactivation of the LigA gene in 
E.coli led to complete non-viability of the growth in all bacteria (Kaczmarek et al., 2001).  
Figure 1.1 shows a general explanation of the sealing of a single nicked DNA with the 
presence of LigA and NAD+ as essential cofactor. The figure shows the AMP group moving 
from NAD+ to the LigA (grey oval) and then transferring to the 5 end of the nick to allow the 
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nick to be sealed.  The complete coding sequence of the open reading frame (ORF) of E.coli
NAD+-dependent LigA was proved to be correct by the determination of the amino acid 
composing of the purified enzyme and is prototypical of all bacterial NAD+-dependent ligases. 
The molecular weight of E.coli LigA protein is 73,690 Da and it has 671 amino acid residues. 
Residues 1-316 consist of amino acids of a core nuclotidyltransferase domain (NTase plus Ia 
domain).  
Four C-terminal domains include 317-404 of amino acid of OB-fold domain, 405-432 
amino acid of a tetracysteine zinc-finger domain, a helix-hairpin-helix domain (433-586 amino 
acid) and a BRCT domain (amino acid 587-671). Each subset of the LigA domain modules has 
a different responsibility during the ligation pathway, with only the NTase domain being 
required for all steps of the ligation (Wang et al., 2009). In 2007, the Shuman group reported 
the crystal structure of E.coli LigA bound to a short (26 bp), nicked DNA molecule at 2.3Å 
resolution, which engaged to adenylated DNA (Shuman et al., 2007) In 2008, the Shuman 
group used mutational and deletion analysis of specific amino acid residues of the LigA protein 
on the OB and HhH domains of E.coli LigA by alanine scanning and conservative substitutions, 
entailing 43 mutations at 22 amino acids. They identified that Arg333, Arg379, Val383 and Ile384
are essential functional groups of amino acids in the OB domain that engage the DNA 
phosphodiester backbone flanking the nick (Wang et al., 2008).  
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Figure 1.1.  Brief Summary of the Fixing of Single Nicked DNA. 
This figure shows the formation of phosphodiester bond at single-strand DNA substrate breaks between 
adjacent 3′-hydroxyl and 5′-phosphate via using LigA protein and NAD+ as essential cofactor. 
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The essential functional groups of amino acids in the HhH domain include four 
glycines: Gly455, Gly489, Gly521, Gly553, which bind the phosphate backbone across the minor 
groove at the outer edge of the LigA-DNA interface. Also, the essential amino acids was Arg487
and Arg44 in HhH domain. Arg487 penetrates the minor groove at the outer edge of 3-OH side 
of the nick, and Arg44 supports the protein to hold and contact the nuclotidyltransferase domain 
(Wang et al., 2008; Lim et al., 2001).  
In Figure 1.2 is shown the details of how E.coli LigA contacts to nicked DNA, showing 
four domains of LigA bound OB and HhH domains of LigA to contact the nicked DNA and 
form the phosphodiester backbone. The same study in 2009 did another mutational and deletion 
analysis, studying the NTase domain and specific amino acid residues of the LigA protein. 
They tested the effects of 29 alanine and conservative mutations at 15 amino acid positions, 
looking at ligase activity in vitro and vivo (Wang et al., 2009). The identified essential 
functional groups of the protein included Arg136, which was necessary for the reaction of LigA 
with NAD+ to form covalent ligase-AMP intermediate and for the subsequent transfer of AMP 
to the nick 5-PO4 to form the DNAadenylate intermediate.  The NTase domain had ten 
individual residues that were identified as essential for E.coli LigA functions to contact the 
AMP adenine: Lys115 (the site of covalent AMP attachment), Asp117, Gly118, Glu173, Arg200, 
Arg208, Arg277, Asp285, Lys290, and Lys314. They were responsible for binding the phosphodiester 
backbone flanking the nick (Wang et al., 2009; Sriskanda & Shuman, 2002a; Zhu & Shuman, 
2005). Figure 1.2 shows the importance Arg136 and Lys115 in NTase domain of LigA to form 
phosphodiester backbone.  
1.3.2.    EcoLigB.    
A second NAD+-dependent DNA ligase in E.coli is called LigB and was identified by the 
similarity of its sequence to LigA. There are no data basic on LigB except one paper published 
from Shuman in 2001 describing its discovery (Sriskanda & Shuman, 2001).  
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Figure 1.2. Mapping of E. coli LigA contacts to nicked DNA (PDB 2OWO).  
The top right image shows the four domains of LigA bound to nicked DNA-adenylate. The middle 
images is double strand of DNA shows two-dimensional, the nicked strands of DNA with 5-adenylate 
on the right side. The nick DNA contacts of LigA side chain and main-chain (NTase, OB and HhH 
domains) are indicated by arrows. Water interactions are shown with red spheres. R208 and R487 with 
red colour are amino acids that contact with outer margin on the 3-OH side of nick DNA. LigA residues 
that penetrate the DNA helix and interact with the bases are indicated within the DNA base pair ladder. 
Figure taken from Wang and Shuman, 2008 and 2009.
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The length of this second NAD+-dependent DNA ligase protein is 562 amino acids, with a 
molecular weight 63,179 Da. It has 97% sequence similarity of the LigB is referred to 
enterohemorrhagic E.coli strain O157:H7 (GenBank no. AE005592) (Sriskanda & Shuman, 
2001). The function of LigB is to catalyse the formation of phosphodiester linkages between 
5'-phosphoryl and 3'-hydroxyl groups in dsDNA. The amino acid sequence of LigB revealed 
its possible function by comparing with E.coli DNA ligase LigA by applying manual 
alignment. Figure 1.3 shows the primary and secondary sequence of LigA and LigB and they 
were aligned using the Clustal programme. Sriskanda & Shuman in 2001 reported that 
recombinant LigB from E.coli had the ability of catalysing the joining of one nicked DNA in 
the presence of a divalent cation and NAD+. Like LigA, it also has nuclotidyltransferase 
domain, which includes five catalytic motifs (I, III, IIIa, V and VI), an OB domain and an HhH 
domain. The active site in E.coli DNA ligase that bind AMP group in LigA is Lys 115, but in 
LigB enzyme it is Lys 126.  
Figure 1.4A shows the primary sequence of NTase domain of E.coli DNA LigA that 
aligned to the primary sequence of LigB by using Clustal programme showing the five motifs 
in both enzymes. However, the C-terminal BRCT domain and two of the four Zn2+ binding 
cysteines that exist in all other bacteria NAD+ ligase are not present in LigB protein (Sriskanda 
& Shuman, 2001). Figure 1.4B and C shows the manually aligned comparison between the 
primary sequence of LigA and LigB E coli explains the absence of  two Zn2+ finger and the 
whole BRCT domain in LigB.  
1.4. Structure of E. coli DNA Ligase LigA.
The tertiary structures of all prokaryote DNA ligases have some similarity in terms of fold 
structure and common domains. Several studies of tertiary structures of DNA ligase proteins 
have stated that they all possess a catalytic core for all domains of life, which contains two 
parts: an adenylation domain (also named as the nuclotidyltransferase or NTase domain), and 
an Oligomer Binding (OB domain) fold (Lee et al., 2000; Georlette et al., 2004).   
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Figure 1.3. Alignment of LigA vs LigB proteins via using Clustal Omega. This image shows the 
visualised primary and secondary sequences between LigA and LigB by using ESPript 0.3 programme 
depending on the PDB structure of LigA protein (20W0). The red colours of amino acids of LigA and 
LigB mean identical, pink colours mean similar structure and black colours are different.   
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: :          :
LigA   69 FSQIRHEVPMLSLDNVFDEES 
LigB   90 -GAVMHPVAHTGVRKMVDKNA 
115 
                  :   :        * ** ::   :  : :  :  :  :  :::    : 
LigA   FLAFNKRVQDRLKNNEKVTWCCELKLDGLAVSILYENGVLVSAATRGDGTTGEDITSNVR 
LigB   LS---------LWMRERSDLWVQPKVDGVAVTLVYRDGKLNKAISRGNGLKGEDWTQKVS 
126 
          : :    :          *  *:                       :   :: 
LigA   TIRAIPLKLHGENIPARLEVRGEVFLPQAGFEKINEDARRTGGKVFANPRNAAAGSLRQL 
LigB   LISAVPQTVSGPLAN--STLQGEIFLQREGHIQQQMGGIN--------ARAKVAGLMMRQ 
       :           *            :     ::      :       :     : ::  
LigA   DPRITAKRPLTFFCYGVGVLEGGELPDTHLGRLLQFKKWGLPVSDRVTLC-ESAEEVLAF 
LigB   DDSD-TLNSLGVFVWA-----WPDGPQLMSDRLKELATAGFTLTQTYTRAVKNADEVARV 
                 : :  ****         :          : **                 
LigA   YHKVEEDRPTLGFDIDGVVIKVNSLAQQEQLGFVARAPRWAVAFKF 315 
LigB   --RNEWWKAELPFVTDGVVVRAA--KEPESRHWLPGQAEWLVAWKY 307 
LigA   PTHCPVCGSDVERVEGEAVARCTGGLIC
LigB   SLTCY-----------------FASDVC 
Figure 1.4. Alignment and Comparison between LigA and LigB in their NTase, Zn and 
BRCT Domains.
Panel A) the primary sequence of LigA and LigB enzymes of E coli that aligned manually in just NTase 
domain by using Clustal programme. NTase domain contains five motifs that highlighted as follow: 
motif I red, motif III as yellow, motif IIIa as purple, motif IV as green and motif V as blue colour. 
Amino acids in LigA that has two black dot on it mean conserved with LigB. Amino acids in LigA that 
has black star mean conserved with LigB but just only in motifs sites. Panel B) showing the primary 
sequence of LigA and LigB enzymes of E coli that aligned manually just in Zinc domain, and the four 
Cysteine in LigA coloured with red and the two Cysteine in LigB coloured in yellow. It is showing that 
Zn figure is important in LigA but maybe does not in LigB. Panel C) This figure explains the 
comparison of the domain structures in LigA and LigB. Both ligases have the la domain, the NTase 
domain and the HhH domain. LigB lacks two of the four Zn2+ fingers hence the smaller size in this 
domain. It also lacks the BRCT domain.  
C 
B 
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The essential ligase enzyme in E.coli is called LigA. In 2007, Shuman and his group 
solved the tertiary structure of LigA bound to a nicked DNA (Nandakumar et al., 2007). E.coli
LigA protein has 671 amino acids in length and monomer molecular weight of 73,690 Da. The 
crystal structure of E.coli LigA bound to the nicked DNA-adenylate (LigA.AppDNA [AMP 
that bind nicked-DNA]) showed that LigA surrounded the helix of DNA as a C-shaped protein 
clamp (Gajiwala & Pinko 2004; Sriskanda & Shuman, 2002). Figure 1.5A shows the crystal 
structure of E.coli DNA Ligase A (PDB 2OWO). In comparison to E.coli LigA, 35%-50% of 
bacterial species have a similar sequence (Ishino et al., 1986). The structure of the NAD+-
dependent catalytic core of ligases from Bacillus stearothermophilus & Thermus filiformis 
have previously been described (Singleton et al., 1999; Lee et al., 2000). Although, more 
recently the crystal structure of E.coli LigA-adenylated nick complex has also been studied, 
revealing the basis of DNA binding and recognition (Nandakumar & Shuman, 2007). 
Figure 1.5A shows the crystal structure of NAD+-dependent DNA LigA has showed 
main domains: a nucleotidyltransferase (NTase domain) (green, 70-316 amino acid) and an 
oligomer-binding (OB fold) (yellow, 317-404 amino acids). The NTase domain has a further 
part called the Ia sub-domain (light blue, 1-69 amino acids). The lysine residue 115 in the 
NTase (adenylation) domain is essential for NAD+ cofactor binding (Singleton et al., 1999 & 
Zhu & Shuman, 2005). The lysine is in a hydrophilic pocket (Shuman and Lima, 2004; 
Sriskanda & Shuman, 2002b; Wilkinson et al., 2005).  
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  Figure 1.5. Crystal Structure of E. coli DNA Ligase A (PDB 2OWO).  
Panel A) These figures are shown the four domains crystal structure of E coli DNA Ligase A with 
double strand of DNA in the centre (closed C-model) via PyMOL programme. The domains are colour 
coded as follow: The first domain I that is so essential for binding the NAD+ molecular and fixing the 
nick has two subdomains: Ia and NTase, which coloured blue and green colour, respectively. Second 
Domain OB (oligo-binding) with yellow colour.  Domain 3 consists from two subdomains (Zn and 
HhH), which coloured with purple and red colour, respectively. The BRCT is fourth domain that is not 
shown in this structure. This Figure was created in PyMOL using PDB code 2OWO. Panel B) Domain 
ordering/layout of LigA. Labelled is the N-terminal residue (1) located at the Ia domain and the C-
terminal residue (671). K115 (lysine 115) in the middle of the NTase domain is in motif I in this 
structure. 
1     69-70 Lys 115      316-317 404-405 432-433 586-587     671
B 
A 
N-term C-term
Ia sub-domain 
Zinc finger (Zn)
Sub-domain
NTase domain 
Helix-hairpin-helix 
sub-domain 
OB domain 
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This lysine 115 of LigA in NTase domain reacts with NAD+ in eubacteria and becomes 
adenylated with an AMP group to form a covalent ligase-(lysyl-N)-AMP intermediate. Later, 
this AMP group is transferred to the DNA nick and eventually is release (Zhao et al., 2006; 
Little et al., 1967). The large NTase domain of E coli DNA ligase has five particular amino 
acid sequence motifs that are named I, III, IIIa, IV, and V which form the nucleotide-binding 
pocket. Figure 1.6 shows the sequence alignment of LigA nucleotidyltransferase domain in 
E.coli and other bacteria stains. Motif I includes Lysine 115 to form a covalent ligase-(lysyl-
N)-AMP intermediate in the first step of the ligase reaction. Side chain of motif I and III, IIIa, 
IV, and V contact to the AMP and are essential for ligase catalytic activity in vitro and in vivo. 
The secondary structure of the NTase domain is composed of anti-parallel β-sheets flanked by 
α-helices, though the construction varies in different species. Studies by alanine-scanning-
mutagenesis identified different amino acid residues in the adenylation domain that were 
important for ligase activity (Singleton et al., 1999). Each of these steps of the ligation reaction 
rely on a various domains of the LigA structure, with the NTase domain, which is being 
required for all steps of the reaction in all bacterial ligases (Wang et al., 2009). 
 The Ia domain is a subdomain of Domain 1. It is unique to NAD+-dependent ligases 
and is required for the reaction of LigA with NAD+ to form the ligase-AMP intermediate (Step 
1, LigA.App) (Benarroch & Shuman, 2006; Singleton et al., 1999). Deleting the Ia domain 
completely abolishes the ligation function for the protein, so is considered essential for the 
reaction (Lim et al., 2001; Jeon et al., 2004: Timson; Wigley, 1999). Alanine substitutions of 
residues were tested within Ia domain of E.coli LigA DNA ligase and have included five amino 
acid residues that are implicated specifically in adenylation and AMP transfer: Y22, H23, D32, 
Y35 and D36, which reduce the activity enzyme to more than 80% (Sriskanda & Shuman, 
2002b). 
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The OB fold (domain 2, 317-404 amino acids) is joined to the adenylation domain in the 
structure of LigA. This domain plays a crucial role for touching the un-nicked (template) strand 
of DNA and binding over the nick to help to form LigA.AppDNA (LigA+AMP+phosphate on 
the DNA). It is also joined in the DNA phosphodiester backbone (Lee et al., 2000; Wang et 
al., 2008). Comparison of the E.coli LigA.AppDNA complex with different bacterial ligases 
that were also captured as the dual LigA (step1 in different stages: LigA.NAD+ and LigA.App) 
revealed that LigA involves a nearly 180º rotation of the OB domain to bind the DNA, which 
explained the concave surface of the OB β- barrel fits into the DNA minor groove (Gajiwala 
& Pinko, 2004)..  
The Zn2+ domain, the HhH domains (Domain 3) which are followed with OB fold and 
the BRCT domain (Domain 4), which placed at C-end of the structure (Lee et al., 2000). The 
subdomain 3 (Zn2+motif) has four cysteine residues that co-ordinate a zinc ion. This module is 
preserved over all known eubacteria NAD+ ligases (except LigB) (Lavesa-Curto et al., 2004). 
The Zinc finger module plays a crucial role in bridging the OB and helix-hairpin-helix domains 
and for recognising the nick site and DNA interaction (Nandakumar et al., 2007).  
The hairpin of the second subdomain (HhH motif) is highly positive and is thought to 
be required for non-specific DNA-binding (Doherty & Suh, 2000).  Finally, The BRCT domain 
of E.coli LigA ligase is called domain 4 and is found in all NAD+ and some ATP-ligases. The 
secondary structure of BRCT domain is composed of parallel β-sheets and α-helices. It is about 
80-100 amino acids in length and has a hydrophobic nature to the fold.  Because the BRCT 
domain is not present in all ligases, it is not looked at to be an important compound to ligase 
function (Timson & Wigley, 1999). However, deletion analysis revealed that the BRCT 
domain of E.coli LigA is required in its totality for effective nick sealing in vitro (Lim et al., 
2001).  
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1.5. DNA Ligation Mechanism.  
The reaction mechanisms of several DNA ligases have been well authenticated (Lehman, 1974; 
Doherty & Suh, 2000; Timson et al., 2000). This is shown on the next page in Figure 1.7 
Briefly, in the first step, a lysine nucleophile in the ligase attacks the α-phosphorus of ATP or 
NAD+ to form a covalent lysylN-AMP intermediate and leave either pyrophosphate, which is 
related to ATP, or nicotinamide mononucleotide (NMN), which is related to NAD+ (Chauleau 
& Shuman, 2016; Shuman, 2009). When LigA reacts with NAD+ in the absence of nucleic acid 
it becomes adenylated and then catalytically active (primed), and is able to bind DNA and 
release NMN (Miesel et al., 2007; Pergolizzi, et al., 2016).
As an example, Figure 1.8A shows the view of NAD+ attached to the Ia sub-domain in
E. faecalis (Efa) (Nandakumar et al., 2007).  This compression method is called the open-
close process; before ligase reacts with NAD+ to be adenylated, the nucleic acid strand face 
of the OB domain is rotated away from the active site. This is the open conformation of the 
protein (Georlette et al., 2004). Once ligase is adenylated with AMP (LigA.Ap), the second 
domain (OB domain) changes its conformation and rotates around, displaying its DNA-binding 
face towards the active site.  
Figure 1.8B shows the view of AMP that bind in Lysine 115 in NTase domain of LigA. 
This is called the closed conformation (Murzin, 1993, Lee et al., 2000, Kaczmareck et al., 
2001; Lavesa-Curto et al., 2004). The conformation of this structure allows the active site of 
ligase to bind to the DNA (Georlette et al., 2003). In the second step, the phosphorus of lysyl-
AMP (LigA.App) binds to the nicked duplex DNA and transfers the adenylate from the active 
site to the 5-PO4 terminus to form the DNA-adenylated intermediate.   
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Figure 1.7. Three-Steps of the Reaction Mechanism of DNA Ligase.  
First step (enzyme-adenylate): the enzyme attaches with cofactor ATP or NAD+ to form a 
phosphoamide -linked AMP with the amino group of the active site lysine and induces a closed 
conformation of the enzyme. R represents the released product: PPi (for ATP Ligases) or NMN 
(for NAD+ Ligases). Second step (DNA-adenylate): LigA.App is transferred to the DNA, at 
the 5-phosphate group of the nick, making an unstable adenylate-bisphosphate group. The 
third step (fixing the nick): The 3-OH group at the nick attacks the bisphosphate group, 
creating a stable phosphodiester bond, and releasing AMP and enzyme (Lehman, 1974). 
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Figure 1.8.     The Movement of Protein Domains of LigA that Bind with NAD+ to ligate the Nick 
DNA. 
Pane A) This view shows the Ia domain (blue) of EfaLigA protein bound to NAD+ (first step). Panel 
B) This view is shown the NTase domain (cyan) that bound to NAD+ and form the covalent AMP 
intermediate by the active side. Panel C) this is shown the AMP attached to the nick DNA (EcoLigA-
AppDNA) and fi the nick. The purple colour refers to the OB domain Of LigA. The brown and green 
colour refers to the HhH and Zn domain, respectively.  Figure taken from Nandakumar et al., 2007. 
The chemical structure of NAD+ is shown in Appendix 1. 
B 
C
A 
NAD+ binding to Ia
(blue colour) sub-
domain in E. faecalis.  
AMP binding to 
NTase (cyan colour) 
domain in E.coli.
AMP binding to 
nicked DNA in E.coli.   
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Figure 1.8C above shows the view of LigA-AMP in NTase domain that bound to nick 
DNA (Lig-App). Nick 3′-OH on the DNAadenylylate forms a 3′5′ phosphodiester and 
releases the AMP (which initially came from the NAD+ cofactor). Ligase then becomes free 
and ready to re-adenylate for another round of ligation (Miesel et al., 2007). 
1.6. Antibiotic Resistance. 
Antibiotic resistance in bacteria is emerging as a potential medical disaster as a result of the 
speed with which bacteria exchange their genetic material or obtain new genes. Large numbers 
of antibiotics that synthesised over the past few decades has caused complacency about the 
threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result 
of mutations that grant natural resistance to individual bacterial cells or the exchange of genetic 
material via plasmids and transposons (Neu, 1991). Antimicrobial resistance is one of the 
highest health issues and called one of the world's most pressing public health problems 
(Davies & Davies, 2010).  
The common and widespread use of antibiotics by humans in medicinal and agriculture 
provides a selective pressure for any resistant organisms to become dominant (Berkowitz, 
1995). Therefore, bacterial pathogens have become more resistant to commonly used 
antibiotics (Feng, 2015). The development of antimicrobial resistance has been described as 
having potentially catastrophic consequences for humanity (Davies & Davies, 2010), and has 
recently been described as a ticking time-bomb by Dame Sally Davies of the General 
Medical Council (GMC). 
 Bacterial ligases are exciting possible new targets for antimicrobial therapies, since 
eukaryotic ligases have different protein sequences, different cofactor, are much larger and are 
composed of many subunits (Montecucco et al., 1988). The obvious goal in this work is to 
block the reaction of the active side of LigA in eubacteria. This could lead to reduced DNA 
repair and replication and kill the bacteria. Biochemical studies have shown that mutations that 
affect in E. coli DNA ligase activity end up being lethal to the entire cell (Modrich & Lehman, 
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1971; Konrad et al., 1973). Bacterial DNA ligases may be a promising antibiotic target, since 
they share no homology in details to eukaryote ligases, and also open the door to other species 
of bacteria, for example genes encoding NAD+-dependent DNA ligase are essential in 
Salmonella typhimurium, Bacillus subtilis and Staphylococcus aureus (Sriskanda & Shuman, 
2001).  
A recent study by Meier et al., 2008 identified a compound (2,4-diamino-7-
dimethylamino-pyrimido[4,5-d]pyrimidine) with the ability to specifically disrupt the function 
of the Streptococcus pneumoniae LigA enzyme in vitro and in vivo but does not disrupt the 
function of ATP-dependent enzymes. Here, we look at identifying compounds that can bind to 
LigA and affect its activity, through a combination of in silico, in vitro and in vivo techniques. 
1.7.            Theory of Biophysical Techniques. 
In this section the background theory to the main experimental techniques in this thesis are 
discussed. These include enzyme kinetics, electrophoretic mobility-shift assay (EMSA),
sedimentation velocity analytical ultracentrifugation of LigA, Beta-clamp protein and
molecular docking programme (MOE).  
1.7.1.        Michaelis-Menten Kinetics. 
Michaelis-Menten kinetics is the way of measuring two important parameters about enzymes: 
Vmax and  Km. The definition of Vmax is the maximum theoretical rate of reaction. This is 
obtained by plotting the initial rate (V0) against varying concentration of the substrate being 
investigated. Figure 1.9A and B shows an overview of Michaelis-Menten kinetics analysis 
explaing the Vmax and Km.  
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Figure 1.9.         An Overview of Michaelis-Menten Kinetics Analysis. 
 Panel A)  samples contained substrate (for example nicked DNA in this thesis), when the timepoints 
increased the product (ligated DNA by the enzyme in this thesis) increased and the free DNA decrease.  
Panel B) is showing grafit to obtain the Vmax and Km. 
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The definition of Km is the concentration of substrate that gives half maximum rate. It 
is obtained from the Michaelis-Menten equation by fitting. The Vmax and Km values were 
elucidated by plotting their V0 values for each timecourse and fitting to the Michaelis- Menten 
equation:  
Equation 1.1: 
Once Vmax is known, the kcat can be calculated. The definition of kcat is the number of 
substrate molecules (nicked-DNA molecules) converted to product per minute. The kcat is also 
known as the turnover number. In this thesis it was calculated by dividing the Vmax (nM/min) 
by the enzyme concentration (30 nM for all the kinetics experiments). 
1.7.2.        Electrophoretic Mobility-Shift Assay (EMSA). 
Electrophoretic mobility shift assay (EMSA) experiments are considered to be a very important 
method to analyse the characterisation of DNA-protein interactions and to assess the binding 
affinity between DNA ligases and nicked-DNA (Hellman & Fried, 2007). The first discovered 
use of EMSA and quantitative analysis of protein-DNA interactions was in 1981 (Fried & 
Crothers, 1981; Garner & Revzin, 1981). The technique of EMSA depends on the separation 
of DNA and DNA-protein complexes by their differing electrophoretic mobility in a 
polyacrylamide gel matrix (Kneale, 1994). Free and bound DNA can be recognised using a 
DNA stain, or the DNA can be labelled fluorescently or radioactively and detected by 
fluorescence or autoradiography. For the experiments described in this thesis DNA was 
labelled with a HEX-fluorophore. Figure 1.10A and B shows an overview of gel-shift (EMSA) 
Analysis explain the Bmax and Kd.
The equilibrium dissociation constant (Kd) of protein-DNA complexes can be 
determined in EMSA, which is a measure of the strength of the interaction. The Kd corresponds 
to the ratio between the molar concentrations of free reactants and those in complex at 
equilibrium. The formation of a protein-DNA (PD) complex (where there is a single binding 
site) can be described by the following scheme:  
V = (Vmax × [S]) / (Km + [S]) 
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Figure 1.10.         An Overview of Gel-Shift (EMSA) Analysis. 
Panel A)  samples contained nicked DNA that bound to the protein to make a complex molecular, when 
the concentration of protein increased the band of bound DNA (complex) increased and the free DNA 
decreased by using native polyacralamide.  Panel B) is showing grafit to obtain the Bmax and Kd of the 
gel-shift experiments. 
0 20 40 60 80 100
0
10
20
30
40
50
60
[Protein]
D
N
A 
B
ou
nd
Kd
Free nicked 
DNA
Bound DNA
A 
B 
Bmax
Calculate %   Bound 
25 
The Kd corresponds to the ratio between the product of the molar concentrations of (free) 
reactants and that of the complex at equilibrium in the following equation: 
Where [P] is the molar concentration of free protein, [D] is the molar concentration of free 
DNA and [PD] is the molar concentration of protein-DNA complex. The Bmax and Kd values 
were calculated by plotting their Bound (B) values for each binding experiment and fitting to 
a single- site binding equation:  
Equation 1.3:
The Kd has the units of molar concentration (M) and the Kd is typically used in preference to 
the association constant (Ka), because the units of concentration can be used with reference to 
reactant concentration. The Kd is the concentration of protein that gives half maximal binding. 
1.7.3.        Sedimentation Velocity Analytical Ultracentrifugation of LigA.
Analytical ultracentrifugation (AUC) is a versatile technique for the hydrodynamic 
analysis of macromolecules in solution. AUC has widely been used for the study of 
macromolecules in a vast amount of solvents and over a vast amount of solute concentrations 
(Cole et al., 2008). There are two types of AUC experiment: sedimentation velocity and 
sedimentation equilibrium centrifugation. In sedimentation velocity, the rate of boundary 
movement and the boundary spreading provides information about the mass, size, shape and 
interactions of molecules. Conventionally, the average velocity sedimentation of pure protein 
is determined via observing the movement of the midpoint of the sedimentation boundary as a 
function of time. Figure 1.11 shows a distinct boundary formed where the particles are 
sediment using AUC, during the experiment the absorbance along the sedimentation path (or 
radial path) of the AUC cell is measured periodically so that the movement of the boundary 
can be recorded.  
P + D ⇌ PD
Kd =[P]×[D] / [PD]Equation 1.2:
B = (Bmax × [P]) / (Kd + [P]) 
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Figure 1.11. Overview of Sedimentation Velocity Analytical Ultracentrifugation. 
Panel A) A single compartment within an AUC cell, which contains a sample of macromolecules in 
solution. The blue colouring represents the concentration of the macromolecules. As the cell rotates the 
molecules sediment, causing the concentration close to the meniscus to drop and a sharp concentration 
gradient to form (the boundary), shown in panel B) By monitoring the movement and diffusion of the 
boundary over time, it is possible to obtain information about the size and shape of the molecules 
present. This figure adapted from Dr Jonathan Chamberlain thesis 2017, Portsmouth University.  
Spinning rotor 
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The high absorption optics of sedimentation velocity in AUC experiments allows the 
monitoring of individual species in a system of strong polydispersity (Karibyants et al., 1997). 
The frictional force and floating (buoyancy) force acting upon the protein has opposed the 
sedimentation, these resisting forces can be characterised in an AUC experiment through the 
Svedberg equation (equation 1.3): 
 = 2 =  (1− ῡ)
Where S is the sedimentation coefficient, v is the rate of sedimentation, ω is the angular 
velocity of the rotor, r is the radius (distance from the centre of rotation), M is the molar mass, 
ῡ is the partial specific volume (density of the protein), ρ is the solvent density, NA is 
Avogadro's constant, and f is the frictional coefficient. The sedimentation coefficient is 
expressed in Svedberg units (S), with 1 S being equal to exactly 10-13 seconds. It provides a 
relatively straightforward method to determine the molecular mass distribution of 
macromolecules over a large range of sizes and concentrations.  
In sedimentation velocity (SV), the sample is spun at very high speeds to sediment 
macromolecules. The maximum absorbance of proteins between 220 nm (peptide bond) and 
280 nm (aromatic bound). However, the maximum absorbance of individual protein can be 
change by primary, secondary, tertiary and quaternary structure, but still the absorbance 
between 220-280 nm. This can be used during AUC analysis to determine their radial position 
in the sample cell using the appropriate light wavelength. The absorbance then recorded to a 
reference cell. This technique was used in this thesis to investigate the stoichiometry of the 
ligase protein by measuring the molecular mass.  
1.7.4. Beta-Clamp Proteins.     
For efficient DNA replication, DNA polymerases are required to achieve a very high degree of 
processivity. This comes from a protein-protein interaction with a ring-shaped protein called 
Equation 1.4:
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sliding clamp that is bound to the template DNA (Hedglin et al., 2013). One surface of the 
sliding clamp binds to the DNA polymerase and interacts with the beta clamp-loader complex, 
which opens and reseals the clamp (Johnson & O'Donnell, 2005; Indiani & O'Donnell, 2006). 
The beta-clamp keeps the polymerase III enzyme at the replication fork of DNA and 
enormously increases processivity (from 10s to 1000s base pairs) at all replication steps 
(Stukenberg et al. 1991).  
Biochemical studies and structural analyses show that the functional structure of clamps 
and clamp loaders is conserved across the three domains of life. Without replication sliding 
clamps in the cell, DNA replication during division would be incredibly slow and affect the 
replication of long size of DNA (O'Donnell & Kornberg, 1985).  In eubacteria, this processivity 
factor is named the beta-sliding clamp. The β-clamp, (γ) gamma clamp-loader complex and 
polymerase III comprise the core of the DNA replication fork (Stukenberg et al. 1991).  
In 1992, Kong et al., stated that the crystal structure of the β-clamp is 35Å diameter, 
which is sufficiently wide to host double-stranded DNA. Two structurally-distinct faces can be 
identified on the β slidingclamp. The clamp monomer consists of three domains and forms a 
homodimer. In 2008, the ODonnell group solved the structure of beta-clamp bound to DNA 
and the structure revealed that DNA pushes through the beta-clamp such as a curtain ring on a 
pole, at a 22° angle (Georgescu et al., 2008). Figure 1.12A shows the crystal structure of E. 
coli beta-clamp protein in complex with DNA in the centre (PDB code 3BEP). 
The gamma clamp loading complex has 5-subunits in a complex: three γ subunits (1,2
and 3), one δ subunit and one δ’ subunit. This complex is important for opening the beta clamp 
and docking it onto the DNA (Jeruzalmi et al., 2001). One face has several small loops and the 
face of the ring that interacts with gamma loader is the C-terminal face (Indiani & O'Donnell, 
2006). The clamp loader complexes that loaded β-clamp onto DNA consists of two types of 
subunits γ and δ (Onrust et al., 1995). The gamma clamp-loader homodimer (Figure 1.12B) 
shows the gamma clamp-loader that contains of two types of subunits.  
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Figure 1.12.       The Crystal Structure of E. coli eta-clamp Protein (PDB code 3BEP).     
Panel A) shows the crystal structure of E. coli beta-clamp binding DNA using PyMole programme. 
The crystal structure of E. coli beta-clamp protein in the existing of DNA in the middle of the clamp.
Panel B) shows the gamma clamp-loader complex contains of two types of subunits. Panel C) shows 
the replication process of DNA polymerase III at a replication fork that explain the work of B-sliding 
Clamp at DNA replication. This pictures B and C were taken from Jeruzalmi, et al., 2001. 
A
c
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The powerful proteins that bind ATP and undergo substantial (but undefined) 
conformational change is γ subunits of the complex (Hingorani and O'Donnell, 1998; Naktinis 
et al., 1995). Ring opening requires the δ subunit wrench, which has affinity for the β subunit 
on its own (Naktinis et al., 1995). Figure 1.12C above shows the replication process of DNA 
polymerase III at a replication fork interacting with β-sliding Clamp.  
1.7.5.             Molecular Docking Programme. 
To conduct in-silico structural molecular docking programme there are a variety of programs 
and MOE is an example of a good accepted program with a broad range of features and free 
online resources (Molecular Operating Environment, 2013). The Molecular Operating 
Environment (MOE) is a global software system for science developed by Chemical 
Computing Group. Drug design is supported strongly by MOE programme through molecular 
stimulation, protein structure analysis, data processing of small molecular and docking study 
of protein and small molecules (Molecular Operating Environment Book, 2013).  
                  Use of MOE for molecular modelling allows researchers to view, display, analyse 
and interpret biomolecular data in a straightforward way by using interactive three-dimensional 
computer graphics tools (Roy & Luck, 2007). MOE can use Protein Data Bank (PDB) codes 
to generate the 3D structures of proteins to analyse (Molecular Operating Environment, 2013). 
Also databases containing large libraries of molecules can dock into the structure of proteins 
to determine the active side of the amino acid by using sophisticated programmes such as MOE 
using a number of docking algorithms. Public resources such as the ZINC database (Sterling 
& Irwin, 2015) and commercial websites such as Sigma-Aldrich are easily used and accessed 
for small molecule database to virtual screening.  
                    In MOE, to predict if there is a ligand conformation that binds to the target site of 
the structure of protein, several ligand orientations can be used by docking, which then allow 
docking of these ligands to be conducted. Strengths of association (binding affinities) between 
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a ligand and a receptor can be predicted using scoring functions, which suggest if the interaction 
will likely form a stable complex. This is also known as the S-value, which is similar to the 
change in free energy for a reaction (ΔG) (Stone, 2017). Figure 1.13 diagram shows the 
interaction between the docked molecule of 2-(Aminomethyl)imidazole as an example and 
amino acid Asp36 of LigA. 
1.8. Purpose of this Work. 
The work described in this thesis aims to bring together the main sections from this introduction 
to find out more about the kinetics and binding of LigA and LigB ligases from E.coli. 
Specifically: 
- To clone, express and purify native LigA and LigB. 
- To find the Vmax, Km and kcat at different conditions, including [nicked DNA], [NAD+], 
temperature, [NMN] and [NH4SO4]. 
- To find the Bmax and Kd of LigA and LigB for nicked DNA. 
- To investigate whether the E.coli β-clamp affects the rate of LigA ligation. 
The other main purpose of this thesis was to explore and develop a pipeline for discovering 
and testing novel inhibitors of bacterial ligases (specifically LigA from E.coli.) These aims 
were: 
- To use molecular docking software (MOE) to identify potential LigA binding compounds (in-
silico). 
- To use in vitro ligase inhibition assays (in vitro). 
-  To use in vivo Kirby-Bauer bacterial lawn inhibition for the growth of bacteria (in vivo). 
32 
Figure 1.13 This diagram shows the interaction between the docked molecule of 2-
(Aminomethyl)imidazole (cyan) as an example and amino acid Asp36 of LigA (PDB 2OWO) 
(the details in Chapter 5).  
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Chapter 2: Materials and Methods 
In this chapter, the key materials and methods used in this thesis will be described. Many of 
these methods, including cloning and expression, were taken from Sambrook & Russell (2001). 
Methods are included in the approximate order in which they were performed. Briefly these 
include electrophoresis, gene cloning, protein expression and purification, kinetic and binding 
assays, biophysical characterisation and molecular docking studies. Different chemicals,
laboratory materials and reagents were ordered from different scientific companies in UK such 
as Fisher Scientific (FS), Sigma Aldrich (SA), BioRad (BR), Qiagen (QG), Thermo-Scientific 
(TS), Life Technologies (LT) and New England Biolabs (NEB).
2.1. Electrophoresis Protocols. 
2.1.1. Agarose gel electrophoresis. 
Materials 
1- Agarose powder. Low EEO: 0.09-0.013. Lonza. 
2- 50× TAE stock: 2 M Tris-acetate, 100 mM EDTA. Used at 1× concentration. 
3- 4× agarose gel loading buffer: 40% (w/v) sucrose, 100 mM Tris-HCl (pH 7.2), 100 mM 
EDTA, bromophenol blue powder, completed with distilled water to desired volume. 
Used at 1× concentration. 
4- Ethidium bromide (EtBr) stain: 10 mg/ml stock solution in distilled water. Used at 0.5 
μg/ml concentration. 
5- SyBr stain, 10,000× stock. Molecular Probes. Used 1 µl per 10 ml distilled water. 
Method 
DNA fragments were separated according to size by gel electrophoresis using BioRad Sub-cell 
Submarine electrophoresis equipment. Three gram of agarose were added to 150 mL of 1× 
TAE buffer to prepare 2% (w/v) agarose gels and the mixture was boiled in a microwave until 
fully dissolved (~ two min). Once the solution had cooled, ethidium bromide was added to a 
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final concentration of 0.5 μg/ml, mixed by gentle agitation, and poured into the gel plate and 
then allowed to set completely for approximately 30 min. 1× TAE running buffer containing 
0.5 μg/ml ethidium bromides was added to the gels. The agarose gel loading buffer (1×) was 
added to the DNA samples and mixed well to load alongside the appropriate 500 bp DNA 
marker (NEB) , the gel was run for 1 hour and 30 min at 80 V (10 V/cm). Gels were imaged 
and photographed by using an ultraviolet light box (G-Box Syngene).
2.1.2. Native Polyacrylamide Gel Electrophoresis (N-PAGE). 
Materials 
1- Gel solution: 40% (w/v) Polyacrylamide (Acrylamide:Bis-Acrylamide (29:1)). Used at 
15% (w/v) concentration. National Diagnostics. 
2- Ammonium persulphate (APS): 20% (w/v). Used at 0.1% (w/v) concentration. Sigma. 
3- TEMED: 98% (v/v). Used at 0.1% (v/v) concentration. Fisher. 
4- 10× Native gel running buffer, TBE: 890 mM Tris-base (pH 8.3), 880 mM boric acid 
and 20 mM EDTA. Used at 2× concentration. 
5- 5× Native gel loading buffer: 40% (v/v) sucrose, 100mM Tris-HCl (pH 8.00), 100 mM 
EDTA, 0.4% (w/v) bromophenol blue, completed with distilled water to desired 
volume. Used at 1× concentration. 
Method 
Oligonucleotides DNA fragments were analysed using native PAGE (Non-denaturing 
polyacrylamide gels) at final concentration of 10-15% (w/v). As an example, to prepare a 15% 
(w/v) PA gel, 40% (w/v) gel solution was added into the 15% PAGE gel cassette including 
0.1% (w/v) APS, 1× TBE and last thing was added 0.1% (v/v) TEMED final concentration, 
inserting the well comb into the top of the cassette and setting aside for 20 minutes. The silicon 
gasket and clamps were taken away from cassette, and the cassette was put into the gel tank, 
and 2× TBE buffer was filled to the tank. The gel was pre-equilibrated for 15 min at 100 V at 
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room temperature after the well comb was taken away from the cassette. Different volumes of 
5× native gel loading buffer were added to 1× concentration to the DNA or RNA samples 
alongside the appropriate DNA marker without heating. The gels were run for about 90 minutes 
at 100 V at room temperature. N-PAGE gels were stained with SYBR Gold and visualised with 
a Fuji FLA-5000 fluorescence phosphorimager. Gels containing fluorescent oligonucleotides 
were analysed without additional staining. 
2.1.3. Denaturing Polyacrylamide Gel Electrophoresis. 
Materials 
1- Denaturing gel solution: 40 % (w/v) Polyacrylamide (Acrylamide:Bis-Acrylamide 
(19:1)). Used at 15% (w/v) concentration. National Diagnostics. 
2- Urea-diluent: 50% (w/v). Used at 26 % (w/v) concentration. 
3- APS: 20% (w/v) (Sigma). Used at 0.1% (w/v) concentration. 
4- TEMED: 98% (v/v) (Fisher). Used at 0.1% (v/v) concentration. 
5- 10× TBE-Urea: 890 mM Tris base pH 8.3, 880 mM boric acid, 20 mM EDTA and 25% 
urea (w/v). Used at 1 × concentration. 
6- 10× denaturing gel running buffer TBE: 890 mM Tris base, 880 mM boric acid and 20 
mM EDTA. Used at 1 × concentration. (EDTA buffer needs a NaOH (sodium 
hydroxide) about 20 g for 1 litter to dissolve completely till pH 8.00). 
7- 5× Denaturing gel loading buffer (stop buffer): Formamide (80% (w/v)), EDTA (10 
mM, pH 8.0), and NaOH (2 mM), bromophenolblue (0.04% (w/v). Used at 1× 
concentration. 
8- Fujifilm FLA-5000 phosphorimager. 
Method 
For denaturing gels, during the experiment of ligase reaction (time-course) 15% (w/v) of 
Polyacrylamide gels (19-1) was used to analyse single strands of Hex-labelled DNA. The size 
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of the gel used in this experiment was 45 cm long to give good resolution of band of the DNA. 
The equipment used was a SequiGEN GT 58 electrophoresis system (Bio-Rad) and set 
following the instruction of the kit. A gel (15% (w/v)) was prepared as above in clean beaker 
and injected into the base of the gel kit and then the comb (18 wells) was added and left till the 
gel completely set about 20 minutes. 
 The gel was pre-run using 1× TBE buffer for 1 hour at 50 W until the temperature of 
tank was at ~50 °C. The wells samples were rinsed by using syringe twice to make them clean 
and the DNA samples were about 10 µl that heated at 100 °C for 2 min prior to loading. The 
denaturing gel was run at 50 W for about 90 min within the samples of DNA. The gel was 
carefully taken away and passed to wet chromatography paper (3MM). For DNA substrates 
that contained a Hex-label, D-PAGE gels were visualised using a Fujifilm FLA-5000 
phosphorimager, using fluorescently labelled oligonucleotides. Image-J software was used to 
quantify reactions. 
2.1.4. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
Materials
1- Resolving gel: 30 % (w/v) Acrylamide plus 0.8% (w/v) Bis-Acrylamide. Used at 10% 
(w/v) concentration. National Diagnostics. 
2- Resolving buffer 4×: 1.5 M Tris-HCl (pH 8.8) and 0.4% (w/v) SDS. Used at 10% (w/v) 
concentration. National Diagnostics. 
3- Stacking gel: 30 % (w/v) Acrylamide plus 0.8% (w/v) Bis-Acrylamide. Used at 5% 
(w/v) concentration. National Diagnostics. 
4- Stacking buffer: 0.5 M Tris-HCl (pH 6.8) and 0.4% (w/v) SDS. Used at 5% (w/v) 
concentration. National Diagnostics. 
5- APS: 20% (w/v). Used at 0.1% (w/v) concentration. Sigma. 
6- TEMED: 98% (v/v). Used at 0.1% (v/v) concentration. Fisher. 
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7- 5× Running buffer of SDS PAGE: 125 mM Tris-HCl (pH 8.3), 125 mM Glycine, 
0.5% sodium dodecyl sulphate (SDS). Used at 1× concentration. 
8- 5× Loading buffer of SDS gel: 50 mM Tris-HCl (pH 6.8), 10 % Glycine, 2 % SDS, 0.1 
% bromophenol blue. Used at 1 × concentration. 
Method 
Samples of proteins were analysed to determine the purity of proteins using a 10% (w/v) 
resolving gel with a 5% (w/v) stacking gel. The kit of SDS gel (including tank, spacer and 
comb of a Bio-Rad Miniprotean) was washed using distal water before assembling together. A 
10% (w/v) resolving gel and 5% (v/v) stacking gel were prepared following the recipe above 
and poured into different beaker, excepting adding 0.1% (w/v) TEMED to the resolving gel in 
the end, and mixed for 20 seconds very well and then poured to the mini cassette 1.5 mm to 1 
cm below the depth of the inserted comb. To prevent oxygen from diffusing inside the gel, 100 
µl of butanol were added to the top of resolving gel.  
When the gel set completely (about 20 min), the butanol was poured out of the cassette 
and the exposed resolving gel top was washed with DW lots of the time. TEMED 0.1% (w/v) 
final concentration was added to the 5% (v/v) stacking gel and mixed for 20 seconds very well 
and then poured on top of the resolving gel, which is set completely in the first step, and the  
comb (10-wells) was added. Once the stacking gel set completely ~20 min, the complex gel 
cassette was putting to gather on the tank. The comb was removed and 1× running buffer of 
SDS gel was added to both side of the chamber covered the top of the cassette in the middle of 
the tank.  
Prior to heating protein samples, ~10 μl of stock β-mercaptoethanol was added to a 1.5 
ml SDS loading buffer. Samples (~20 µl) were prepared and heated to 95 °C for two min in 
100 µl SDS gel-loading buffer (1×) for analysing and testing proteins on SDS PAGE. Heated 
samples were cooled on ice and then loaded onto the SDS PAGE gel and were electrophoresed 
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in SDS Tris-Glycine running buffer. Gels were run at 80 V (i.e. 8 V/cm) until the dye arrived 
to the resolving gel border, and then voltage increased to 150 V. Protein gel were washed twice 
time by DW and heated using microwave for 2 min to get rid of the SDS buffer. The gel was 
stained with protein Safe-stain (Fisher) using microwave, but before reach to boiling point and 
washed again with DW few times and then distained use microwave again. Then left in a 
staining tray containing DW overnight and visualised using white light transillumination (G-
BOX).
2.1.5. Spectrophotometry. 
Ultraviolet light spectroscopy was used to determine the concentration of oligonucleotides, 
PCR fragments, plasmids and protein molecules. DNAs and proteins molecules in this research 
were determined at 260 nm and 280 nm wavelengths respectively. The instrument used was a 
Nanoodrop 2000c UV Spectrophotometer. This was calibrated and blanked using a buffer-
matched solution containing no DNA or protein and then the absorption of light between 220 
and 380 nm was measured through the sample containing DNA or protein. There were different 
settings in this instrument for measuring dsDNA, ssDNA and oligonucleotides. 
DNA concentrations were given in ng/μl, and proteins concentrations were given in 
mg/ml. Those were converted to molar concentrations (such as nM or mM) via molecular mass. 
To measure the cell density when growing E. coli cultures, visible light spectroscopy was used 
to determine the optical density at 600 nm (OD600) of bacterial cell cultures using a CO8000 
Cell Density Meter. 
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2.2. Purification Protocols.  
2.2.1. Overview of LigA and LigB purification. 
This flow diagram below (Figure 2.1) shows how the work on cloning, expression and 
purification of ligases was done. 
Figure 2.1 Flowchart of ligase cloning, expression and purification strategy each box above 
was explained in details down. 
Sending for sequencing, checking the sequence of native LigA and LigB, 
plus LigB His-tag. 
Order PCR primers for 
obtaining LigA and LigB 
genes direct from E.coli
genome using Phusion and 
Taq polymerases. (Not taken 
further).
Order gene sequences of native LigA 
and LigB, for direct cloning. From 
GeneArt. 
Cloning into pET29c and pET28b 
using NdeI and BamHI enzymes, 
dephosphorylation of synthesised 
gene, ligation.  
Transformation into competent cells, growing in kanamycin plates. Cloning 
and colony PCR to identify recombinants.
Mini-inductions of LigA and LigB, grown to 0.6 OD, added 1 mM IPTG. 
Tested on SDS gels for induction of proteins.
See 
Appendix 2 
for LigA 
and LigB 
DNA and 
protein seq.  
Obtain gene sequence of DNA E. coli Ligase A and Ligase B (NCBI)
See Appendix 2 for pET29c and 
pET28b sequences and map. 
Main-inductions of LigA and LigB, to express proteins, as above. Harvested,
sonicated and spun. Test sonication condition, test sonicate and test 
solubility in 300 mM NaCl, test Triton 0.1x, test concentrating. 
Soluble, Ammonium sulphate, functional Ligase. Purify by HPLC (DEAD, 
heparin, HiTrap F.F. and size exclusion column) and ligase experiment for 
each proteins. 
See Appendix 3 
for correct 
sequencing of 
LigA, LigB and 
LigB-His-tag. 
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2.2.2. Initial cloning of LigA and LigB genes by PCR from E.coli genomic DNA. 
Materials 
1- 20 units of Phusion enzyme (NEB). 
2- Template DNA of E coli K12. 
3- Forward and reverse primers of LigA and LigB:  
LigA TOP 5- ATGGAATCAATCGAACAACAACTGACAGAA 
LigA BOT 5- TCAGCTACCCAGCAAACGCAGCATTTCCGC 
LigB TOP 5- ATGAAAGTATGGATGGCGATATTAATAGGT  
LigB BOT 5- CTAAGGTTCAAAACCTGTGATCTGCTGGGC 
4- 1 µM of dNTPs. 
5- Free water to complete the volume of reaction till 50 µl. 
Method  
The complete coding sequence of the open reading frame of Ligase A and B of E. coli DNA ligases 
were obtained from the NCBI database. For LigA the gene code was 946885 and for LigB 948164. 
PCR primer pairs (30 bases) were designed to amplify the LigA or LigB genes directly. Standard 
PCR reactions of 25 cycles of  99°C denaturing stage for 30 seconds, a 65°C annealing stage for 
30 seconds, and a 72°C elongating step for 90 seconds were carried out on E. coli K12 using 0.5 
μL Phusion enzyme or Taq enzyme. PCR reaction products were monitored by 1% agarose gel. 
2.2.3. Transformation of Plasmids. 
Materials  
1. Competent cells: E. coli BL21 (DE3) (NEB). 
2. Plasmids:  pET-29c and pET-28b. At 200 ng/µl. Plasmids sequences are given in the 
appendix 1. 
3. SOC Stable Outgrowth Medium (NEB) B9035S). 
4. LB Miller agar plates (Fisher Scientific): 15 g Agar, 10 g Tryptone, 5 g Yeast extract 
and 10 g sodium chloride, completed with to 500 ml with distilled water and autoclave 
sterilised instantly.  When the bottle of LB agar cooled to be warm to touch, 50 μg/ml 
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of kanamycin was added, which was the convenient antibiotic for pET-29c. The agar 
was poured into plastic petri dishes to about 5 mm in depth. Once the plates set nicely 
then were stored at 4°C in cold room for a maximum one month. 
Method
Plasmids ~20-100 ng of pET-29c or pET-28b were transferred into tubes containing 50 μl of 
competent BL21 (DE3) (NEB) cells. The mixtures were incubated on ice for half an hour. They 
were transferred to a heat block at 42°C for exactly half a minute, and then left them on ice for 
2 minutes. SOC outgrowth medium (1 mL) was added to each tube of the mixture and they 
incubated at 37°C for 1 hour. ~50 µl of growth mixture was then spread onto a LB agar plate 
containing 50 μg/ml kanamycin and grown overnight at 37°C. The full DNA sequence of pET-
29c or pET-28b is given in Appendix 2.5 and 2.6. 
2.2.4. DNA Extraction (Qiagen purification). 
Materials 
1- LB broth (Fisher Scientific): 10 g Tryptone, 5 g Yeast extract and 10 g sodium chloride, 
completed up with distilled water to the desired volume and autoclaved instantly.   
2- Kanamycin: 10 mg/ml stock solution. Filter sterilised immediately. Sigma. 
3- QIAGEN Kit for Miniprep (Fisher Scientific). 
Method 
A 37°C overnight incubation of 3 mL of LB media with the appropriate antibiotic was 
inoculated with a single plate colony of cells containing plasmid. The following morning 1 mL 
of the culture was centrifuged at 15000× g for 5 minutes. The supernatant was discarded and 
the cell pellet was re-suspended in 250 μl Buffer P1 and transferred to a micro centrifuge tube 
(Ensure that RNase A has been added to Buffer P1). After suspension of the pellet, 250 μl 
Buffer P2 was added and gently inverted the tube 46 times to mix until the solution became
viscous and slightly clear. Buffer N3 (350 μl) was added to the tube and immediately mixed 
42 
and inverted the tube 46 times. The tube mixture was centrifuged for 10 min at 13,000 rpm. 
The supernatants from the last step were applied to the QIAprep spin column by decanting or 
Pipetting and then QIAprep spin column was spun for 30-60 second and the flow-through was 
discarded. 
  The QIAprep spin column was washed by adding 0.5 ml Buffer PB and was spun for 
60 seconds and the flow-through was discarded. The QIAprep spin column also was washed 
by adding 0.75 ml Buffer PE and spun for 60 second and the flow-through was discarded.  
The QIAprep spin column was placed in a clean 1.5 ml microcentrifuge tube and 50 µl of 
Elution buffer was added to elute the plasmid (DNA). The concentration of plasmid DNA was 
determined by spectrophotometry at 260 nm using a Nanodrop ND-2000C and a sample tested 
on 1% agarose gel. 
2.2.5. Obtaining LigA and LigB Genes by Commercial Synthesis (GeneArt). 
To save time, the complete coding sequence of the open reading frame of LigA and LigB genes 
of E.coli DNA ligases were synthesised using GeneArt (Life Technology). These came as 
double-stranded DNA. They each had an NdeI site at either end or only for LigB His-tag had 
an NdeI and BamHI site, so that they could be cloned directly into the NdeI site of pET-29c or 
into NdeI and BamHI of pET-28b for LigB His-tag. The NdeI site is shown within each primer 
as a CATATG site for native LigA and LigB, whereas the NdeI and BamHI are shown within 
each primer as a CATATG and GGATCC sites only for LigB His-tag. The full DNA sequence 
and protein sequence of native LigA and LigB are given in Appendix 2.1, 2.2, 2.3 and 2.4.
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2.2.6. DNA Restriction Enzyme Digests. 
Materials 
1- DNA substrate: ~ 500 ng of LigA, LigB (Gene Art Synthesis) pET-29c or pET-28b 
vectors. 
2-  Restriction enzymes: ~ 20 units of NdeI enzyme (NEB). 
3- Restriction enzymes: ~ 20 units of BamHI enzyme (NEB) for LigB His-tag. 
4- 1× Restriction digest buffer (NEB) for each enzyme. 
5- Shrimp Alkaline Phosphatase (SAP) ~ 10 units/reaction. 
6- 1× Shrimp Alkaline Phosphatase buffer. 
7- Free water to complete the volume of reaction. 
Method 
LigA and LigB (~500 ng each) were each digested with NdeI and with NdeI/BamHI for LigB 
His-tag at 37°C for 2 hrs. The enzymes were then denatured by heating to 65°C for 5 min and 
the DNA precipitated by ethanol precipitation (see next section). They were re-suspended in 
nuclease-free water and the concentration calculated by spectrophotometry (260 nm) using a 
NanoDrop-2000c. 
Suitable vectors for expression were kindly supplied by Dr Andy Pickford and Prof. Collayhan, 
University of Portsmouth. Fresh pET-29c and pET-28b plasmids miniprep were prepared 
(Qiagen kit) as above and a sample (1 μg) was digested with NdeI and BamHI enzymes, 
respectively, then dephosphorylated using 10 units Shrimp Alkaline Phosphatase (SAP) at 
37°C for 30 minutes for each sample. The enzymes and SAP were removed by heating and 
ethanol precipitation. Samples (100 ng) of the uncut and NdeI/BamHI-cut genes were run on 
1% agarose gels to observe them. 
2.2.7. Ethanol Precipitation. 
Materials
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1- DNA substrate: ~ 500 ng of NdeI cut of LigA and LigB (Gene Art Synthesis), 
NdeI/BamHI cut LigB his-tag, NdeI cut of pET29c and NdeI/BamHI cut of pET28b 
vectors.  
2- 3 M (NaOAc) sodium acetate or 10 M of ammonium acetate. 
3- 100% and 70% ethanol. 
Method 
Alcohol precipitation was used to desalt, purify and concentrate plasmid DNA. A volume of 
DNA in solution was measured and 0.1 equivalent volumes of 3 M sodium  acetate was added, 
followed by 2 total equivalent volumes of ice-cold 100% (v/v) ethanol. The solution was mixed 
and placed in a freezer -28 0C for 60 min (or overnight). Precipitated DNA was pelleted in an 
Eppendorf cooled-rotor centrifuge for 60 min at 13,000 rpm. The supernatant was removed and 
3 volumes of ice-cold 70% (v/v) ethanol were added to remove the salt. DNA was centrifuged 
again for 30 min and the alcohol removed. The pellet was allowed to air dry until any remaining 
solvent had evaporated and then re-suspended by elution buffer. The concentration of all DNA 
samples were checked using a Nanodrop 2000-c spectrophotometer. 
2.2.8.  Ligation into pET29c or pET28b. 
Materials 
1- Ligase genes: ~500 ng of NdeI cut LigA or LigB (from GeneArt Synthesis). ~500 ng 
of NdeI and BamHI cut LigB His-tag (from GeneArt Synthesis).These were the three 
genes to be cloned. Cloning plasmids: ~500 ng of pET-29c cut with NdeI only (for 
native LigA). ~500 ng of pET-29c cut with NdeI only (for native LigB). ~500 ng of 
pET-28b cut with NdeI and BamHI (for His-tag LigB), the ration of DNAs was 1:1.  
2- Competent cell of E. coli: 50 µl of 10-Beta cells (NEB). 
3- 2× NEB Instant Sticky ligation Mix. 
4- SOC Outgrowth Medium (NEB). 
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5- LB Miller agar plates (Fisher Scientific): 15 g Agar, 10 g Tryptone, 5 g Yeast extract 
and 10 g sodium chloride, completed up with distilled water to the desired volume and 
autoclave sterilised immediately. Kanamycin (50 μg/ml) was added, which was the 
convenient antibiotic for pET29c. The agar was poured into plastic petri plates about 5 
mm in depth under the circumstance sterilization. Once the plates set nicely then were 
stored at 4 °C in cold room for a maximum one month. 
Method 
The NdeI-cut LigA and LigB genes, and NdeI and BamHI cut of LigB with His-tag (from 
GeneArt) were each ligated into NdeI/SAP-treated pET29c and NdeI-BamHI/SAP-treated 
pET28b, respectively. A ratio of 1:20 (insert: vector) was used (5 μL), with 5 μL of 2× NEB 
Instant Sticky ligation Mix. The pET29c-LigA/LigB and pET28b-LigB His-tag ligation 
mixtures were incubated on ice with competent E. coli 10-Beta cells (NEB) for 20 minutes, 
heat-shocked at 42°C for 30 seconds to facilitate plasmid uptake by the cells, and incubated at 
37°C for one hour to recover. They were then plated onto agar plates containing kanamycin 
(50 µg/ml) and incubated overnight at 37°C until colonies grew. Figure 2.2 shows the brief 
summary of the ligation and cloning of native LigA and LigB in pET29c or pET28b plasmids. 
2.2.9.      Colony PCR. 
Materials  
1. Forward and reverse primers (1 µM) for pET-29c. Sequences of 30 base primers were: 
Top: 5-TGATGCCGGCCACGATGCGTCCGGCGTAGA 
Bot: 5-GGTACCCAGATCTGGGCTGTCCATGTGCTG 
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2. Forward and reverse primers (1 µM) for pET-28b. Sequences of 30 base primers were: 
Top 5-TGATGCCGGCCACGATGCGTCCGGCGTAGA  
Bot 5-CTTGTCGACGGAGCTCGAATTCGGATCCCG  
3. 2× Taq Master Mix enzymes (NEB). 
4. Single colony of transformed Beta-10 cells.  
5.  Free water to complete the volume of reaction to 50 µl. 
Method 
Rather than sending many colonies for sequencing, colony-PCR was carried out on 30 of the 
kanamycin-resistant colonies that grew, to identify bacteria that had a recombinant LigA or 
LigB gene. For these 50 μl PCR reactions, 25 µl of Taq Master Mix (NEB) was used, with a 
PCR primer pair that amplified the part of pET-29c and pET-28b either side of the cloned gene.  
2.2.10.      DNA sequencing. 
Materials 
1- 100 ng of recombinant LigA and LigB plasmids. 
2- Forward and reverse primers (10 µM) for pET-29c. Sequences of 30 base primers were:  
Top: 5-TGATGCCGGCCACGATGCGTCCGGCGTAGA 
Bot: 5-GGTACCCAGATCTGGGCTGTCCATGTGCTG 
3. Forward and reverse primers (10 µM) for pET-28b. Sequences of 30 base primers were: 
Top 5-TGATGCCGGCCACGATGCGTCCGGCGTAGA  
Bot 5-CTTGTCGACGGAGCTCGAATTCGGATCCCG 
Method 
Plasmids minipreps (from 2.2.4) were made from 5 ml overnight cultures of E. coli Beta-10 
bacteria containing either recombinant pET-29c LigA, pET-29c LigB or pET-28b LigB His-
tag. A sample (100 ng) of each plasmid was sent for DNA sequencing (Beckman Coulter/ 
Genewiz). The sequencing primers were the same as those used for colony-PCR, and were used 
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separately to sequence the Top (upper) and Bot (lower) strands of the recombinant LigA, LigB 
and LigB His-tag genes. Sequencing data were opened in Chromas 2.0 software and the DNA 
sequence checked by base manually.  
2.2.11.       Cell Culture Optical Density. 
Materials 
1- Cell density meter (CO8000 Cell Density Meter). 
2- 1 ml plastic cuvettes. 
Method 
The optical density of cell cultures was measured by visual (600 nm) light spectrophotometry. 
A cell density meter was initially blanked using reference sample of cell media in a 
polypropylene cuvette. An inoculated sample was then measured using the optical density via 
press reading button and then the results were given in absorbance units.  The instruments was 
used and maintained according to the manufacturers recommendations. 
2.2.12.     Mini Inductions of LigA and LigB.  
Materials 
1- LB Miller agar plates (500 ml): 15 g agar, 10 g tryptone, 5 g yeast extract and 10 g 
sodium chloride, completed up with distilled water to the desired volume and autoclave 
sterilised instantly. Plates were poured and contained 50 µg/ml kanamycin. Fisher 
Scientific. 
2- LB Broth (500 ml): 10 g tryptone, 5 g yeast extract and 10 g sodium chloride, completed 
up with distilled water to the desired volume and autoclaved instantly. When cooled, 
kanamycin was added to 50 µg/ml.  Fisher Scientific. 
3- Isopropyl β-D-1-thiogalactopyranoside (IPTG): 1 M was prepared and filter sterilised 
immediately. 
4- Competent cell: E. coli BL21 (DE3). NEB. 
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5- Antibiotic: kanamycin 10 mg/ml, stock solution were filter sterilised immediately. 
Sigma.
6- Protein marker (Blue Protein Standard, Broad Range). NEB.
7- Commercial LigA (1 U/µl). NEB.
Method 
A small-scale protein expression trial of E. coli BL21 (DE3) containing either pET-29c LigA, 
pET-29c LigB or pET-28b LigB His-tag construct were conducted. A small amount (2 ng) of 
the LigA or LigB plasmids were transformed into competent cells of E. coli BL21 (DE3) (NEB) 
and incubated at 37°C for one hour in an orbital shaker. They were plated onto an agar plate 
containing 50 μg/mL of kanamycin and incubated overnight at 37°C. A single colony was 
picked and added to 1 mL LB broth with 50 μg/mL kanamycin at 37°C overnight with shaking. 
A 50 μL aliquot of overnight culture was added to 5 mL LB broth containing kanamycin.
 The bacterial samples were cultured until an optical density at 600 nm (OD600) of 0.6 
was reached (approximately 2 hours). Protein expression was then induced with 1 mM IPTG 
and cells grown at 37°C with shaking until 3 hours after the induction and samples of pre- and 
post-IPTG induction were taken at regular time points. Samples of pre- and post-IPTG 
induction were run on a 10% SDS-PAGE with both a protein marker and also a separate sample 
(1 U) of commercially-available LigA from NEB as a size guide. 
2.2.13.     Testing the Solubility of Native LigB.
Materials 
1- LB broth (Fisher Scientific): 10 g Tryptone, 5 g Yeast extract and 10 g sodium chloride, 
completed up with distilled water to the desired volume and autoclaved instantly.   
2- Kanamycin: 10 mg/ml stock solution. Filter sterilised immediately. Sigma. 
3- Isopropyl β-D-1-thiogalactopyranoside (IPTG): 1 M was prepared and filter sterilised1 
immediately. 
4- Benzamidine and PMSF 100 mM stock. Used at 10 mM. 
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5- Protease inhibitor. Used at each 2 g of pellet in 100 µl cocktail proteases. 
6- Resuspension buffer (Sodium phosphate Mon. and Di. (pH 7.0)) 100 mM stock buffer. 
Used at 10 mM and completed up to the desired volume with distilled water, filter 
sterilised and vacuum degassed for 20 min. 
Method 
A 5 mL aliquot of an overnight bacterial culture of recombinant LigB protein was added to 500 
mL LB broth containing kanamycin, in an orbital shaker at 37°C until an optical density 
(OD600) of 0.6 was reached. Protein expression was then induced with 1 mM IPTG and cultures 
were incubated at 37°C until an OD600 of approximately 2.0 was reached (typically 3 hours). 
Bacteria cultures were harvested by centrifugation (6000 rpm, 20 minutes, 4°C) in a Beckman 
Coulter Avanti J-20XP refrigerated centrifuge using a JLA 8.1000 rotor, and the supernatant 
(media) was discarded. The pellets were resuspended in 10 ml of sodium phosphate buffer pH 
7.0 containing protease inhibitors (benzamidine, PMSF and cocktail proteases). A test of how 
much sonication was needed was carried out by sonicating (Fisher Scientific) the 10 ml sample 
on ice first for 1 min (a total of six 10 second pulses, with five 10 seconds pauses). At this point 
a 25 µl sample of sonicate was taken for loading on to an SDS gel. The same 10 ml sample was 
sonicated in the same way at 1 min intervals for a total for 5 min. Also, for the 5 min sonicated 
sample, this was spun down by centrifugation at 18000 rpm for 20 minutes and a sample of the 
supernatant and the cell pellet (debris) prepared in SDS buffer.  
2.2.14.    Testing the Solubility of Expressed LigB Protein in NaCl and TritonX-100. 
Materials 
1- LB broth (Fisher Scientific): 10 g Tryptone, 5 g Yeast extract and 10 g sodium chloride, 
completed up with distilled water to the desired volume and autoclaved instantly.   
2- Kanamycin: 10 mg/ml stock solution. Filter sterilised immediately. Sigma. 
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3- Isopropyl β-D-1-thiogalactopyranoside (IPTG): 1 M was prepared and filter sterilised 
immediately. 
4-  Benzamidine and PMSF 100 mM stock. Used at 10 mM. 
5-  Protease inhibitor. Used at each 2 g of pellet in 100 µl cocktail proteases.  
6-  Resuspension buffer (Sodium phosphate Mon. and Di. (pH 7.0)) 100 mM stock buffer. 
Used at 10 mM and completed up to the desired volume with distilled water, filter 
sterilised and vacuum degassed for 20 min. 
7-  NaCl 5 M stock. Used at 150 and 300 mM. 
8-  TritonX-100. Used at 0.1%. 
Method
As a result of finding that the expressed LigB protein was mainly insoluble, an experiment to 
test if the protein could be re-solubilised in either NaCl or with a small amount of TritonX-100 
detergent was tried. A sample (10 ml) of resuspended LigB cell pellet with inhibitors from a 
500 ml induction was sonicated on ice for a total of 5 minutes (with 10 second pauses between 
10 second pulses), to ensure that the pellet was completely disrupted as much as possible. A 
third of this (3.3 ml) was kept (0 mM NaCl). Another third was mixed with 150 mM NaCl and 
the other third was mixed with 300 mM NaCl. Each third (3.3 ml) was left at room temperature 
for 30 minutes, to allow any soluble protein to leave the pellet.  
The 150 mM and 300 mM NaCl samples were then split in two (1.7 ml each) and 0.1% (v/v) 
TritonX-100 added to one of the two 1.7 ml samples. These two samples (containing 150 or 
300 mM NaCl plus 0.1% TritonX-100) were mixed and left at room temperature for 45 
minutes. All five samples were spun at 18000 RCF for 15 minutes to separate the supernatant 
from the cell debris. This gave a total of 10 samples (supernatant and debris from each 
condition). An aliquot of 25 µl of each sample was loaded on a 10% SDS-PAGE gel. 
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2.2.15.      LigB Refolding Experiment. 
Materials 
1- Urea powder (reagent grade). Used at 8, 6, 3 and 1.5 M concentrations. 
2- Guanidine hydrochloride powder. Used at 0.25 M. 
3- Tris-HCL buffer at different pHs. Used at 8.6, 8.0, 7.2 and 7.0. 
4- Dithiothreitol (DTT) 1M stock. Used at 20 mM.  
5-  Mg+2 1 M stock. Used at 10 mM. 
6-  ZnCl2 1 M stock. Used at different concentrations. 
7- Cystamine dihydrochloride 1 M. used at 20 mM. 
8-  2-hydroxyethyl-disulfide 8 M. Used at 1 mM.  
9- Β-mercaptoethanol 14 M. Used at 5 mM. 
10-   NaCl 1 M: used at 0.15 M. 
11-  Dialysis materials. Lab stirrer and dialysis membrane (SpectraPor MWCO 6-8 KDa).  
12-  Resuspension buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 100 mM 
stock buffer. Used at 10 mM and completed up to the desired volume with distilled 
water, filter sterilised and vacuum degassed for 20 min. 
13- Solubilisation buffer I (SBI): 1 L beaker of 8 M urea, 0.25 M GdmCl, 50 µM ZnCl2
and 20 mM Tris-HCl pH 8.6 with addition of 20 mM of fresh DDT. 
14-  Solubilisation Buffer (SBII): 1 L beaker of 50 mM Tris-HCl pH 8.0, 6 M urea, 10 mM 
Mg+2, 0.1 mM ZnCl2, 20 mM cystamine dihydrochloride and 20 mM DDT 
15-  Buffer SBIII: 1 L beaker of 50 mM Tris-HCl pH 8.0, 3.5 M urea, 10 mM Mg+2, 0.1 
mM ZnCl2, 5 mM B-ME and 1 mM 2-hydroxyethyl-disulfide. 
16-  Buffer SBIV: 1 L beaker of 50 mM Tris-HCl pH 7.2, 1.5 M urea, 10 mM Mg+2, 0.1 
mM ZnCl2 and 0.15 M NaCl. 
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17-  Buffer SBV: 1 L beaker of 50 mM Tris-HCl pH 7.2, 10 mM Mg+2, 0.1 mM ZnCl2, 
0.15 M NaCl. 
Method 
A fresh 500 ml LigB induction was centrifuged, resuspended in 10 ml resuspension buffer and 
sonicated for 5 min. the sonicate was spun at 18000 RPM for 15 minutes to separate the 
supernatant from the pellet. The final pellet that had insoluble protein of LigB was resuspended 
in 20 ml solubilisation buffer I (SBI). This solution was mixed very well and stirred at 4°C in 
a cold room overnight. The solubilised inclusion body cell suspension was centrifuged at 18000 
rpm for 30 min at 4°C and the clear supernatant was kept in a fridge. The protein concentration 
of supernatant at 280 nm was measured by spectrophotometry on a Nanodrop ND-2000c. 
Buffer SBII was then used to dilute the supernatant to 0.2 mg/ml and subjected to serial 
overnight dialysis. SpectraPor molecular porous membrane (MW cut off: 6-8 KDa) was used 
to dialyse 15 ml of the 0.2 mg/ml supernatant into buffer SBIII in a 1 L beaker and then stirred 
overnight at 4°C in cold room. After overnight stirring, buffer SBIII was changed to 1 L of 
buffer SBIV. Finally, buffer SBIV was changed to 1 L of buffer SBV.  A sample of the refolded 
native LigB protein (25 µl) was run on 10% SDS-PAGE gel.   
2.2.16.      Main Inductions of LigA and LigB. 
Materials 
1. LB Miller agar plate: 15 g agar, 10 g tryptone, 5 g yeast extract and 10 g sodium 
chloride, completed with distilled water to the desired volume and autoclaved sterilised 
instantly. Fisher Scientific. 
2. LB Broth: 10 g tryptone, 5 g yeast extract and 10 g sodium chloride, completed up with 
distilled water to the desired volume and autoclaved instantly. Fisher Scientific. 
3. Isopropyl β-D-1-thiogalactopyranoside (IPTG): 1 M was prepared and filter sterilised 
immediately and kept at 4°C. 
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4. Competent cells: E. coli BL21 (DE3). NEB. 
5. Kanamycin: 10 mg/ml stock solution. Filter sterilised immediately. Sigma. 
6 Resuspension buffer1: sodium phosphate (mono and diphosphate, pH 7.0) at 100 mM 
stock buffer. Used at 10 mM and completed up to the desired volume with distilled 
water. 
7 Resuspension buffer2: 50 mM Tris-HCL, pH 7.2, 0.5 M NaCl and 0.1% (v/v) Triton 
X-100. Completed up to the desired volume with distilled water. 
8 NaCl 5 M stock. Used at 1 M. 
9 Benzamidine and PMSF, 100 mM stock. Used at 10 mM. 
10  Protease inhibitor, 1 ml tube. Used at 100 µl for each 10 g of cell pellet.  
11 Column binding buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 100 mM 
stock buffer. Used at 10 mM and completed up to the desired volume with distilled 
water. 
12 Dialysis materials. Lab stirrer and dialysis membrane (SpectraPor MWCO 6-8 KDa). 
Method 
All E. coli cultures were grown in LB media containing kanamycin at 50 μg/ml. The pET29c 
LigA, LigB or pET28b LigB His-tag plasmids were transformed into competent cells of E. coli
BL21 (DE3) on ice for 30 min and heating shock for 10 seconds and then incubated at 37°C 
for one hour in an orbital shaker. They were plated onto an agar plate containing 50 μg/mL of 
kanamycin and incubated overnight at 37°C. A single colony was picked and added to 5 mL 
LB broth with 50 μg/mL kanamycin at 37°C overnight with shaking. A sample (1 mL) aliquot 
of the overnight bacterial culture of either recombinant LigA or LigB protein was added to 500 
mL LB broth containing kanamycin, in an orbital shaker at 37°C until an optical density 
(OD600) of 0.6 was reached. Protein expression was then induced with 1 mM IPTG and the 
cultures were incubated at 37°C until an OD up to 1.50 (typically 3h.).  
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Bacteria cultures were harvested by centrifugation (6000 rpm, 20 minutes, 4°C) in a 
Beckman Coulter Avanti J-20XP refrigerated centrifuge using a JLA 8.1000 rotor, and the 
supernatant (media) was discarded. The cell pellets were re-suspended in 20 ml lysis buffer (10 
mM sodium phosphate, pH: 7.0) containing protease inhibitors (cocktail protease, 
Benzamidine and PMSF). Cells were lysed by sonicating for 5 minutes and spun down by 
centrifugation at 18000 rpm for 20 minutes and separated to supernatant and cell pellet (debris) 
(soluble and insoluble fractions).
Because the expressed LigB (also LigB His-tag) was totally insoluble in the supernatant 
using this method, it was induced and purified with different conditions to LigA above. For 
LigB, 1 mL aliquot of the overnight bacterial culture of recombinant LigB protein was added 
to 500 mL LB broth containing kanamycin, in an orbital shaker at 37°C until an optical density 
(OD600) of 0.6 was reached. Protein expression was then induced with 2 mM IPTG and cultures 
were incubated at 17°C until up to OD 1.50 overnight, only for LigB His-tag before adding the 
IPTG the culture was added on ice for ~20 min. The pellets of cultures were re-suspended in 
15 ml of 50 mM resuspension buffer 2 containing protease inhibitors (cocktail protease, 
Benzamidine and PMSF). The lysate was sonicated for 5 minutes and spun down by 
centrifugation at 18000 rpm for 20 minutes and separated to supernatant and cell pellet (debris). 
This method, using 2 mM IPTG and growth at 17°C, did provide a low concentration of soluble 
LigB.  
The soluble native LigA and LigB (and His-tag LigB) fractions were then purified using the 
same following techniques. The first step was preventing protein-DNA interactions by adding 
NaCl to final concentration of 1 M. the second step was to precipitate LigA or LigB by 
ammonium sulphate fraction. All steps were performed at 4°C. For step 1, NaCl 1 M was added 
to the clarified lysate to remove the DNA and RNA from the proteins. For step 2, they were 
then made up to 40% (w/v) (NH4)2SO4 by gradual addition of the solid with slowly mixing at 
55 
4°C for 2 hours to precipitate the proteins. The samples were centrifuged at 18000 rpm for 20 
minutes and then the supernatant was discarded, and the pellet (containing the precipitated 
proteins) re-suspended in the appropriate volume of column binding buffer (usually about 1-2 
ml). The samples (which still contained NaCl and (NH4)2SO4) were then dialysed via 
membrane dialysis overnight in column binding buffer. For soluble native LigA not all the 
previous purification steps were used with all the purified protein of LigA.   
2.2.17.      LigA Purification Strategy 1. 
Materials 
1. HiTrap Heparin-Sepharose affinity chromatography column, 5 ml (GE Healthcare).   
This is for purifying DNA binding protein and is based on cross-linked agarose. 
2. HiTrap Q-Sepharose Fast Flow (FF) chromatography column, 5ml (GE Healthcare). 
This is a strong anion exchange resin, cross-linked agarose  
3. Size exclusion column 120 ml, HiprepTM 16/60 SepharcrylTM S-300 HR (GE 
Healthcare). 
4. Column binding buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM, 
filter sterilised and vacuum degassed for 20 min. 
5.  Column elution buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM 
plus 1 M NaCl, filter sterilised and vacuum degassed for 20 min. 
6. AKTA Basic HPLC Chromatography instrument. GE Healthcare Ltd. 
7. Ethanol 20%: completed with distilled water, filter sterilised and vacuum degassed for 
20 min. 
8. Distilled water, filter sterilised and vacuum degassed for 20 min. 
9.   Spin column. Membrane Vivaspin 20 5-20 ml samples MWCO 30,000. Sartorius (Lab 
Technology). 
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10.  Ligase storage buffer: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM 
NAD+, 50 μg/ml BSA and 30% (v/v) glycerol. 
Method 
In this method native LigA was purified by HiTrap Heparin-Sepharose affinity, HiTrap Q-
Sepharose Fast Flow (FF) and size exclusion columns. All the steps were done at 4°C in a cold-
room or at room temperature. Five column volumes of degassed distilled water was run to pre-
equilibrate a 5 ml heparin column and then five column volumes of column binding buffer 
were run through. The soluble native LigA (1-2 ml) was loaded into a clean 15 ml glass 
superloop. The LigA was injected in column binding buffer on to the heparin column. LigA 
protein was eluted using column elution buffer during a 0-100% gradient for 40 min and 
fractions of 1 ml were collected.  
Once the purification of protein finished, minimum five column volumes of distilled 
water was used to wash the heparin column and then followed with minimum five column 
volume of 20% ethanol for storage. An SDS-PAGE gel (section 2.1.4) was used to test each 
peak separately for proteins and any fractions containing the desired native LigA protein 
(depending on the molecular weight) were taken and stored at 4°C. The most pure fractions 
(about 2 ml) were added together and concentrated by a spin column till ~1 ml and then dialysed 
back into column binding buffer.  
The dialysed soluble protein of LigA ~1 ml was injected in column binding buffer on to the 
HiTrap column (F.F.). LigA protein was eluted using column elution buffer during a 0-100% 
gradient for 40 min and fractions of 1 ml were collected. Once the purification of protein 
finished, minimum five column volumes of distilled water was used to wash the HiTrap column 
(F.F.) and then followed with minimum five column volume of 20% ethanol for storage. An 
SDS-PAGE gel (section 2.1.4) was used to test each peak separately for proteins and any 
fractions containing the desired native LigA protein (depending on the molecular weight) were 
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taken and stored at 4°C. The most pure fractions (about 2 ml) were added together and 
concentrated by a spin column till ~1 ml and then dialysed back into column binding buffer.     
The dialysed soluble protein of LigA was added together and ~2 ml were injected into 
the plastic superloop and purified via using size exclusion column 20 ml (GE Healthcare) on 
AKTA basis machine. All the steps were done at room temperature. Minimum one column 
volumes of distilled water was run to pre-equilibrated the column and then one column volumes 
of binding buffer (A). The samples were injected in the loop and the buffer that used for running 
the purification was column binding buffer by one and a half column volumes to resolve and 
elute the protein. Once the purification of protein finished, minimum one column volumes of 
distilled water was used to wash the column and then followed with one column volume of 
20% ethanol for storage. An SDS-PAGE gel (section 2.1.4) was used to test each peak 
separately for proteins and any fractions containing the desired native LigA protein (depending 
on the molecular weight) were taken and stored at 4°C. The most pure fractions (about 2 ml) 
were added together and concentrated by a spin column till ~1 ml and then dialysed into ligase 
storage buffer. 
2.2.18.      LigA Purification Strategy 2. 
Materials 
1. HiTrap Diethylaminoethyl (DEAE) chromatography column, 5ml (GE Healthcare). 
This is a week anion exchange resin, cross-linked agarose. 
2. Column binding buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM, 
filter sterilised and vacuum degassed for 20 min. 
3.  Column elution buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM 
plus 1 M NaCl, filter sterilised and vacuum degassed for 20 min. 
4. AKTA Basic HPLC Chromatography instrument. GE Healthcare Ltd. 
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5. Ethanol 20% (v/v): completed with distilled water, filter sterilised and vacuum 
degassed for 20 min. 
6. Distilled water, filter sterilised and vacuum degassed for 20 min. 
7. Spin column. Membrane Vivaspin 20 5-20 ml samples MWCO 30,000. Sartorius (Lab 
Technology). 
8. Ligase storage buffer: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM 
NAD+, 50 μg/ml BSA and 30% (v/v) glycerol. 
Method 
In this method native LigA was purified by DEAE column. All the steps were done at 4°C in 
a cold-room. Minimum five column volumes of degassed distilled water was run to pre-
equilibrate a 5 ml DEAE column and then minimum five column volumes of column binding 
buffer were run through. The soluble native LigA (1-2 ml) was loaded into a clean 15 ml glass 
superloop. The LigA was injected in column binding buffer on to the DEAE column. LigA 
protein was eluted using column elution buffer during a 0-100% gradient for 40 min against 
column binging buffer and fractions of 1 ml were collected. Once the purification of protein 
finished, minimum five column volumes of distilled water was used to wash the DEAE column 
and then followed with minimum five column volume of 20% ethanol for storage. An SDS-
PAGE gel (section 2.1.4) was used to test each peak separately for proteins and any fractions 
containing the desired native LigA protein (depending on the molecular weight) were taken 
and stored at 4°C. The most pure fractions (about 2 ml) were added together and concentrated 
by a spin column till ~1 ml and then dialysed into ligase storage buffer.  
2.2.19.         LigB Purification Strategy1. 
Materials  
1. HiTrap Q-Sepharose (HP) chromatography column, 5 ml (GE Healthcare).  
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2. Column binding buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM, 
filter sterilised and vacuum degassed for 20 min. 
3.  Column elution buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM 
plus 1 M NaCl, filter sterilised and vacuum degassed for 20 min. 
4. AKTA Basic HPLC Chromatography instrument. GE Healthcare Ltd. 
5. Ethanol 20%: completed with distilled water, filter sterilised1 and vacuum degassed for 
20 min. 
6. Distilled water, filter sterilised and vacuum degassed for 20 min. 
7. Spin column. Membrane Vivaspin 20 5-20 ml samples MWCO 30,000. Sartorius 
(Lab Technology). 
8. Ligase storage buffer: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM 
NAD+, 50 μg/ml BSA and 30% (v/v) glycerol. 
Method 
The soluble protein (~1 ml) was injected into the glass superloop and purified via using AKTA 
basis machine. All the steps were done at room temperature. Minimum five column volumes 
of distilled water and vacuum degassed was run to pre-equilibrate the HiTrap HP column and 
then minimum five column volumes of column binding buffer. The soluble native LigB (1-2 
ml) was loaded into a clean 15 ml glass superloop. The LigB was injected in column binding 
buffer on to the heparin column. LigB protein was eluted using column elution buffer during a 
0-100% gradient for 40 min against column binging buffer and fractions of 1 ml were collected. 
Once the purification of protein finished, minimum five column volumes of distilled water was 
used to wash the column and then followed with minimum five column volume of 20% ethanol 
for storage. SDS PAGE gel (2.2.1) was used for test each peak separately and any fractions 
containing the desired protein (depending on the molecular weight) were taken and stored at 
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4°C. The most pure fractions (about 2 ml) were added together and concentrated by a spin 
column till ~1 ml and then dialysed into ligase storage buffer.
2.2.20.     LigB Purification Strategy 2. 
Materials  
1. HiTrap Heparin-Sepharose affinity chromatography column, 5 ml (GE Healthcare). 
This is for purifying DNA binding protein and is based on cross-linked agarose. 
2. Column binding buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM, 
filter sterilised and vacuum degassed for 20 min. 
3.  Column elution buffer: sodium phosphate (mono and diphosphate, pH 7.0) at 10 mM 
plus 1 M NaCl, filter sterilised and vacuum degassed for 20 min. 
4. AKTA Basic HPLC Chromatography instrument. GE Healthcare Ltd. 
5. Ethanol 20%: completed with distilled water, filter sterilised1 and vacuum degassed for 
20 min. 
6. Distilled water, filter sterilised and vacuum degassed for 20 min. 
7. Spin column. Membrane Vivaspin 20 5-20 ml samples MWCO 30,000. Sartorius (Lab 
Technology). 
8. Ligase storage buffer: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM 
NAD+, 50 μg/ml BSA and 30% (v/v) glycerol. 
Method 
The soluble protein (~1 ml) was injected into the glass superloop and purified via using AKTA 
basis machine. All the steps were done at room temperature. Minimum five column volumes 
of distilled water and vacuum degassed was run to pre-equilibrate the heparin column and then 
minimum five column volumes of column binding buffer. The soluble native LigB (1-2 ml) 
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was loaded into a clean 15 ml glass superloop. The LigB was injected in column binding buffer 
on to the heparin column. LigB protein was eluted using column elution buffer during a 0-
100% gradient for 40 min against column binging buffer and fractions of 1 ml were collected. 
Once the purification of protein finished, minimum five column volumes of distilled 
water was used to wash the heparin column and then followed with minimum five column 
volume of 20% ethanol for storage. SDS PAGE gel (2.2.1) was used for test each peak 
separately and any fractions containing the desired protein (depending on the molecular 
weight) were taken and stored at 4°C. The most pure fractions (about 2 ml) were added together 
and concentrated by a spin column till ~1 ml and then dialysed into ligase storage buffer.
2.2.21.      LigB Purification Strategy 3.
Materials  
1. HisTrap HP column (5 ml), Nickel Affinity Chromatography (Ni-NTA resin (QIAGEN)).   
2. Column binding buffer: 10 mM sodium phosphate (pH 7.0), 20 mM imidazole and 500 mM 
NaCl, completed up to the desired volume with distilled water, filter sterilised and vacuum 
degassed for 20 min. 
3. Column elution buffer: 10 mM sodium phosphate (pH 7.0), 500 mM imidazole and 500 mM 
NaCl, completed up to the desired volume with distilled water, filter sterilised and vacuum 
degassed for 20 min.  
4. Distilled water, filter sterilised and vacuum degassed for 20 min 
5. Stripping buffer: 10 mM sodium phosphate pH 7, 50 mM EDTA and 500 mM NaCl, 
completed up to the desired volume with distilled water, filter sterilised and vacuum degassed 
for 20 min. 
6. Nickle buffer (NiSO4): 10 mM of NiSo4, completed up to the desired volume with distilled 
water, filter sterilised and vacuum degassed for 20 min. 
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7. 20 % Ethanol: completed with distilled water to the desired volume, filter sterilised and 
vacuum degassed for 20 min.  
Method 
The soluble protein (1 ml) was injected into the class superloop and purified via using AKTA 
basis machine. All the steps were done at room temperature. Minimum five column volumes 
of distilled water and vacuum degassed was run to wash the HisTrap from the 20% ethanol and 
to pre-equilibrate the HisTrap column and then minimum five column volumes of column 
binding buffer. The soluble LigB His-tag (1-2 ml) was loaded into a clean 10 ml glass 
superloop. The LigB His-tag was injected into column binding buffer on to the HisTrap 
column. LigB His-tag protein was eluted using column elution buffer containing 10 mM of 
sodium phosphate pH 7, 0.5 M sodium chloride and 500 mM imidazole during a 0-100% gradient 
for 40 min against column binding buffer and fractions of 1 ml were collected.  
Once the purification of protein finished, minimum five column volumes of distilled water was 
used to wash the HisTrap column and then followed with minimum five column volumes of 
stripping buffer containing 10 mM sodium phosphate pH 7, 50 mM EDTA and 500 mM NaCl 
was used to wash and remove all the NiSO4 buffer that used from the HisTrap column. After 
that minimum five column volumes of 10 mM fresh NiSO4 buffer was used to charge the 
column again and then 20% ethanol for storage. SDS PAGE gel (2.2.1) was used for test each 
peak separately and any fractions containing the desired protein (depending on the molecular 
weight) were taken and stored at 4°C. The most pure fractions (about 2 ml) were added together 
and concentrated by a spin column till ~1 ml and then dialysed into ligase storage buffer or 
column binding buffer.  
2.2.22. Mass Spectrometry of LigA and LigB. 
Material 
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1- Pure LigA and LigB (both from first strategy). 
2- Instant Blue (Expendeon). 
3- Nuclease free water. 
Method 
Despite knowing molecular weight and amino acid sequences of LigA and LigB proteins, the 
determination of molecular mass is needed. The LigA from purification strategy1 and LigB 
from purification strategy2 were used for mass spectrometry to check they were correct 
proteins with the right molecular weight. A sample (different amount of µg for native LigA 
and LigB) of each ligase was run on a SDS gel and stained in a clean plastic dish with Instant 
Blue (Expendeon) for six hours or overnight. Gloves were worn at all stages to prevent 
contamination from human skin proteins. A slice of the SDS gel with each ligase was cut out 
by autoclaved razor blade and added to an autoclaved tubes. The gels sliced were covered with 
about ~500 µl of nuclease free water. Each sample was sent to Mass Spectrometry 
Facility/Leeds University, to check the amino acids sequence and molecular mass. After two 
weeks, the results were sent back by spreadsheet and checked for accuracy.  
2.3. Kinetic Characterisation Study: 
2.3.1. Establishing a Functional DNA Ligase Assay. 
In vitro assays of ligation activity were performed using a double stranded DNA substrate with 
a single nick. The oligonucleotides used in this study were designed and purchased from 
Invitrogen (ThermoFisher Scientific) in powdered form, with the %GC set to 50%.  These 
oligonucleotides included one bottom strand DNA of length 50 bases (5- 
CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCATACGCGAGAT-3) and 
two top stranded DNA of length 20 bases (5-ATCTCGCGTATGGGCCTTCG-3) and 30 
bases (5-CTGCTCACAGGACACCTGGTATACGTAATG-3), both of which were 
complementary to the 50 base bottom strand. The 20 bases long oligonucleotide had a 
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hexachlorofluorescein (HEX) group attached to its 5-end and a hydroxyl group (OH) attached 
to its 3-end, whereas the 30 bases long oligonucleotide had a phosphate group attached to its 
5-end. This nicked DNA substrate would have two purposes. First, it would allow the activity 
of ligase to be checked during purification steps. Secondly, it would allow a set of kinetic 
characterisation experiments on native ligase (LigA and LigB) to be started in this project. 
2.3.2.   Checking Annealing of the Three Oligonucleotides. 
Materials 
1. Three single strands of DNA (as mentioned above): 50 BOT, 30 TOP with phos and 20 
TOP with Hex: 
20TOP-HEX 5-HEX-ATCTCGCGTATGGGCCTTCG 
 30TOP-PHOS 5-P-CTGCTCACAGGACACCTGGTATACGTAATG 
 50BOT 5-CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCATACGCGAGAT 
2. Nuclease free water: Used to complete up to the desired volume of the reaction. 
3. 10 × DNA ligase buffer: 300 mM Tris-HCl (pH 8.0), 40 mM MgCl2, 10 mM DTT, 260 
µM NAD+ and 500 μg/ml BSA. Used at 1 × concentration.
4. 15% (w/v) native polyacrylamide gel (described in 2.1.2). 
5. PCR instrument (Veriti) programmed to heat oligos to 100ºC and cool to 4ºC at 0.1ºC 
/min.  
HEX-5-ATCTCGCGTATGGGCCTTCGCTGCTCACAGGACACCTGGTATACGTAATG-3
    3-TAGAGCGCATACCCGGAAGCGACGAGTGTCCTGTGGACCATATGCATTAC-5 
HEX-5-ATCTCGCGTATGGGCCTTCGCTGCTCACAGGACACCTGGTATACGTAATG-3 
    3-TAGAGCGCATACCCGGAAGCGACGAGTGTCCTGTGGACCATATGCATTAC-5
Nick
20 Top
50 Top
Ligase ± cofactors
30 Top
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Method 
To form the oligoduplex, different ratios of the two top strands (20 and 30 Top) and 50 Bot 
were tried. They were suspended in nuclease-free water at the following ratios: 
20:30:50  1:1:1  10:10:10 µM 
20:30:50  1.5:1.5:1 15:15:10 µM
20:30:50  2:2:1  20:20:10 µM   
These three reactions were set up in 1× ligation buffer and were annealed by slow cooling 
overnight in a PCR machine. Samples of each were checked on a 15% (w/v) native 
polyacrylamide gel (described above in 2.1.2).  
2.3.3.      Determining the Precise Concentration of Commercial (NEB) LigA. 
Materials  
1. Commercial LigA, 0.5 U/µl (NEB). 
2. A quantitative protein marker, (Affymetrix, USB Products, USA). 
3. 10% (w/v) SDS PAGE gel. 
4. Gel stain (SimplyBlueTM SafeStain) (Fisher Scientific). 
Method 
NEB LigA concentration was unknown (units only). Therefore the concentration of NEB LigA 
was determined by running an SDS-PAGE gel with three concentrations of the enzyme as 
follows: 1 μl, 2 μl and 4 μl NEB LigA. Also, 5 μL of a quantitative protein marker was loaded. 
Each band of this marker had 0.5 μg protein. By comparing between them, it was shown that 
the concentration of 1 μl NEB LigA was equivalent to 0.5 µg. With a molecular weight of 73 
kDa, the NEB LigA concentration was ~ 6 µM. This was used as a positive control enzyme to 
test and check the sealing of nick in the DNA substrate. 
2.3.4. Testing the 5 and 3 Groups required at a nick. 
Materials 
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Five single strands of DNA: 20TOP-HEX, 30TOP-PHOS, 30TOP, 50BOT and 50BOT-HEX: 
20TOP-HEX 5-HEX-ATCTCGCGTATGGGCCTTCG 
 30TOP-PHOS 5-P-CTGCTCACAGGACACCTGGTATACGTAATG 
 30TOP 5-P-CTGCTCACAGGACACCTGGTATACGTAATG
 50BOT 5-CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCATACGCGAGAT
 50BOT-Hex 5-CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCATACGCGAGAT
1. Phosphorylated 30TOP oligonucleotide (500 nM), from a 50 µl reaction with 20 U
polynucleotide kinase (PNK) (NEB) and purified by micro spin column.    
2. Commercial LigA, 0.5 U/µl (NEB) stock at 6 µM (Section 2.3.3). 
3. 10 × DNA ligase buffer: 300 mM Tris-HCl (pH 8.0), 40 mM MgCl2, 10 mM DTT, 260 
µM NAD+ and 500 μg/ml BSA. Used at 1 × concentration.
4. Nuclease free water: Used to complete up to the desired volume of the reaction. 
5. 15% (w/v) denaturing PAGE gel (see Section 2.1.3). 
Method 
The 5 and 3 side of the nick in the 50 bp oligoduplex was tested to see how different groups 
affected the ligation. The six oligonucleotides from items 1 and 2 above were annealed in 
different combinations to give five different nicked DNA substrates, called A, B C, D and E. 
These were annealed at 1:1:1 ratios about 100 nM concentration. These are shown on the next 
page in Figure 2.3. The dotted purple circles show the groups present at the nick. Substrate A 
had two OH groups at the nick and would not be expected to ligate. Substrate B had a 
5phosphate and 3OH group and would be expected to ligate. Substrates C and D were the 
same as Substrates A and B, except that they had a HEX group at the 5 end of the 50BOT 
strand. Substrate E used a 30TOP strand with a 5 OH group, which was then phosphorylated 
using 20 U of Polynucleotide Kinase (PNK) enzyme. 
A short ligation timecourse reaction (as described in Section 2.3.5 below) was performed using 
~1 µM of commercial LigA (NEB) on these five substrates. 
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     Substrate A
   Substrate B
    Substrate C 
    Substrate D 
    Substrate E 
P OH 20 Top Hex30 Top
Phosphorylated by PNK enzyme
OH OH 20 Top Hex30 Top
50 Bot
P30 Top 20 Top Hex
OH OH 
3- 
P
-5 3- -5
OH 
50 Bot Hex
30 Top
5- -3
20 Top 
3- -5 3- -5
5- -3
3- -5 3- -5
5- -3
30 Top 20 Top Hex
3- -5 3- -5
OH 
5- -3
50 Bot Hex
50 Bot
3-
50 Bot
-5 3- -5
5- -3
Figure 2.2. DNA substrates A-E, with different 5 and 3 groups at the nick, or Hex group (dotted 
circles).
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2.3.5.     Timecourse kinetics of Native LigA and LigB.
Materials 
1. Purified native LigA (70, 35 or 20 µM stocks) or LigB (4 or 2 µM stocks). 
2. Commercial LigA, 0.5 U/µl (NEB) stock at 6 Um (Section 2.3.3). 
3. 1 µM of oligoduplex substrate (from 10 µM stock). Usually DNA Substrate B (Figure 
2.1) prepared as in Section 2.3.2. 
4. 10 × DNA ligase buffer: 300 mM Tris-HCl (pH 8.0), 40 mM MgCl2, 10 mM DTT, 260 
µM NAD+ and 500 μg/ml BSA. Used at 1 × concentration.
5. Nuclease-free water: Used to complete up to the desired volume of the reaction. 
6. PCR machine to control timecourse temperature. 
7. Ligase Stop buffer: formamide (80% (w/v)), EDTA (10 mM, pH 8.0), and NaOH (2 
mM), bromophenolblue (0.04% (w/v).  
8. Denaturing PAGE gel equipment, SequiGen (Bio-Rad), 50 cm length, 0.3 mm thick. 
9. 15% (w/v) denaturing PAGE gel. 
10. 3MM chromatography paper. 
Method
Timecourse experiments on the 50 bp oligoduplex sequence were used throughout this thesis. 
The DNA substrate used most regularly was Substrate B (see Figure 2.1), with a HEX group 
on the 20TOP strand only. Annealing of oligonucleotides to make this oligoduplex was carried 
out as in Section 2.3.2 above. A typical timecourse reaction (50 µl) was started and contained 
the components in the following order: 
1- Nuclease-free water. 
2- 1× DNA ligase buffer (from 10× stock). 
3- 100 nM of oligoduplex substrate (from 1 µM stock). 
4- 30-40 nM of purified ligase (native LigA or LigB). 
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The reaction was incubated at 16ºC in a PCR machine, with 5 µl of aliquots being removed at 
various time points. In a typical reaction time-points at 30 seconds, 1 min., 3 min., 5 min., 10 
min., 30 min., and 180 min were taken. Time-points were stopped using 6 µl of Ligase Stop 
buffer. Samples were heated at 100ºC for 2 min and then loaded on to a denaturing gel. The 
gel was run as in Section 2.1.3. 
2.3.6.   Additional Cofactors and Conditions.
As described in future sections, different components were also added to the typical time-
course reactions described above in Section 2.3.5. These were as follows: 
-  DNA  5-100 nM FROM 1 µM stock. 
-  NAD+  0-25 µM  FROM 100 µM stock. 
- Temperature 5-35ºC. 
- NMN  25-400 µM FROM 1mM stock. 
- Ammonium sulphate (NH4SO4) FROM 50-10,000 µM  FROM 1M stock. 
2.3.7.   Quantitation of Timecourse gels. 
The bands on the denaturing gels were quantified using the program ImageJ (imagej.nih.gov). 
The density values of the peaks from ImageJ were used to calculate the percentage of LigA 
and LigB activities in terms of reduction of 20TOP-HEX intensity and increase in 50TOP-
HEX intensity at every single time point. Initial rates of reaction (V0) were determined by 
obtaining the gradient of a line of best fit for the first 20% of the formation of the 50TOP-HEX 
product for each reaction in Microsoft Excel. The Vmax and Km values were elucidated by 
plotting their V0 values for each timecourse and fitting to the Michaelis- Menten equation: 
Equation 2.1:  V = Vmax + [S]/ Km + [S]  
The definition of Vmax is the maximum theoretical rate of reaction. It was obtained by plotting 
the initial rate (V0) against the varying concentration of the substrate being investigated. Since 
V0 was measured in nM/min, the Vmax values were also in nM/min. 
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The definition of Km is the concentration of substrate that gives half maximum rate. It was 
obtained from the Michaelis- Menten equation fit.  
The definition of kcat is the number of substrate molecules (nicked-DNA molecules in this 
thesis) converted to product per minute. The kcat which is also known as the turnover number. 
It was calculated by dividing the Vmax (nM/min) by the enzyme concentration (30 nM for all 
the experiments). 
The software used for all curve-fitting was Grafit version 5.0.11 (Erithicus Software). 
2.4. Electrophoretic Mobility Shift Assays (EMSAs) on LigA and LigB. 
Materials 
1- 1 µM of annealed oligoduplex (Section 2.3.4). This contained three single strands of  
DNA (oligos): 50BOT, 30TOP with phos and 20TOP with Hex, used at 50 nM 
concentration. 
2- 5× Binding buffer I: 50 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 100 mM NaCl, kept at 
room temperature, used at 1× concentration. 
3- NAD+ at 1 mM. Used at 50 uM final concentration. 
4- 3× Loading buffer I: 3× Binding buffer I, 40%(w/v) sucrose, 0.01% (w/v) of 
bromophenol blue and kept at room temoerature, used at 0.6 × concentration.  
5- Gel solution (native PAGE gel): 40% (w/v) Polyacrylamide (Acrylamide:Bis-
Acrylamide (29:1)). Used at 6% (w/v) prepared as in Section 2.1.2.
6- 10× TBE. Used at 0.5× TBE for preparing the gel and running buffer.
Method 
The experiments of bandshift were carried out using non-denaturing gel electrophoresis on 
purified wildtype LigA and LigB bound to nicked DNA. Bandshift buffers was tested, this 
contained 0.1 mM EDTA (Binding buffer I) with 10 mM Tris- HCl (pH 7.5) and 20 mM NaCl. 
Each microfuge reaction tube had a total of 25 µl, with 50 nM nicked-DNA substrate, 1× 
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Binding buffer I, and  50 µM NAD+ and a specific concentration of native LigA or LigB. The 
concentration range (in nM) of LigA used was 0, 7, 15, 32, 64, 125, 250, 500, 1000 and 2000 
nM. For LigB, the range used was 0.0, 31.0, 62.0, 125.0, 250.0, 500.0, 1000.0, 2000.0, 4000.0 
and 6000.0 nM. The DNA-ligase complex was incubated for 1 hour at 4ºC. A 5 µl aliquot of 
3× Loading buffer I was added to each complex according to each experiment. Bandshifts 
samples were loaded on a pre-equilibrated 6% native polyacralamide gel in 0.5X TBE buffer 
and the running buffer as well was 0.5× TBE. The gel was run for 3 hours at 70 V at room 
temperature. Native gels were visualised using a Fujifilm FLA5000 phosphorimager, using 
fluorescently HEX-labelled oligonucleotides. ImageGauge software was used to quantify 
reactions of the free nicked DNA and the ligase-bound nicked-DNA. The Kd was estimated by 
fitting the concentration (in nM) of ligase-bound DNA using the Bound versus Total model 
contained within the GraFit software: 
Equation 2.1:  B = (Bmax × [ligase]) / (Kd + [ligase])  
The Kd where bound is the percentage of counts from the gel; [ligase] is the free concentration 
LigA or LigB; Bmax is the percentage at which the reaction between the nicked DNA and the 
ligases reached saturation; and Kd is the dissociation constant measured in nM in these 
experiments which corresponds to the concentration of LigA and LigB with nicked DNA that 
gives half maximal binding. The software used for all curve-fitting was Grafit version 5.0.11 
(Erithicus Software). 
2.5. Analytical Ultracentrifugation (AUC) 
Materials 
1- AUC buffer: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM NAD+, 3% 
(v/v) glycerol. 
2- AUC buffer + LigA: 30 mM Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM 
NAD+, 3% (v/v) glycerol and 2 µM native LigA. 
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3- AUC Instrument: Beckman Optima XL-A analytical ultracentrifuge (Beckman-
Coulter).  
4- AUC Software: Sedfit version 15.01b and Sednterp. 
Method 
Analytical ultracentrifugation (AUC) is a powerful technique of characterizing molecules in 
solution. A Beckman Optima XL-A analytical ultracentrifuge (Beckman-Coulter, Palo Alto, 
CA) was used for sedimentation equilibrium experiment. AUC experiments of purified native 
LigA were carried out at 15°C, and data were analysed using Sedfit version 15.01b (Schuck, 
2000). The partial specific volume (c) of LigA protein was estimated using Sednterp as 0.743 
mL/g (Laue et al., 1992). All stoichiometries are indicated to assuming that LigA is monomeric. 
Two-sections of AUC cell were used for each sample. Each cell contained 400 μL of AUC 
buffer and 425 μL of AUC buffer + LigA in the appropriate sectors of each cell. Each assembly 
contained a centrepiece with a 12 mm optical path length.  
Each cell was assembled by individual components by order as follow (Figure 2.4): a 
window gasket, window liner, and quartz window were put in order into each of the window 
holders after cleaned them very well with absolute alcohol and sterile water. One of the cells 
was placed into the cell housing followed by the 12 mm Epon charcoal-filled centrepiece 
guided by its keyway. The second window holder was placed up the centrepiece followed by 
the greased screw ring washer and the greased screw ring and tightened to 700 kPa. A sample 
of 400 μL AUC Buffer was injected into the left filling hole and a 425 μL sample of AUC 
Buffer + LigA was injected into the right filling hole. The difference between the sample and 
reference volumes allowed for discrimination between the two menisci.  
To finish, the plug gaskets and housing plugs were screwed into the cell housings. Cells 
were loaded into an An-50 Ti analytical rotor which was left in the centrifuge overnight to 
equilibrate to 15°C. Experiments were performed at 40,000 rpm, and radial scans were 
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recorded at 10-minute time-points. This flow chart explains the software that was used in the 
AUC experiment:  
Proteomelab  File  New  8 hole  speed 
 30,000  Velocity    Absorbance  sample  Details
 Overlay last 15   Method     Time between scan   OK. 
The AUC that explained in this chapter were achieved with the help of Dr. Simon Streeter 
(Institute of Biomedical and Biomolecular Sciences, University of Portsmouth).   
2.6. Beta-sliding Clamp Experiments. 
Materials 
1- 10× β-clamp reaction buffer: 8× Ligase buffer (NEB), 200 µM ATP and added 
nuclease-free water to desired volume.  Used at 1×. 
2- 1 µM five single strands of three-nicked DNA (100 bp) used at 100 nM as follow: 30 
TOP with phos1, 20 TOP with phos, 30 TOP with phos2, 20 TOP with Hex and 100 
BOT: 
30TOP-PHOS1 5-P-CTGCTCACAGGACACCTGGTATACGTAATG 
20 TOP- PHOS   5-P-CTGCTCACAGTGGGCCTTCG 
30 TOP PHOS2   5-PCTGCTCACAGCGCAAGCTAGTGGGCCTTCG 
20TOP-HEX 5-HEX-ATCTCGCGTATGGGCCTTCG
100BOT 5-CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCACT 
GTGAGCAGCGAAGGCCCACTAGCTTGCGCTGTGAGCAGCGAAGGCCCATACG
CGAGAT  
3- Stock β-clamp protein at 10 µM (measured as hexamer). Stored in 0.5× Ligase buffer 
(NEB) with 5% (v/v) glycerol. Used at 500 nM. 
4- Stock Gamma clamp-loader complex at 10 µM. Stored in 0.5× Ligase buffer (NEB) 
with 5% (v/v) glycerol. Used at 500 nM. 
5- Purified native LigA protein: used at 30-40 nM and Storage buffer: 0.5× Ligase buffer 
(NEB), 30% (v/v) glycerol.  
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Figure 2.3. Installation of the AUC cell. 
The single components of the AUC cells that set by 
order as described above, which was adapted from 
flow-through centrepiece assembly manual, (Beckman 
Coulter, 2003). 
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Methods 
Purified β-sliding clamp protein and Gamma clamp-loader complex (γ complex) were very 
kindly supplied from Prof. Mike O'Donnell (HHMI, Rockefeller University, NY).  They 
arrived in ice-box as one aliquot of ~100 µl in 1× clamp-loader storage buffer.  The Mr of β-
sliding clamp as a dimer was 81,200 Da. The Mr of Gamma clamp-loader was 200,000 Da. In 
these experiments, timecourse experiment was used by preparing two tubes in the ice, the first 
tube was without β-clamp proteins (control tube), but included native LigA. Whereas the 
second tube contains β-clamp and native LigA proteins. 50 µl of the second tube was prepared 
by adding 100 nM of double strand of three nicked-DNA (100 bp), 1× Beta-clamp buffer 
reaction, 500 nM of each Beta and Gamma proteins and 30-40 nM of purified LigA (first 
strategy of LigA purification). The complex mixture was completed with free water till the 
desired volume. The mixture of complex compounds were mixed very well plenty of time 
before doing timecourse at 15ºC .Timepoints were taken at 0.5, 1, 3, 5, 10, 30 and 60 minutes. 
A table with the components use in these experiments is shown below in Table 2.1. 
Table 2.1 
Component  Expt 1  Expt 2
Free water  -  - 
Clamp-buffer  1×  1× 
Three Nicked DNA 100 nM 100 nM 
Fix Beta  0 nM  500 nM 
Fix Gamma protein 0 nM  500 nM 
Ligase enzyme (LigA) 40 nM 30 nM  
 A 15% (w/v) denaturing gel (as described in Section 2.1.3) was used to determine if the β-
sliding clamp will increase the processivity of DNA ligases along double strand of nicked 
DNA. 
2.7. Molecular Operating Environment (MOE). 
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The method for using the in silico docking software, Molecular Operating Environment (MOE) 
is described in full in Chapter 5. The University of Portsmouth subscribed to a full version of 
MOE 7.0 (Chemical Computing Group).  
2.8. In vitro Inhibition Assay of Native LigA Protein. 
Materials  
1. 1 µM of annealed oligoduplex (Section 2.3.4). This contained three single strands of  
DNA (oligos): 50BOT, 30TOP with phos and 20TOP with Hex, used at 100 nM 
concentration. 
2. 10× DNA ligase buffer: 300 mM Tris-HCl (pH 8.0), 40 mM MgCl2, 10 mM DTT, 260 
µM NAD+ and 500 μg/ml BSA. Used at 1× concentration.
3. Purified native LigA (20 µM stocks): Used at 30-40 nM final concentration. 
4. 5× Denaturing gel loading buffer (stop buffer): Formamide (80% (w/v)), EDTA (10 
mM, pH 8.0), and NaOH (2 mM), bromophenolblue (0.04% (w/v). Used at 1× 
concentration. 
5. Eight solid compounds were used (S i gm a  A l d r i c h ) :  Oxidised Glutathione, 5-
Azacytidine, Geneticin (G418), Chlorhexidine, Bestatin, 2-(Aminomethyl) 
imidazole, Imidazolidinyl Urea and Imidazo [1,2-a]pyridine-7-carboxylic acid. 
6. Nuclease-free water: Used to complete up to the desired volume of the reaction. 
Method 
Compounds were ordered in solid form depending on the numbers of S-value that we had from 
MOE software (Chapter 5).  T h e y  w e r e  suspended in nuclease-free water to a concentration 
of 3 mM and stored at 4°C. They were tested at increasing concentrations   (40 nM  400 
µM) to analyse their effect on LigA nick ligation of DNA.  For each concentration  a 5 0   
µI reaction  mixture (l00 nM DNA,  30-40 nM  LigA,  l×  DNA  Ligase  buffer  and  the 
required  compound   concentration) was  made  with nuclease-free water. The timepoints 
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were taken of each reaction mixture (timecourse) and added to a denaturing stop buffer to 
quench the reaction.  The samples were heated at l00°C for two minutes and then run on a 
15% Urea denaturing Polyacrylamide gel at 50 watts for one hour. 
The gel was analysed on a Fujifilm FLA-5000 phosphorimager, which identified the 
fluorescent HEX tags on the 20 base DNA strand.  The  resulting  image  was analysed   
using  the computer programme  ImageJ  to determine the percentage of total DNA existing  
as an incomplete 20 base strand compared to the DNA existing  as a fully repaired  double  
stranded  50 base complex.  
2.9. In vivo Kirby-Bauer Experiment.   
Materials 
1. Mueller-Hinton LB agar: 15 g agar, 10 g tryptone, 5 g yeast extract and 10 g sodium 
chloride, completed with distilled water to the desired volume and autoclaved 
sterilised instantly. Fisher Scientific. 
2. LB Broth: 10 g tryptone, 5 g yeast extract and 10 g sodium chloride, completed up 
with distilled water to the desired volume and autoclaved instantly. Fisher Scientific. 
3. Wild type E. coli K12 (NEB) glycerol stock.
4. Ampicillin as positive control: 2.5 mg/ml stock solution. Filter sterilised 
immediately. Sigma. 
5. Nuclease-free water as negative control. 
6. Antimicrobial susceptibility test discs. Fisher Scientific. 
7. Four solid compounds were used:  5-Azacytidinc, Geneticin (G418), Chlorhexidine 
and Imidazolidinyl Urea. Sigma Aldrich. 
Method 
The in vivo Kirby-Bauer technique is one of the most useful tools to determine the effectiveness 
of which compounds on the growth of the bacteria. Autoclave Hinton agar was used to prepare 
KirbyBauer plate which were plated using a wild type E.coli K12 (NEB) and incubated at 
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37°C for overnight. A small colony was suspended in l ml of LB broth in a plastic cuvette till 
the OD600 of the broth was between 0.08-0.13, which is the measure of the absorbance using a 
spectrophotometer at 625 nm (Hudzicki, 2016). This concentration was streaked across fresh 
Mueller-Hinton plates using a sterile swab, covering the plates four times. Six sterile disks 
were placed on the plate using tweezers, they were soaked in either a control or a compound.
A disk soaked in H20 reaction buffer was used as a negative control and 2.5 mg/ml Ampicillin 
as a positive control, and different concentrations of compounds were used at varying 
concentrations of the compound tested. These plates were left to incubate for 2 4  hours at 
37ºC and were analysed. The diameter values of zone inhibition of each disk was measured in 
ImageJ software and curve of IC50 inhibition was used in vivo experiments. The diameter data 
were fit to a modified Michaelis-Menten equation using Grafit software. The Vmax and Km were 
modified to Imax (Maximum Inhibition) and IC50 (like Km).
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Chapter 3: Cloning, Expression and 
 Purification of Native LigA and LigB 
In this chapter the first step towards the goal of studying the kinetics and binding 
characterisation of native LigA and LigB was taken. This involved cloning the genes of LigA 
and LigB that were carried out in this study by using different plasmids and a cloning kit. The 
focus of the work presented in this chapter was to purity native LigA and LigB proteins by 
using different columns, conditions and buffers, and comparing their solubility, activity and 
properties under a range of experimental conditions. Also, Section 3.5.2 contains analytical 
ultracentrifugation (AUC) results, a powerful technique for the hydrodynamic analysis of 
macromolecules in solution (proteins).  
3.1. Introduction. 
E.coli DNA ligase (LigA) was first discovered in 1967 by the Lehman group and other 
laboratories (Olivera and Lehman, 1967, Gellert, 1967a). DNA ligases in E.coli has two 
proteins called LigA and LigB in different DNA and different protein sequence (Sriskanda & 
Shuman, 2001).  
The main objective of the chapter was to clone, express and purify native LigA and 
LigB, which are two of the key repair enzymes in E.coli. The challenge was to determine how 
best to induce and purify the two native enzymes, using a combination of chromatography 
techniques. A key part of this was the decision not to use a His-tagged version of each protein 
(as previous literature reports have), since this positively-charged group can interfere with 
DNA binding properties (Chant et al. 2005). The kinetics and binding properties measured 
(described in Chapter 4) of these enzymes have been measured on DNA nicks under these 
native (no-tag) expression conditions. 
 This chapter is organised in to three main sections. Section 3.2 (cloning) includes the 
two strategies for cloning these genes were used to clone LigA and LigB: a PCR primer 
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approach and synthetic gene and also ligate, transform and sequences. In Section 3.3
(expression), which required the IPTG at different concentrations, contains two steps for LigA 
protein: small and large scale induction. The expression for LigB (which was completely 
insoluble) includes four stages: small scale induction, solubility, refolding and large scale 
induction at different conditions and buffers. In section 3.4 (purification) that includes different 
strategies for LigA by using few columns: heparin column, Diethylaminoethyl column, HiTrap 
column and size exclusion column, but the purification for LigB used only three columns: 
HiTrap Q-Sepharose (HP), heparin and nickel column.   
3.2. Cloning. 
3.2.1. Cloning of LigA and LigB genes by PCR from E.coli genomic DNA. 
The LigA and LigB coding sequence were cloned into pET-29c vector by using Phusion 
enzyme as described in section 2.2.2, using PCR primers that were designed according to the 
NCBI database. An N-terminal or C-terminal His-tag was not included in these gene cloning 
experiments. The concentration of each primer pair was 500 nM. Standard PCR reactions of 25 
cycles of 99°C denaturing stage for 30 seconds, a 65°C annealing stage for 30 seconds, and a 72°C 
elongating step for 90 seconds were carried out on E.coli K12 using 0.5 μl. A control PCR reaction 
was included. Experiments were monitored by 2% agarose gel as shown in Figure 3.1A.  This 
gel showed that all three PCR reactions worked, producing the expected PCR sizes (shown to 
the right of the gel): LigA was 2016 bp, LigB 1683 bp and control PCR 1450 bp However, 
repeated ligation attempts of the LigA and LigB PCR products into pET29c did not give a 
recombinant vector.   
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3.2.2. Cloning of LigA and LigB Genes by Gene Synthesis.
Subsequently, the complete coding sequence of LigA, LigB and LigB His-tag genes of E.coli
DNA ligases were synthesised (GeneArt, Life Technologies. Fisher Scientific). Two vectors 
were used for cloning: pET-29c and pET-28b. 
In the first round of cloning, the native LigA and LigB genes were synthesised with a 
single NdeI site at either end of the gene (this gave non-directional insertion) for cloning into 
pET-29c. Each gene was digested with NdeI restriction enzyme. A sample (100 ng) of the 
undigested and digested LigA and LigB genes were run on a 1% agarose gel and are shown in 
Figure 3.1B. The gel showed that the full-length synthesised LigA and LigB genes (lanes 1 
and 3) ran at expected size (2045 and 1712 bp). Lanes 2 and 4 showed the digested genes which 
were 32 bp shorter, ready for cloning. Lanes 5 and 6 showed empty pET29c vector uncut 
(circular) and NdeI-cut (linear 5372 bp). 
In the second round of cloning, the LigB His-tag gene was synthesised with an NdeI at 
the 5 and BamHI site at either end (3) to allow directional cloning into pET-28b. This was to 
give a His-tag form of LigB gene to help with purification. There was an NdeI site and BamHI 
site at each end, so that they cloned directly into the NdeI site and BamHI site of pET28b 
(Figure not shown). 
The restriction enzymes were removed by heating, and then the DNA precipitated by 
ethanol precipitation (Section 2.2.7) and re-suspended in 10 mM Tris-HCL and pH 8.0.  The 
two vectors that used were also cut with the correct restriction enzymes and purified via ethanol 
precipitation. The two cut vectors were then dephosphorylated by using Shrimp Alkaline 
Phosphatase (SAP).  
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Figure 3.1. Initial PCR Cloning from E.coli K12 and GeneArt Synthesised Genes. 
Panel A) 2% of agarose gel showing the initial PCR cloning from E. coli K12 as follows: Lane M  1 
k bp DNA marker (NEB), showing sizes of DNA between 500 bp to 10,000 bp. Lane 1 - PCR product 
from amplification of LigA gene using Phusion proofreading DNA polymerase (NEB), the length of 
LigA is 2016 bp. Lane 2 - PCR product from amplification of LigB gene using Phusion proofreading 
DNA polymerase (NEB), the length of LigB is 1683 bp. Lane 3 - PCR reaction using control plasmid 
and primers from cloning kit (NEB). The expected PCR fragment size was 1,300 bp. Panel B) 2% of 
agarose gel showing the synthesised genes by GeneArt as follows: Lanes 1 and 2 - LigA gene via 
GeneArt without and with cut by NdeI restriction enzyme (NEB), respectively. Lanes 3 and 4 - LigB 
gene via GeneArt without and with cut by NdeI restriction enzyme (NEB), respectively. Lanes 5 and 6 
- pET29C plasmid vector without and with cut by NdeI restriction enzyme (NEB), respectively. 
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3.2.3. Ligation into pET29c and pET28b and Colony PCR. 
The NdeI-cut LigA and LigB genes or NdeI and BamHI-cut for LigB His-tag (from GeneArt) 
were each ligated into NdeI/SAP-treated pET-29c or pET-28b as described in Section 2.2.8. 
Briefly, this involved ligation using a T4 ligase kit (Instant Sticky-end, Ligase Master Mix, 
NEB), followed by transformation into component E.coli Beta-10 strain. The competent cells 
were grown successfully for native LigA and LigB in agar plate that containing kanamycin 
(Figure 3.2A) (LigB His-tag not shown). Rather than pick one random colony from the culture 
and send to check the sequencing of the DNA, colony PCR was performed. For each gene a 
pair of 30 base PCR primers were used to identify bacteria that had a recombinant LigA or 
LigB gene (see Section 2.2.9). The colony PCR products from about ~60 individual colonies 
on each plate were carried out. Successful cloning of LigA would gave a PCR product of 2227 
bp. For LigB the PCR product was 1894 bp and for LigB His-tag was 1949 bp. A sample of 
each PCR reaction was run on 1% agarose gel (Figure 3.2B, C and D for native LigA, LigB 
and LigB His-tag, respectively). Successful inserts are shown with an arrow next to each gel. 
All successful colony PCR products were sent for DNA sequencing. 
3.2.4. DNA Sequencing.
Fortunately, colony-PCR reactions of recombinant genes of LigA, LigB and LigB His-tag were 
obtained and sent for sequencing for each gene to Beckman Coulter Genomics (now called 
Genewiz). The sequencing primers were the same as those used for colony-PCR (Section 
2.2.9), and were used separately to sequence the top and bottom strands of the recombinant 
LigA and LigB plasmids or LigB His-tag plasmid. This allowed the DNA sequence of the 
whole gene to be checked carefully using Chromas programme. Figure 3.3 shows an example 
of the successful DNA sequencing for LigA, LigB and LigB His-tag.  
84 
Figure 3.2. Agar Plates Following Ligation and Transformation, and Agarose Gel of Colony 
PCR for LigA, LigB and LigB His-tag. 
Panel A (1): An agar plate of 50 µl of LigA transformation mix grown at 37°C for overnight with 
Kanamycin (50 µg/ml). A (2) Showing the agar plate of 50 µl of LigB transformation mix grown at 
37°C for overnight with Kanamycin (50ug/ml). Panel B) Showing agarose gel (1%) of colony-PCR 
reaction, the final lane (lane 14) shows a PCR product with a size of ~2200 bp, showing the native LigA 
gene was present. Panel C and D) Showing agarose gel (1%) of colony-PCR reaction, the first lane 
(lane 1) shows a PCR product with a size of ~1900 bp, showing the native LigB and LigB His-tag gene 
were presented, respectively. 
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3.3. Expression of LigA and LigB.  
Methionine
B
Figure 3.3. The sequencing results of Native LigA, Native LigB and LigB His-tag Genes. 
Panel A) This figure shows example of the Top sequencing of cloned GenArt native LigA gene of E.coli
DNA ligase. Panel B) shows the Top sequencing of cloned GenArt native LigB of E.coli DNA ligase. 
Panel C) shows the Bot sequencing of cloned GenArt LigB with His-tag gene, which conformed via 
Beckman coulter/Genewiz for all of them. The whole correct sequencing for all the genes are in Appedix 
3. Blue arrows on the top of the figures explain the sequencing direction. 
Methionine
Stop codon
A
C
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3.3. Expression of LigA and LigB 
3.3.1 Small Scale Inductions of LigA and LigB. 
For LigA, LigB and LigB His-tag expression, competent E.coli BL21 (DE3) cells were 
transformed with 100 ng plasmid (pLigA, pLigB and pLigB His-tag) and grown overnight at 
37ºC on LB-agar containing 50 µg/ml kanamycin. A single colony was picked and grown 
overnight in an orbital shaker at 37ºC in 5 mL LB media. For mini induction a 50 μl aliquot of 
overnight culture was added to 5 mL LB broth containing kanamycin. The bacterial samples 
were cultured until an optical density at 600 nm (OD600) of 0.6 was reached (approximately 2 
hours). A plot of bacterial growth (OD600) of LigA and LigB is shown below (Figure 3.4A and 
B).  
The curve is shown the determining of bacteria growth of LigA and LigB with IPTG 
induction, the red box shows the OD600 after 2 hours of growth (pre-induction), 1 mM IPTG 
was added here. The green box shows the OD600 2 hours after IPTG addition (post-induction), 
the OD600 was 1.3. Proteins expression were then induced with 1 mM IPTG and cells grown at 
37 °C with shaking until 3 hours after the induction and samples of pre- and post-IPTG 
induction were taken at regular time points. Samples of pre- and post-IPTG induction (25 µl) 
of LigA, LigB and LigB His-tag were run on a 10% SDS PAGE (Figure 3.5A, B and C) with 
both a protein marker and some NEB LigA as a size guide.  
In Figure 3.5A, B and C below (across two pages) show that induction with 1 mM 
IPTG produces a protein at for LigA 73606.07 Da and 63179.37 Da of LigB and LigB His-tag, 
respectively. This is smaller than the expected molecular weight for LigB (63179.37 Da), 
because it may be related to the charge or pI value for LigB protein (9.11, which is completely 
negative charge) that causes it to run faster in the gel. 
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Figure 3.4. The Growth of E.coli Bacteria with the Expressed of Native LigA and LigB.  
Panel A) The curve is shown the determining of bacteria growth with IPTG induction for native LigA, 
the red box shows the OD600 after 2 hours of growth (pre-induction), 1 mM IPTG was added here. The 
green box shows the OD600 2 hours after IPTG addition (post-induction), the OD600 was 2. Panel B) 
The curve is shown the determining of bacteria growth with IPTG induction for native LigB, the red 
box shows the OD600 after 2 hours of growth (pre-induction), 1 mM IPTG was added here. The green 
box shows the OD600 2 hours after IPTG addition (post-induction), the OD600 was 1.3. 
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Continued over the page... 
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Figure 3.5. Small Scale Inductions of LigA and LigB in E. coli BL21 (DE3). 
Panel A) A 10% (w/v) SDS PAGE gel is shown the mini induction of LigA as follow: Lane M is an 
NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane N is 0.5 ug of NEB of 
LigA (73kDa) for size comparison. Lanes 1 and 2 are shown pre-induction at 1h. and 2h., respectively. 
Lanes 3 and 4 are shown post-induction of LigA at 1h. and 2h., respectively. The red box indicates 
probably the induced LigA protein. Panel B) A 10% (w/v) SDS PAGE gel is shown the mini induction 
of LigB as follow: Lane M, N, 1 and 2 is the same as above on panel A. Lanes 3 and 4 are shown post-
induction of LigB at 1h. and 2h., respectively. The red box indicates probably the induced LigB protein. 
Panel C) A 10% (w/v) SDS PAGE gel is shown the mini induction of LigB His-tag as follow: Lane M 
is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lanes 1 is shown pre-
induction at 1h. Lanes 3 and 4 are shown post-induction of LigB His-tag at 1h. and 2h., respectively. 
The red box indicates probably the induced LigB protein. 
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3.3.2. Solubility of LigA. 
From the mini induction and initial experiment of main induction of LigA (Section 3.3.2), 
native LigA was shown to be mostly soluble and could be scaled up for large scale induction 
with IPTG, data shown in 3.3.7
3.3.3.  The Insolubility of LigB. 
 The main purpose of this experiment was to determine the solubility of native LigB protein, 
which was found to be completely insoluble. The overnight bacterial culture of recombinant 
LigB protein was added to 500 mL LB broth containing kanamycin 50 ug/ml at 37°C until an 
optical density (OD600) of 0.6 was reached. LigB expression was induced with 1 mM IPTG and 
cultures were incubated at 37°C until an OD600 was approximately between 1.50-2.00 was 
reached (typically 3 hours). Centrifugation at 6000 rpm, 20 minutes, 4°C was used to harvest 
the bacteria culture of expressed LigB, and the supernatant (media) was discarded. The pellets 
were resuspended in 20 ml of sodium phosphate buffer (Mono and Di) pH 7.00 containing 
protease inhibitors (see Section 2.2.13 in Chapter 2). A test of how much sonication was 
needed was carried out by sonicating samples for 1, 2, 3, 4 or 5 min in total, and taking 25 µl 
of each mixture out for loading on to an SDS gel. Also, for the 5 min sonicated sample, this 
was spun down by centrifugation at 18000 rpm for 20 minutes and a sample of the supernatant 
and the cell pellet (debris) prepared in SDS buffer. These samples are shown in Figure 3.6 
below. The key finding was that the induced LigB protein was not soluble in the sonicator, but 
was still in the cell pellet. 
3.3.4. The solubility of Expressed LigB Protein in NaCl and TritonX-100.
The sample of 10 ml re-suspended cell pellet from the experiment in Figure (Figure 3.6 lane 
7) below was re-sonicated again for 30 minutes at 9.9 pulses, to ensure that the pellet was 
completely disrupted as much as possible. A third of this (3.3 ml) was kept. Another third was 
mixed with 150 mM NaCl and the other third was mixed with 300 mM NaCl.  
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Figure 3.6. The Test of Sonication (time course) on LigB Protein. 
This 10% SDS gel shows the insolubility of LigB through the sonication during regular time points. 
Lane M is shown NEB protein ladder. Lane 1 is shown 1 minute sonication on expressed LigB at 9.9 
pulses.  Lane 2 is shown 2 minute sonication on expressed LigB at 9.9 pulses. Lane 3 is shown 3 minute 
sonication on expressed LigB at 9.9 pulses.  Lane 4 is shown 4 minute sonication on expressed LigB at 
9.9 pulses. Lane 5 is shown 5 minute sonication on expressed LigB at 9.9 pulses.  Lane 6 is shown 
sample of supernatant of LigB protein at 18000 RCF. Lane 7 is shown sample of the re-suspend cells 
debris of LigB protein.                                            
M             1         2        3         4        5        6        7         
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Each third (3.3 ml) was left at room temperature for 30 minutes, to allow any soluble protein 
to leave the pellet. The 150 mM and 300 mM NaCl samples were then split in two (1.7 ml 
each) and 0.1% (v/v) TritonX-100 added. These samples were left at room temperature for 45 
minutes. All the samples were spun at 18000 RCF for 15 minutes to separate the supernatant 
from cell debris and 25 µl of each sample was loaded on a 10% SDS gel. These gels are shown 
below in Figure 3.7A and B (the legend is on the next pages). Unfortunately, they all showed 
that the LigB remained in the cell debris (probably as inclusion bodies in the E.coli cells). 
3.3.5. Refolding LigB Protein.  
The mainly insoluble purification of native LigB protein led to do refolding LigB protein 
experiment for trying to get it soluble. Urea (8 M) and Guanidine hydrochloride (GdmCl) (0.25 
M) were used in this experiment to resuspend the cell debris that collected by harvesting those 
via using centrifugation at 18000 rpm at 40C to separate the supernatant away in the sonication 
step (see Section 2.2.15). All the complex mixture of cell debris, which contained 8 M urea, 
0.25 M GdmCl, 50 µM ZnCl2 and 20 mM Tris-HCl pH 8.6 with addition of 20 mM of fresh 
DDT (Solubilisation buffer I (SBI)), was stirred at 4ºC in the cold room for 24 hours. The 
solubilised inclusion body cell suspension was centrifuged at 18000 rpm for 30 min at 40C and 
the clear supernatant was kept in fridge.  
The clean supernatant was subjected to serial overnight dialysis with different buffer 
and different materials to get rid of the urea concentrations from the mixture gradually (as 
described in 2.2.13). The clean supernatant of the refolded LigB was tested for ligase activity 
and passed down a heparin column (Figure not shown). Unfortunately, the activity assay of 
final step of refolding native LigB protein did not show any ligase activity and the fractions of 
purification from the last step of the dialysis steps of the refolding protein by using heparin 
column did not match to the native LigB by tested them on SDS gel (gel is not shown).      
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Figure 3.7. Solubility Tests of Expressed LigB Protein on 10% SDS gel. 
Panel A) 10% SDS gels are tested the solubility of expressed LigB by using different concentrations of 
NaCl and Triton as follow:  Lane M is shown NEB protein ladder. Lane 1 is shown supernatant of 
sonication for 30 minute at 9.9 pulses. Lane 2 is shown cells debris of sonication for 30 minutes at 9.9 
pulses. Lane 3 is shown supernatant of re-sonication the debris for 30 minutes at 9.9 pulses. Lane 4 is 
shown cells debris of re-sonication the debris for 30 minutes at 9.9 pulses Lane 5 is shown supernatant 
of 150 mM of NaCl for 30 minutes at room temperature. Lane 6 is shown cells debris of 150 mM of 
NaCl for 30 minutes at room temp. Lane 7 is shown supernatant of 300 NaCl mM for 30 minutes at 
room temp. Lane 8 is shown cells debris of 300 NaCl mM for 30 minutes at room temp. Panel B) 10% 
SDS gels are tested the solubility of expressed LigB by using different concentrations of NaCl and 
Triton as follow:  Lane 9 is shown supernatant of sonication for 5 minutes with 0.1% (v/v) Triton. Lane 
10 is shown cells debris of sonication for 5 minutes with Triton. Lane 11 is shown supernatant of 150 
mM of NaCl for 30 minutes with Triton. Lane 12 is shown cells debris of 300 NaCl mM for 30 minutes 
with Triton. Lane 13 is shown supernatant of Triton for 45 minutes with Triton. Lane 14 is shown cells 
debris of Triton for 45 minutes with Triton. 
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3.3.6. New Strategy to Obtain Soluble LigB.
For LigB the solubility in NaCl and TritonX-100 and refolding experiments did not give any 
soluble LigB. At this stage a new strategy was tried, in which the incubation temperature for 
induction was decreased from 37ºC to 17ºC and left for ~17 hours. IPTG was added at OD600
0.60 and after 17 hours was about 1.50-2.00.   
3.3.7. Large Scale Induction of LigA and LigB. 
A large-scale protein expression of BL21 (DE3) cells containing pET29c-LigA, pET29c-LigB 
or pET28b-LigB His-tag construct were conducted. A 10 mL aliquot of the overnight bacterial 
culture of recombinant LigA, LigB and LigB His-tag proteins were added to 500 mL LB broth 
containing kanamycin 50 ug/ml, in an orbital shaker at 37°C until an optical density (OD600) 
of 0.6 was reached (about 2 hours). Protein expression was induced with 1 mM isopropyl B-
D-thiogalactoside (IPTG) as above, and the culture incubated at 37ºC for 2 hours and half  
(LigA and LigB His-tag) or at 17ºC overnight (LigB) (Sriskanda & Shuman, 2001) until an 
OD600 ~ 1.50-2.00 was reached to increase the solubility of LigB. Bacterial cultures were 
harvested by centrifugation at 6000 rpm for 20 minutes at 4°C and the media discarded.  
The cell pellet was re-suspended in 15 ml Lysis buffer (10 mM sodium phosphate, pH 
7.0, containing benzamidine and PMSF protease inhibitor cocktail (Sigma-Aldrich, UK)) (see 
Section 2.216). Lysis buffer for LigB also contained 500 mM NaCl and 0.1% (v/v) Triton X-
100. Cells were sonicated on ice in 10 second pulses over 3 minutes and spun at 18000 rpm for 
20 minutes at 4ºC to separate supernatant and cell debris. Samples of pre- and post-IPTG 
induction were run on a 10% SDS PAGE (for LigA Figure 3.8A, for native LigB 3.8B and 
for LigB His-tag 3.8C). Figure 3.8A and B (native LigA and native LigB) showed 10% SDS 
gel that includes five lanes with the marker (NEB protein ladder- blue protein standard), with 
sizes (in kDa) displayed to the left of the gel. Lane 1 was the pre-induction of expressed native 
LigA and native LigB before the OD600 reach to 0.60, respectively. Lanes 2 was post-induction 
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of expressed native LigA and native LigB by adding 1 mM IPTG when the OD600 was about 
1.50-2.00, respectively. Lanes 3 was a sample of sonication of native LigA and native LigB 
that got obtained through the sonication, respectively. Lane 4 is a sample of supernatant of 
expressed native LigA and native LigB, respectively. Lane 5 is a sample of debris of expressed 
native LigA and native LigB, respectively. Figure 3.8C for LigB His-tag was a 10% SDS 
PAGE gel that shown the Main Induction of LigB His-tag in E.coli BL21 (DE3) as follow: 
Lane M is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane 1 is 
pre-induction of expressed LigB His-tag. Lane 2 is post-induction of expressed LigB His-tag. 
Lane 3 is a sample of supernatant of expressed LigB His-tag. Lane 4 is a sample of debris of 
expressed LigB His-tag. 
3.4. Purification of LigA and LigB.  
3.4.1. Purification of Native LigA.   
Up to this stage, the appropriate genes of LigA was cloned into the bacterial expression vector 
of pET29c. The expression plasmid pET29c LigA was induced in E.coli BL21 (DE3) by adding 
1 mM IPTG, strain that contains the T7 RNA polymerase gene under the control of lac operator 
promoter. 
The next stage was to purify the enzymes. In the first step, NaCl was adjusted to 1M in 
order to disrupt protein-nucleic acid interactions. DNA ligase LigA was subsequently purified 
from the supernatant using ammonium sulphate; all steps were at 4ºC. Ammonium sulphate 
was added slowly over two hours to a final concentration of 40% (w/v) in order to precipitate 
the LigA enzyme (Figure 3.9).  
96 
Continued over the page... 
A
M 21 3 54
75 kDa
58 kDa
Expressed LigA 
(73606.07 Da) 
5M 431 2
75 kDa
58 kDa
B
Expressed LigB 
(63179.37 Da) 
97 
Figure 3.8.        Large Scale Inductions of LigA, LigB and LigB His-tag in E.coli BL21 (DE3).   
Panel A) 10% SDS PAGE gel is shown the Main induction of LigA in E. coli BL21 (DE3) as follow: 
Lane M is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane 1 is pre-
induction of expressed LigA. Lanes 2 is post-induction of expressed LigA. Lanes 3 is a sample of 
sonication of LigA. Lane 4 is a sample of supernatant of expressed LigA. Lane 5 is a sample of debris 
of expressed LigA. Panel B) 10% SDS PAGE gel is shown the Main induction of LigB in E. coli BL21 
(DE3) as follow: Lane M is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. 
Lane 1 is pre-induction of expressed LigB. Lanes 2 is post-induction of expressed LigB. Lane 3 is a 
sample of sonication of expressed LigB. 4 is a sample of supernatant of expressed LigB. Lane 5 is a 
sample of debris of expressed LigB. Panel C) 10% SDS PAGE gel is shown the Main induction of 
LigB His-tag in E. coli BL21 (DE3) as follow: Lane M is an NEB protein ladder, with sizes (in kDa) 
displayed to the left of the gel. Lane 1 is pre-induction of expressed LigB His-tag. Lanes 2 is post-
induction of expressed LigB His-tag. Lane 3 is a sample of supernatant of expressed LigB His-tag. Lane 
4 is a sample of debris of expressed LigB His-tag. 
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Figure 3.9.       Removal of DNA/RNA and nucleases from the purified supernatant LigA. 
10% SDS PAGE gel is shown different concentration of Ammonium sulphate of purify supernatant of 
LigA as follow: Lane M is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. 
Lane 0 is a 0% of Ammonium Sulphate (Am. Sul.) on LigA. Lane 1 is a 10% supernatant of Am. Sul. 
on LigA.  Lanes 2 is a 10% pellet of Am. Sul. on LigA. Lanes 3 is a 20% supernatant of Am. Sul. on 
LigA.  Lane 4 is a 20% pellet of Am. Sul. on LigA. Lane 5 is a 30% supernatant of Am. Sul. on LigA. 
Lane 6 is a 30% pellet of Am. Sul. on LigA. Lane 7 is a 40% supernatant of Am. Sul. on LigA. Lane 8 
is a 40% pellet of Am. Sul. on LigA. 
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Therefore different concentrations of ammonium sulphate purification step did work in LigA. 
Following centrifugation at 18000 rpm for 20 minutes, the pellet was re-suspended in an 
appropriate volume of column binding buffer (10 mM sodium phosphate, pH 7.0) and the top 
solution was removed. Salt was removed via membrane dialysis (Spectra/Por-MWCO: 6-8 
KDa) overnight at 40C in column binding buffer ready for column loading. Native LigA was 
purified from the soluble fraction using two strategies (as described in materials and methods, 
Section 2.2). The first strategy for LigA was to use a HiTrap Heparin affinity chromatography 
column (5 ml, GE Healthcare) that was carried out by using column binding buffer first and 
column elution buffer next (10 sodium phosphate plus 1 M NaCl) (see Section 2.2.17). 
Fractions eluting from the column were analysed by SDS/PAGE in order to confirm which 
contained the proteins, depending on the molecular weight of the enzyme along the marker. 
Figure 3.10A shows flow chart of the purification of LigA procedure. Figure 3.10B shows the 
corresponding samples of native LigA (shown by blue arrows down) were run on an 10% (w/v) 
SDS-PAGE gel that pooled protein from heparin column as follow: Lane M is an NEB protein 
ladder in the left side, with sizes (in kDa) displayed to the left of the gel. Lane 1 to 9 are the 
purification of LigA on heparin column. Figure 3.10C shows a peak in 280 nm at 100% elution 
buffer by using HiTrap Heparin affinity column of native LigA protein that highlighted with 
black star. Any fractions containing the desired protein (depending on the molecular weight) 
were taken and then buffer was exchanged with column binding buffer using dialysis for 
purified native LigA. Fractions containing the purified protein of native LigA were pooled 
together in volume of 2 ml. The soluble protein (~2 ml) were dialysed overnight in column 
binding buffer and loaded into the glass superloop and purified using HiTrap Q-Sepharose, 
Fast Flow (FF) chromatography column (5ml, GE Healthcare).   
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Figure 3.10.      Purification of Native LigA by Using Heparin Column: 
Panel A) shows flow chart of the first strategy purification of LigA procedure .Panel B) shows the 
corresponding samples of native LigA (shown by blue arrows) run on an 10% (w/v) SDS-PAGE gel 
that pooled protein from heparin column as follow: Lane M is an NEB protein ladder, with sizes (in 
kDa) displayed to the left of the gel. Lane 1 to 9 are the purification of LigA on heparin column. Panel 
C) Gel filtration shows a peak in 280 nm at 100% elution buffer of native LigA protein that is 
highlighted with black star. 
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Figure 3.11A shows the corresponding samples of native LigA (shown by blue arrows) 
were run on an 10% (w/v) PAGE gel that pooled protein from HiTrap column FF. Figure 
3.11B shows a peak in 280nm at 100% elution buffer via using HiTrap Q-Sepharose F.F of 
native LigA protein that highlighted with black star. 
Any fractions containing the desired protein (depending on the molecular weight) were 
taken and then buffer was exchanged with column binding buffer using dialysis for purified 
native LigA. The purified samples of LigA was injected in the plastic loop by using size 
exclusion column 120 ml (GE Healthcare) (Hiprep 16/60 Sephacryl S-300 HR) and the buffer 
that used for running the purification was column binding buffer by one and a half column 
volumes to resolve and elute the protein.  
Figure 3.12A shows an 10% (w/v) SDS gel of the final purification of native LigA that 
includes Lane M as an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. 
Lane 1 is commercial LigA protein (NEB) as a control and lane 2 is a native LigA (73606.07 
KDa) that purified on size exclusion column. The fractions containing the desired protein 
(depending on the molecular weight) were taken and then buffer was exchanged for purified 
native LigA to storage buffer containing 30% (v/v) glycerol and 1x ligase buffer. A spin 
concentrator column using concentrated column and storage for long time at -20 0C.  
The purified and stored native LigA after all three stages of purification strategy 1 
above was tested for activity by using denaturing gel 15% and was effectively work. The DNA 
substrate used here is described in detail at the start of Chapter 4. Figure 3.12B shows the 
activity test of LigA on denaturing gel 15 % (w/v), with and without Phosphate on 30 Top. 
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Figure 3.11.      Purification of Native LigA by Using HiTrap Column Fast Flow: 
Panel A) shows the samples of native LigA (shown by blue arrows) were run on an 10% (w/v) SDS-
PAGE gel that pooled protein from HiTrap column FF as follow: Lane M is an NEB protein ladder, 
with sizes (in kDa) displayed to the left of the gel. Lane 1 to 9 are the purification of LigA on DEAE 
column. Panel B) Gel filtration shows a peak in 280 nm at 100% elution buffer of native LigA protein 
that highlighted with black star. 
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Figure 3.12. The Final Purification of Native LigA by Size exclusion Column and ligation 
Activity Test on LigA.  
A) 10% SDS gel (w/v) shows the final purification of native LigA as follow: Lane M is an NEB protein 
ladder, with sizes (in kDa) displayed to the left of the gel. Lane 1 is commercial LigA protein (NEB). 
Lane 2 is a native LigA (73606.07 KDa) that purified on size exclusion column. Lane 3 is a native LigB 
(63179.37 KDa) purified on HiTrap heparin column (all details of purified LigB in Section 3.4.2). B) 
is shown the activity of LigA by using denaturing gel 15%. The DNA subastrate that used here was 
described in detail in Chapter 4, which includes 50 BOT, 20 TOP with Hex and 30 TOP with phosphate 
in lane 1 and without phosphate in lane 2. 
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The second strategy was carried out with HiTrap Diethylaminoethyl (DEAE) chromatography 
column 5ml (GE Healthcare), and the same process above (first strategy) were applied in this 
second strategy (Figures not shown).  
3.4.2. Purification of native and His-tag LigB. 
The appropriate genes of LigB and LigB His-tag were cloned into the bacterial expression 
vector of pET29c and pET28b. The expression plasmid pET29c and pET28b His-tag LigB 
were induced to the E.coli BL21 (DE3) by adding 1 mM IPTG, strain that contains the T7 RNA 
polymerase gene under the control of lac operator promoter .In the first step, NaCl was adjusted 
to 1M in order to disrupt protein-nucleic acid interactions. DNA LigB ligase was subsequently 
purified from the supernatant using ammonium sulphate; all steps were at 4ºC. Ammonium 
sulphate was added slowly over two hours to a final concentration of 40% (w/v) in order to 
precipitate the LigB enzyme (Figure 3.13).  
Figure 3.13 for native LigB showed 10% (w/v) SDS PAG gel with different 
concentration of ammonium sulphate of purify supernatant of LigB as follow: Lane M is an 
NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane 0 was a 0% of 
ammonium sulphate on LigB. Lane 1, 3, 5 and 7 were a 10%, 20, 30% and 40 of the supernatant 
of ammonium sulphate on LigB, respectively.  Lanes 2, 4, 6 and 8 were a 10%, 20%, 30% and 
40% pellet of ammonium sulphate on LigB, respectively. Following centrifugation at 18000 
rpm for 20 minutes, the pellet was re-suspended in an appropriate volume of column binding 
buffer (10 mM sodium phosphate, pH 7.0) and the top solution was removed. Salt was removed 
via membrane dialysis (Spectra/Por-MWCO: 6-8 KD) overnight at 4 0C in column binding 
buffer ready for column loading. Native LigB and LigB His-tag were purified from the soluble 
fraction using three strategies (as described in materials and methods, see Section 2.2).  
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Figure 3.13.       Removal of DNA/RNA and Nucleases from the Purified Supernatant LigB. 
10% SDS PAG gel is shown different concentration of Ammonium sulphate of purified supernatant of 
LigA as follow: Lane M is an NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. 
Lane 0 is a 0% of Ammonium Sulphate on LigB. Lane 1 is a 10% supernatant of Am. Sul. on LigB.  
Lanes 2 is a 10% pellet of Am. Sul. on LigB. Lanes 3 is a 20% supernatant of Am. Sul. on LigB. Lane 
4 is a 20% pellet of Am. Sul. on LigB. Lane 5 is a 30% supernatant of Am. Sul. on LigB. Lane 6 is a 
30% pellet of Am. Sul. on LigB. Lane 7 is a 40% supernatant of Am. Sul. on LigB. Lane 8 is a 40% 
pellet of Am. Sul. on LigB.
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The first strategy for native LigB was to use a HiTrap HP (see Section 2.2.19) chromatography 
column (5 ml, GE Healthcare) that was carried out by using column binding buffer first and 
column elution buffer with next (10 mM sodium phosphate plus 1 M NaCl) (see Section 
2.2.17). Fractions eluting from the column were analysed by SDS/PAGE in order to confirm 
which contained the proteins, depending on the molecular weight of the enzyme along the 
marker. Figure 3.14A shows flow chart of the purification of LigB procedure. Figure 3.14B
shows an SDS gel of the first purification of native LigB that includes Lane M as an NEB 
protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane 1 is commercial LigA 
protein (NEB) as a control. Lane 2 is commercial T4 protein (NEB). Lane 3 is a native LigA 
and lane 4 is a native LigB (73606.07 KDa) that purified on just HiTrap HP column. The stored 
native LigB after all three stages of purification strategy 1 above was tested its activity by using 
denaturing gel 15 %. The DNA substrate that used here is described in detail at the start of 
Chapter 4 (the corresponding fractions of native LigB on SDS gel was not shown). Figure 
3.14C shows a peak in 280 nm at 100% elution buffer by using HiTrap HP column of native 
LigB protein that highlighted with black star. 
Any fractions containing the desired protein (depending on the molecular weight) were 
taken and then buffer was exchanged for purified native LigB to storage buffer containing 30% 
(v/v) glycerol and 1× ligase buffer. A spin concentrator column using concentrated column 
several time and storage at -20ºC. Figure 3.16B (next two pages) shows the activity test of 
native LigB that purified by HiTrap HP on denaturing gel 15% down next few pages. The 
second strategy for native LigB was to use a HiTrap Heparin affinity chromatography column 
(5 ml, GE Healthcare) that was carried out by using column binding buffer first and column 
elution buffer with next (10 sodium phosphate plus 1 M NaCl) (see Section 2.2.17). Fractions 
eluting from the column were analysed by SDS/PAGE in order to confirm which contained the 
proteins, depending on the molecular weight of the enzyme along the marker. 
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Figure 3.14. The First Purification of Native LigB by HiTrap HP Column.  
Panel A) shows flow chart of the first strategy purification of LigB procedure. Panel B) 10% SDS gel 
(w/v) shows the purification of native LigB as follow: Lane M is an NEB protein ladder, with sizes (in 
kDa) displayed to the left of the gel. Lane 1 is commercial LigA protein (NEB). Lane 2 is commercial 
T4 protein (NEB). Lane 3 is a native LigA (73606.07 KDa) that purified on size exclusion column (see 
Section 3.4.1). Lane 4 is a native LigB (63179.37 KDa) purified on HiTrap HP column. Panel C) Gel 
filtration shows a peak in 280 nm at 100% elution buffer of native LigB protein by HiTrap HP that 
highlighted with black star.
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Figure 3.15A shows flow chart of the purification of LigB procedure using heparin column.
Figure 3.15B showed the corresponding samples of native LigB (shown by blue arrows down) 
were run on an 10% (w/v) SDS-PAGE gel that pooled protein from heparin column as follow: 
Lane M is an NEB protein ladder in the left side, with sizes (in kDa) displayed to the left of the 
gel. Lane 1 to 6 are the purification of LigB on heparin column. Figure 3.15C shows a peak in 
280 nm at 100% elution buffer by using HiTrap Heparin affinity column of native LigB protein 
that highlighted with black star. Any fractions containing the desired protein (depending on the 
molecular weight) were taken and then buffer was exchanged for purified native LigB to 
storage buffer containing 30% (v/v) glycerol and 1× ligase buffer. A spin concentrator column 
using concentrated column several time and storage at -20ºC. Figure 3.16A shows an SDS gel 
of the final purification of native LigB that includes Lane M as an NEB protein ladder, with 
sizes (in kDa) displayed to the left of the gel. Lane 1 is commercial LigA protein (NEB) as a 
control and lane 3 is a native LigB (73606.07 KDa) that purified on just heparin column. The 
purified and storage native LigB after all the  purification in strategy 1 above and 2 was tested 
for activity by using denaturing gel 15 % (w/v) and was effectively work. The DNA substrate 
that used here is described in detail at the start of Chapter 4.  
Figure 3.16B shows the activity test of native LigB by first and second strategies 
(HiTrap HP and heparin column) on denaturing gel 15 % (w/v). The third strategy of LigB His-
tag was carried out with Nickel Affinity Chromatography by using HisTrap HP column (5 ml) 
that was carried out by using Binding buffer (buffer A) (see Section 2.2.17 in materials and 
methods Chapter) that includes 20 mM imidazole and 500 mM NaCl first and elution buffer 
(buffer B) with next 500 mM imidazole and 500 mM NaCl. Fractions eluting from the column 
were analysed by DS/PAGE in order to confirm which contained the proteins, depending on 
the molecular weight of the enzyme along the marker (Figure not shown). Unfortunately the 
fractions of LigB His-tag came out with the flow rate and trapped with unbinding proteins.  
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Figure 3.15.     Purification of Native LigB by Using Heparin Column: 
Panel A) shows flow chart of the second strategy purification of LigB procedure. Panel B) 10% 
SDS gel shows the corresponding fractions of native LigB (shown by blue arrows) were run on an 10% 
SDS-PAGE gel that pooled protein from heparin column as follow: Lane M is an NEB protein ladder, 
with sizes (in kDa) displayed to the left of the gel. Lane 1 to 6 are the purification of LigB. Panel C)
Gel filtration shows a peak in 280 nm at 100% elution buffer of native LigB protein using heparin 
column that highlighted with black star.
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Figure 3.16.  The final Purification of Native LigB by Using Heparin Columna and ligation 
Activity Test on Native LigB. 
Panel A) 10% SDS gel shows the final purification of native LigA and LigB as follow: lane M is an 
NEB protein ladder, with sizes (in kDa) displayed to the left of the gel. Lane 1 is commercial LigA 
protein (NEB). Lane 2 is a native LigA (73606.07 KDa) that purified on size exclusion column (see 
Section 3.4.1 above). Lane 3 is a native LigB (63179.37 KDa) purified on HiTrap heparin column. 
Panel B) shows the activity of native LigB with first strategy (HiTrap HP column, lane 2) and second 
strategy (heparin column, lane 3) by using denaturing gel 15%. The DNA  that used here was described 
in details in Chapter 4, which includes 50 BOT, 20 TOP with Hex and 30 TOP with phos in lane 2 and 
3, and without phos in lane 1. 
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3.5.  Determining Concentrations of Purified DNA Ligases.
It was also important at this stage to exactly determine the molar concentration of E.coli DNA 
ligase for native LigA, LigB and LigA NEB that were purified via different columns. This was 
done via sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (see 
Section 3.4), a quantitative protein marker (see Section 4.2 in Chapter 4) and mass 
spectrometry (see Section 3.4.4).  
3.5.1.   Mass Spectrometry on LigA and LigB. 
Despite knowing the molecular weight of LigA and LigB proteins known on the NCBI database
or SDS gel, the determination of molecular mass is needed to confirm the enzymes were pure 
and correct proteins and correct mass. The LigA from purification strategy1 and the LigB from 
purification strategy2 were used for mass spectrometry to check their molecular mass. A 
sample of each ligase was run on a SDS gel and stained in a clean plastic dish for few hours 
(see Section 2.2.22). The DNA ligases for LigA and LigB were sliced on the gel and sent to 
Leeds University to check the amino acids sequence and molecular mass. Figure 3.17A shows 
10% (w/v) SDS gel of native LigA and LigB, which stained with special stain called Instant 
Blue (Expendeon), includes three lanes. Successfully the results were sent back by spreadsheet 
and then checked for each protein (LigA and LigB) accuracy and they were correct (see Figure 
3.17B and C). the full results of LigA and LigB are given in Appendix 3.1 and 3.2, and these 
show all the small fragments of each polypeptide and how these match sequence.  
3.5.2.    Analytical Ultracentrifugation (AUC) for Native LigA. 
Having cloned, expressed and purified LigA and LigB (Section 3.2) and checked the sequence 
by mass spectrometry (Section 3.4.4). The correct shape and fold of native LigA (but not native 
LigB) was tested by AUC.   
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Figure 3.17.  The Final Purification and Summary Brief of Mass Spectrometry reading on 
Native LigA and LigB. 
Panel A) 10% SDS gel shows the final purification of native LigA and LigB as follow: Lane 1 is a 
native LigA (73606.07 KDa) that purified from strategy 1. Lane 2 is a native LigB (63179.37 KDa) that 
purified from strategy 2. They were stained with special stain called Instant Blue (Expendeon). Panel 
B) shows the success reading and comprising of native LigA by mass spec with one species of bacteria. 
Panel C) shows the success reading and comprising of native LigB by mass spec with four species of 
bacteria. Please see Appendix 3. 
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To determine the shape, molecular mass distribution (c(S)) and the size of native LigA, 
A Beckman Optima XL-A analytical ultracentrifuge (Beckman-Coulter, Palo Alto, CA) was 
used for sedimentation equilibrium experiment for LigA protein. The total molecular weights 
of LigA proteins in the present study were 73,606.07 Da (NCBI). The partial specific volume 
(ῡ) of LigA protein was estimated using Sednterp as 0.743 mL/g (Laue et al., 1992). All 
stoichiometries are indicated assuming that LigA is monomeric. Two-sections of AUC cell 
were used for each sample. Each cell contained 400 µL of AUC buffer that contains 30 mM 
Tris-HCl (pH 8.0), 4 mM MgCl2, 1 mM DTT, 26 µM NAD+, 3% (v/v) glycerol and 425 µL of 
AUC buffer + ~2 µM LigA in the appropriate sectors of each cell.  
Each assembly contained a centrepiece with a 12 mm optical path length. The rotor was 
accelerated to 21000 to 28000 rpm and radial scans were recorded at 10-minute time-points. 
The temperature that used in this study was set at 15ºC. Figure 3.18A shows 150 recorded 
radial scans, in which migration of the LigA protein moved down the cell due to the high 
gravity field (acceleration applied). Figure 3.18B shows the measurement of the residuals to 
the fit for each of the 150 fits. These show how well the data were fit and the nearly straight 
line shows this was a good data set. Figure 3.18C shows a plot of the sedimentation coefficients 
(s) calculated from the radial scans. The S value is defined as the sedimentation velocity divided 
by the gravity field (s = vt/a). Most LigA molecules had an S value of 3.0, which gave a 
molecular mass of 69,110 Da (see the top of peak).  
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Figure 3.18.  Sedimentation Velocity AUC of LigA. 
Panel A) shows 150 recorded radial scans (dark blue, light blue, yellow and red), in which migration 
of the LigA protein moved down the cell (shown in cm) due to the high gravity field. Panel B) shows 
the residual plot and panel. Panel C) shows a plot of the sedimentation coefficients [S] calculated from 
the radial scans. The [S] value is defined as the sedimentation velocity divided by the gravity field (s = 
vt/a).  
A
B
Radial Position (cm)
Sedimentation coefficient [S] 
R
es
id
ua
l A
28
0
C
6.3                        6.4                       6.5                        6.6                      6.7                 6.8
Radial Position (cm)
c(
S)
A
bs
or
ba
nc
e 
A
28
0
115 
3.6. Discussion and Conclusions 
The work in this chapter has shown that the genes for LigA, LigB and LigB His-tag were 
successfully cloned into pET28b and pET29c vectors that was purchased from Gene Art 
(GeneArt, Life Technologies. Fisher Scientific). The genes for LigA and LigB were first 
attempted to be cloned by PCR using fusion enzyme on E.coli K12, but this was unsucessful 
because the end postion of the primer (forward and reverse) that was used to clone native LigA 
and LigB did not have the end site of NdeI enzyme, but was worth to check the cloning by 
PCR.  
The colony PCR for pET28b vector that was used for cloning LigB His-tag was faster 
and easier than pET29c, because pET28b vector had NdeI and BamHI-cut in the end of the 
vector and the genes, which was called LigB bidirectional. The cloning of native LigA and 
LigB that used pET29c was challenging during undertaking colony PCR, and the reason was 
that pET-29c had just NdeI site at either end of the plasmid and genes (unidirectional cloning), 
which gave non-directional insertion, and obtained high chance to ligate the plasmid without 
the insert gene because some of them had wrong direction.   
The expression of native LigA in competent cell E.coli BL21 (DE3) by adding 1 mM 
IPTG gave high amount of expressed LigA and has shown to be mostly soluble in the water ~ 
37 µM  n 1 ml. However, the expression for native LigB was shown to be completely insoluble. 
The positive solubility of native LigA and the high amount of expressed LigA allowed us to 
use different column. The purification of native LigA was carried out by using two strategies 
(1 and 2) (see Section 3.4). The activity assay for purified LigA  showed very potent ligation 
by using strategy 1 and 2 as showing in Chapter 4, and there was no different activity by 
comparing between these two stratgeies to purify native LigA.   
The negative solubility and small amount of expressed native LigB were a hard 
challenge which led us to use different way and method to make LigB soluble. The solubility 
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of expressed native LigB protein in NaCl and TritonX-100 and refolding native LigB protein 
experiments did not gave any soluble native LigB (see Section 3.3.3, 3.3.4 and 3.3.5). At this 
stage new two strategies were tried for LigB. Firstly, in which the incubation temperature for 
induction was decreased from 37ºC to 17ºC and left for ~17 hours. IPTG was added at OD600
0.60 and after 17 hours was about 1.50-2.00. Secondly, whilst doing the first strategy, LigB 
were cloned again via using different plasmid (pET28b) that contained a His-tag cloning 
sequence, to give LigB His-tag to increase the chance to get it maybe soluble. 
Successfully the native LigB protein and LigB His-tag were expressed and obtained 
soluble by using these two strategies. Unfortunately, the purification of LigB His-tag using 
HisTrap column (see Section 2.2.17 in materials and methods) was not successful, but the 
native LigB induced at 17ºC was purified using HiTrap heparin column. The comparative study 
of the activity assay of native LigA and LigB are compared in Chapter 4 (next Chapter), and 
the results showed that native LigA was faster than native LigB, but native LigB was tighter 
than LigA by doing kinetic and binding experiments. More discussion with other studies was 
added in the final discussion in Chapter 7. 
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Chapter 4: Comparative Kinetics and DNA Binding 
Studies of Native LigA and Native LigB 
Having shown in Chapter Three that native LigA and native LigB could be purified, a large set 
of kinetics and DNA binding experiments to compare LigA and LigB with each other were 
carried out. The main purpose of the work in this chapter was to examine the behaviour of 
native LigA and LigB since this has not been reported before. More we know about DNA 
ligases enzymes the higher the chance of developing a commercially viable inhibitor which can 
stop the advance of antibiotic resistance (Pergolizzi et al., 2015 & Stokes et al., 2011).  
4.1. Introduction.
The first section in this Chapter (Section 4.2) explains the development of a nicked 
DNA ligation assay. This involved firstly designing and annealing oligonucleotides to make 
suitable DNA ligase substrate. This substrate was checked by using a commercial LigA ligase 
from NEB and the concentrations of this NEB LigA had to be determined (no commercial stock 
of LigB was available). The reason for using NEB LigA was early in the beginning of the 
project whilst cloning and purifying LigA and LigB were in progress and the NEB LigA 
allowed the development of DNA substrate assay. 
In Section 4.3 a number of parameters (cofactors and reaction conditions) were tested 
using purified native LigA and LigB to compare these two ligases against each other. This 
include finding the Vmax and Km for these enzymes under many different reaction conditions. 
These include changes in [DNA], [NAD+], Temperature, [NMN] and [NH4SO4]. The Km values 
measured for [DNA] and [NAD+] correspond to real Km values, for [NMN] an IC50 value was 
measured and for [NH4SO4] an apparent Km was measured.
In Section 4.4, Electrophoretic Mobility Shift Assay (EMSA) experiments were carried 
out on native LigA and LigB binding to nicked oligodeoplexes. EMSA is considered to be a 
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very potent method to analyse the characterisation of DNA-protein interactions and to assess 
the binding affinity between DNA ligases and nicked-DNA and to see the difference between 
LigA and LigB through this study. The equilibrium dissociation constant (Kd) of protein-DNA 
complexes was determined by EMSA, which provides a measure of the strength of the 
interaction (Hellman & Fried, 2007).  
Finally, in Section 4.5 a novel interaction was investigated between LigA and the E.coli
polymerase sliding clamp (beta-clamp). This was carried out using native LigA with beta-
clamp and gamma-loader proteins (a gift from Professor Mike ODonnell, Rockefeller 
University, New York). The main aim of these experiments were to see if they interact to speed 
up the LigA kinetics. This might be a path way for developing promising of new antibiotic 
drug target.  
4.2. The Development of a Nicked DNA Ligation Assay. 
4.2.1. Determining the Precise Concentration of Commercial (NEB) LigA. 
Whilst native LigA and LigB were being cloned and purified commercial LigA was used to 
develop a nicked DNA assy. The concentration of NEB LigA protein (commercial protein 20 
units/µl) was determined by running an SDS-PAGE gel with three concentrations of the 
enzyme as follows: 4 μl, 2 μl and 1 μl NEB LigA. This is shown in Figure 4.1A in lanes 1, 2 
and 3, respectively.  Also, 5 μL of a quantitative protein marker (Affymetrix) was loaded. Each 
band of this marker had 0.5 μg protein.  
By comparing between them, it was shown that the concentration of 1 μl (lane 3) NEB 
LigA was equivalent to 0.5 µg with a molecular weight of 73 kDa, we estimated that the NEB 
LigA concentration was ~ 7 µM. This concentration was used to test and check the sealing of 
nick in the DNA substrate. 
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4.2.2. Checking Annealing of the Three Oligonucleotides
As explained in Section 2.3.1 and 2.3.2 in materials and methods, a nicked DNA substrate was 
made from three oligos. The ratio of oligos was determined by annealing three single strands 
of DNA: 50BOT, 30TOP-PHOS and 20TOP-HEX. They were added in following three ratios 
(in µM): 1:1:1, 1.5:1.5:1 and 2:2:1. These three reactions were set up in 1× ligation buffer and 
were annealed by slow cooling overnight in a PCR machine. Figure 4.1B shows samples of 
these run on a native polyacrylamide gel 15% (w/v). 
 Lane M is shown low molecular weight of DNA ladder (NEB). Lane 1 shows the ratio 
of oligos that designed at (1:1:1), respectively, with 1 μM final concentration for each oligo. 
Lane 2 shows the ratio of oligos that designed at (1.5:1.5:1), respectively, with 1.5 µM 30Top 
and 50Bot and 1 μM 20Top. Lane 3 shows the ratio of oligos that designed at (2:2:1), 
respectively, with 2 µM 30Top and 50Bot and 1 μM 20Top. The ratio 1:1:1 of each oligo seem 
to be the best ratio to choose and do all the kinetics experiments of native LigA and native 
LigB. Using 1:1:1 ratio of oligos to be sure all the two top oligos annealed completely with all 
50 Bot. 
4.2.3. Testing the 5 and 3 Groups Required at a Nick
As explained in Section 2.3.4 and Figure 2.3, to check the phosphate and hydroxyl groups 
required at the position of the nick, five nicked DNA substrates (A to E) were annealed at 1:1:1 
µM ratios. A short ligation timecourse reaction using 100 nM of each nicked DNA substrate 
was performed using about 0.5 µl  (10 units) of commercial LigA (NEB) and the timepoints 
used were 0, 0.5 and 5 minutes.  
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Figure 4.1. Determining the Concentration of NEB LigA and the Annealing Reactions Using 
Different Ratios of Oligos. 
Panel A) shows 10% (w/v) SDS gel shows different lanes as follow: Lanes M are markers of protein 
(Affymetrix) with 0.5 µg for each band of protein. Lane 1 is 4 μL E.coli DNA Ligase (NEB). Lane 2 is 
2 μL E.coli DNA Ligase (NEB). Lane 3 is 1 μL E.coli DNA Ligase (NEB). Panel B) Native 
polyacrylamide gel 15% (w/v) shows annealing reactions of oligos using different ratios as follow: Lane 
M is shown low molecular weight of DNA ladder (NEB). Lane 1 is shown the ratio of oligos that 
designed at (1:1:1), respectively, with 1 μM final concentration for each oligo. Lane 2 is shown the ratio 
of oligos that designed at (1.5:1.5:1), respectively, with 1.5 µM 30Top and 50Bot and 1 μM 20Top. 
Lane 3 is shown the ratio of oligos that designed at (2:2:1), respectively, with 2 µM 30Top and 50Bot 
and 1 μM 20Top. The red box shows the annealed 50 bp nicked duplex. 
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  In Figure 4.2A shows five nicked DNA substrates as follow: Substrate A annealed with 
50BOT, 30TOP and 20 TOP-HEX. Substrate B annealed with 50BOT, 30TOP-PHOS and 20 
TOP-HEX. Substrate C annealed 50BOT-HEX, 30 TOP and 20TOP-HEX. Substrate D was 
50BOT-HEX, 30 TOP-PHOS and 20 TOP-HEX. Substrate E set with 50 BOT (Phosphorylated 
by PNK enzyme, in the lab), 30 TOP-PHOS and 20 TOP-HEX (see Figure 2.3 in Chapter2).  
On these five substrates showed that the substrates with a 5-phosphate and 3OH group 
are ligated (Substrate B), since the equivalent substrate with a 50 Bot-HEX strand (Substrate 
D) showed unclear results. Subsequently the substrates and products migrate through the gel 
as single stranded molecules. Thus, the amount of DNA ligation is easily distinguishable as the 
distance migrated by the DNA will be dependent on the degree of ligation. Ligated products 
where the 20 and 30 base strands have been joined will migrate less distance on the denaturing 
gel, compared to just the 20 base strand and the visualisation of the unlighted and ligated 
products in the denaturing gel is possible due to the attached fluorescent HEX group.  
4.2.4. Testing the Nick-Joining Ligation Activity of Native LigA and LigB. 
The two native proteins purified in this study (Chapter 3 (3.4)) were first tested on substrate 
B (Figure 2.3). As before, DNA substrate B was made by adding a single stranded bottom 
strand oligonucleotide of length 50 bases to two top stranded oligonucleotides of length 20 
and 30 bases, both of which were complementary to adjacent sections of the 50 base bottom 
strand. The complementarity between the bottom and top strands positions the two top strands 
adjacent to each other in a way such that the 3-hydroxyl group of the 20 base strand and 5-
phosphate group of the 30 base strand were exposed at the nick. Figure 4.2B shows the test 
activity of native LigA and LigB via using 15% (w/v) denaturing gel. 
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Figure 4.2. Denaturing Gel of LigA (NEB) Timecourses Using DNA Substrates A-E for 
Testing 5 and 3 Groups Required at a Nick and the Activity Test of Native LigA and LigB.  
Panel A) 15% (w/v) denaturing polyacrylamide gel is shown the ligation reactions on DNA substrates 
A-E. Substrates were at 100 nM final concentration and the LigA (NEB) was at 20 units. Timepoints 
are shown above each lane. The different substrates are shown above the gel (as in Section 4.2.3). Panel 
B) 15% (w/v) denaturing polyacrylamide gel is shown the activity of LigA and LigB (first strategy) 
with and without phosphate. Lane 1 and 3 show the activity ligation for LigA and LigB with phosphate, 
respectively. Lane 2 and 4 show no activity ligation for LigA and LigB without phosphate, respectively. 
50 Top (product)
20 Top (substrate)
LIGATION 
LigA LigB
± 5 Phosphate       +        - +         -
on 30 Top
50 Top
20 Top
Bromo blue 
1      2              3        4        
50 Top
B
0 30S. 5 m. 0 30S. 5 m. 0 30S. 5 m. 0 30S. 5 m.0 30S. 5 m.
A B C D E
A
123 
Once a solution containing nicked DNA substrate of 100 nM and LigA or LigB of the 
requisite concentration were incubated at the appropriate conditions, the nick on the top strand 
would be sealed by the proteins. The aliquots taken at specific time points and added to the 
stop buffer essentially provides a snapshot of the extent of ligation that occurred over a defined 
duration. During electrophoresis of the aliquots, the denaturing gel (that has urea) disrupts the 
double-strand structure of the DNA and causes it to unfold into a linear chain.  
4.3. Kinetics of Native LigA and LigB on Different Reaction Cofactors, Conditions and 
Temperature. 
In this section the concentration of five different parameters were tested to determine the 
parameters Vmax and Km. These were [DNA], [NAD+], Temperature, [NMN] and [NH4SO4]. 
Kinetic assays on LigA and LigB were carried out in 1× Ligase reaction buffer. The 
concentration of nicked oligoduplex was 100 nM in most experiments, save for those in which 
this was varied between 5-100 nM. Reactions were also supplemented with various cofactors 
(Sigma-Aldrich, UK) depending on each experiment: NAD+ (from 0 to 25 µM), NMN 
(nicotinamide mononucleotide, from 0 to 400 µM) or NH4SO4 (from 0 to 10 mM).  
        Each timecourse (50 µl) contained nicked oligoduplex Substrate 2 (see Figure 4.2 above), 
1× Ligase buffer, the requisite cofactor(s) and 30 nM of either LigA or LigB (first strategy of 
purification). Experiments were routinely conducted at 15ºC or 16ºC, though for one subset of 
experiments, the reaction temperature was varied between 5 and 35ºC. Timepoints (~7 µl) were 
taken at regular intervals over one or two hours and added to 6 µl Stop buffer (80% (v/v) 
deionised formamide, 10 mM EDTA, 2 mM NaOH and 0.4% (v/v) bromophenol blue). 
4.3.1. Varying [DNA] Substrate. 
In order to characterise the kinetic behaviour of LigA and LigB at varying DNA substrate 
concentrations, ligation was carried out at substrate concentrations ranging from 5 nM to 100 
nM.  
124 
For LigA the varying DNA substrate was 5, 10, 30, 60, 80 and 100 nM. Figure 4.3A
shows 15% (w/v) denaturing gel used to analyse the time course samples of LigA activity with 
100 nM of [DNA] as an example for all the substrates and cofactors, to catalyse the nicked 
DNA into ligated DNA. Fig 4.3B shows the raw and corrected data percentage of substrate 
(%/min, in this thesis (nM/min)) converted product which were determined from band intensity 
analyse by using ImageJ and Excel programme. Fig 4.3C is a graph showing the percentage 
average of 20mer substrate Vs 50mer product by plotted just the correct data of 50mer (to get 
the initial rate (V0) of 50mer fixed DNA at between 20-30% of the reaction). 
Figure 4.4A shows a 15% (w/v) denaturing gel with eight timepoints at a DNA 
substrate concentration of 100 nM as an example of a lots of denaturing gels. All the gels 
corresponding to the experiments of varying [DNA] substrate are shown in Appendix 4.1, 2 
and 3. The band intensity of free DNA (20Top) and the nicked DNA (50Top) were analysed 
using ImageJ and plotted in the Excel programme to get the V0 for each timecourse of DNA 
substrate.  For LigA and LigB, optimal nick joining activity was observed between 0.8 and 0.1 
µM. Figure 4.4B shows the corrected data of the initial rate (V0) for all the varying DNA 
substrate against the time by using the single exponential fit in GraFit programme.  
Figure 4.4C shows a graph that plotted of initial rate for all varying DNA substrate, 
which contained the Vmax and the Km (Michaelis-Menten kinetics, Section 1.7). The Vmax
obtained by plotting the initial rate against varying DNA substrate concentrations was nM/min 
and the Km (the [DNA] substrate that given half Vmax rate), was nM. The kcat (turnover number) 
was min-1. The Vmax was 62.10±8.56 nM/min and Km was 12.22±6.42 nM. The kcat was 2.07 
min-1. 
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Figure 4.3.         Ligase A Reaction with Varying [DNA] Substrate Concentration. 
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction assay 
with 100 nM of [DNA]. Lanes are labelled with loaded quenched timecourse samples (10μl), lanes 1-8 were 
time points: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. Also labelled were the 20Top and 50Top 
bands, representing free DNA and ligated DNA, respectively. Panel B) Table raw and corrected data of [DNA] 
substrate converted to DNA product with 100 nM by ImageJ and Excel programme. Panel C) Graph shows 
plotted percentage average of 20mer substrate Vs 50mer product against the time to get the (V0) only for 50mer.    
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Figure 4.4.       Ligase A Reaction with Varying [DNA] Substrate Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction assay 
with 100 nM of [DNA]. The concentration of NAD+ was 25 µM. Lanes are labelled with loaded quenched 
timecourse samples (10μl), lanes 1-8 were time pointes: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. 
Also labelled were the 20 Top and 50 Top bands, representing free DNA and ligated DNA, respectively. Panel 
B). Table shows the corrected data of the initial rate (V0) for all the varying DNA substrate (5-100 nM). Panel 
C) Graph shows plotted percent (nM) of varying [DNA] substrate converted to ligated product against time 
(V0), using GraFit programme, the graph also shows maximum speed of varying [DNA] substrate which was 
(Vmax) 62.10±8.56 nM/min and Km was 12.22±6.42 nM.  
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For LigB, the varying DNA substrate was 5, 10, 30, 60, 80 and 100 nM.  Figure 4.5A
shows a 15% (w/v) denaturing gel with eight timepoints at a DNA substrate concentration of 
100 nM as an example of twelve of denaturing gels. All the gels corresponding to the 
experiments of varying [DNA] substrate are shown in Appendix 4.4, 5 and 6. The band 
intensity of free DNA (20Top) and the nicked DNA (50Top) were analysed using ImageJ and 
plotted in the Excel programme to get the V0 for each time-course of DNA substrate. Figure 
4.5B shows the corrected data of the initial rate (V0) for all the varying DNA substrate by using 
the single exponential fit in GraFit programme. Figure 4.5C shows a graph of initial rate for 
all varying DNA substrate against the time by using LigB protein, which contained the Vmax
and the Km. The Vmax obtained was 9.73±0.58 nM/min and Km was 3.50±1.34 nM. The kcat
(turnover number) was 0.32 min-1.
4.3.2. Varying [NAD+] Cofactor. 
The master solutions of NAD+ were prepared from a different stock of Nicotinamide Adenine 
Dinucleotide obtained from Sigma-Aldrich. The NAD+ obtained from Sigma-Aldrich was 
initially in powdered form, so the required amount (in grams) needed to make up the stocks 
were determined by multiplying the molecular weight of NAD+ with the final volume and the 
required molarity. NAD+ is one of the most important cofactor in the ligation process. LigA 
requires NAD+ to obtain the AMP group that is used during the mechanism of ligase. Without 
the NAD+ the reaction of ligation will be stopped completely (Shuman, 2009). In order to 
examine the effect of NAD+, varying concentrations were tested; ligation was performed in the 
presence of NAD+ concentrations ranging from 0.1 μM to 25 μM. For LigA the varying NAD+
cofactor was 0.1, 0.5, 1, 5, 10 and 25 µM.  Figure 4.6A shows 15% (w/v) denaturing gel with 
eight timepoints at a [NAD+] cofactor concentration of 25 µM as an example of twelve of 
denaturing gels.  
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Figure 4.5.         Ligase B Reaction with Varying [DNA] Substrate Concentrations.
Panel A) Denaturing gel 15 % (w/v) shows separate timecourse samples collected from ligation reaction assay 
with 100 nM of [DNA]. The concentration of NAD+ was 25 µM. Lanes are labelled with loaded quenched 
timecourse samples (10μl), lanes 1-8 were time pointes: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. 
Also labelled were the 20Top and 50Top bands, representing free DNA and ligated DNA, respectively. Panel B) 
Table shows the corrected data of the initial rate (V0) for all the varying DNA substrate (5-100 nM). Panel C) 
Graph shows plotted percent (nM) of varying [DNA] substrate converted to ligated product against time (V0), 
using GraFit programme, the graph also shows maximum speed of varying [DNA] substrate which was (Vmax) 
9.73±0.58 nM/min and Km was 3.50±1.34 nM.  
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All the gels corresponding to the experiments of varying [NAD+] cofactor are (for space 
reasons) given as high resolution .tif files on the attached CD. The band intensity of free DNA 
(20Top) and the nicked DNA (50Top) were analysed using ImageJ and plotted in the Excel 
programme to get the V0 for each time-course of NAD+ cofactor. At low NAD+ concentrations, 
initial rates rises rapidly until around 25 μM. Figure 4.6B shows the corrected data of the initial 
rate (V0) for all the varying NAD+ cofactor by using the single exponential fit in GraFit 
programme. Figure 4.6C shows a graph of initial rate for all varying NAD+ cofactor against 
the time, which contained the Vmax and the Km. The Vmax was 61.14±3.22 µM/min and Km was 
1.55±0.33 µM. The kcat was 2.038 min-1. 
For LigB the varying NAD+ cofactor was 0.1, 0.5, 1, 5, 10 and 25 µM.  Figure 4.7A
shows 15% (w/v) denaturing gel with eight timepoints at a [NAD+] cofactor concentration of 
25 µM as an example of twelve of denaturing gels. All the gels corresponding to the 
experiments of varying [NAD+] cofactor are (for space reasons) given as high resolution .tif 
files on the attached CD. The band intensity of free DNA (20Top) and the nicked DNA (50Top) 
were analysed using ImageJ and plotted in the Excel programme to get the V0 for each time-
course of NAD+ cofactor. At low NAD+ concentrations, initial rates rises rapidly until around 
5 μM, where the increase slows down and by around 10 and 25 μM the curve begins to plateau. 
Figure 4.7B shows the corrected data of the initial rate (V0) for all the varying NAD+
cofactor by using the single exponential fit in GraFit programme. Figure 4.7C shows a graph 
of initial rate for all varying NAD+ cofactor against the time by using LigB protein, which 
contained the Vmax and the Km. The Vmax was 15.37±0.52 µM/min and Km was 0.16±0.03 µM. 
the kcat was 0.512 min-1. 
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Figure 4.6. Ligase A Reaction with Varying [NAD+] Cofactor Concentration.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 25 µM of [NAD+]. Lanes are labelled with loaded quenched timecourse samples (10μl), 
lanes 1-8 were time pointes: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. Also labelled were 
the 20Top and 50Top bands, representing free DNA and ligated DNA, respectively. The concentration 
of DNA substrate was 100 nM. Panel B) Table shows the corrected data of the initial rate (V0) for all 
the varying NAD+ cofactor. Panel C) Graph shows plotted percent (nM) of varying [NAD+] cofactor 
converted to ligated product against time (V0), using GraFit programme, the graph also shows maximum 
speed of varying [NAD+] cofactor which was Vmax 61.14±3.22  nM/min and Km  was 1.55±0.33 nM. 
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Figure 4.7. Ligase B Reaction with Varying [NAD+] Cofactor Concentration.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 25 µM of [NAD+]. Lanes are labelled with loaded quenched timecourse samples (10μl), 
lanes 1-8 were time pointes: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. Also labelled were 
the 20 Top and 50 Top bands, representing free DNA and ligated DNA, respectively. The concentration 
of DNA substrate was 100 nM. Panel B) Table shows the corrected data of the initial rate (V0) for all 
the varying NAD+ cofactor. Panel C) Graph shows plotted percent (nM) of varying [NAD+] cofactor 
converted to ligated product against time (V0), using GraFit programme, the graph also shows maximum 
speed of varying [NAD+] cofactor which was Vmax 15.37±0.52  nM/min and Km  was 0.16±0.03 nM. 
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4.3.3. Temperature.  
Temperature plays a very important role in any reaction catalysed by an enzyme. The collision 
frequency of enzyme, substrate and cofactor increases with temperature. There is a certain 
temperature at which the enzyme activity is at its optimum and any increase beyond this 
temperature can results in breakdown of the enzyme structure. The effects of temperatures in 
these experiments ranged from 5, 10, 15, 20, 25, 30 and 35ºC and were studied at an enzyme 
concentration of 30-40 nM of LigA or LigB. For LigA, the overall amount of the activity 
ligation was very low at 5°C, but the best nick joining activity was observed at 15°C. Figure 
4.8A shows 15% (w/v) denaturing gel with eight timepoints at 15 ºC as an example of twelve 
of denaturing gels. All the gels corresponding to the experiments of different temperature are 
(for space reasons) given as high resolution .tif files on the attached CD.
Figure 4.8B shows the corrected data of the initial rate (V0) for all the temperature by 
using the single exponential fit in GraFit programme. Figure 4.8C shows graph that plotted of 
initial rate of LigA in nM/min for all seven temperatures. For LigA the optimum temperature 
was ~20°C as shown in Figure 4.8.  
 For LigB, the overall amount of the activity ligation was very low at 5°C, but the best 
nick joining activity was observed at 16°C. Figure 4.9A down shows 15% (w/v) denaturing 
gel with eight timepoints at 15ºC as an example of a lots of denaturing gels. All the gels 
corresponding to the experiments of different temperature are (for space reasons) given as high 
resolution .tif files on the attached CD. Figure 4.9B shows the corrected data of the initial rate 
(V0) for all the temperature by using the single exponential fit in GraFit programme. Figure 
4.9C shows graph that plotted of initial rate of LigA in nM/min for all seven temperatures. For 
LigB the optimum temperature was 16°C as shown in Figure 4.9. 
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Figure 4.8. Ligase A Reaction at Different Temperatures.
Panel A) Denaturing gel 15% (w/v) shows separate time-course samples collected from ligation 
reaction assay with 15 ºC. Lanes are labelled with loaded quenched timecourse samples (10μl), lanes 
1-8 were time pointes: 0.5, 1, 3, 5, 10, 20, 60 and 120 minutes, respectively. Also labelled were the 20 
Top and 50 Top bands, representing free DNA and ligated DNA, respectively. The concentration of 
DNA substrate was 100 nM and NAD+ was 25 µM. Panel B) Table shows the corrected data of the 
initial rate (V0) for all the varying NAD+ cofactor. Panel C) the Graph shows the initial rate of LigA in 
nM/min as a function of incubation temperature (5-35 ºC). 
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Figure 4.9. Ligase B Reaction with Different Temperature.
Panel A) Denaturing gel 15% (w/v) shows separate time-course samples collected from ligation 
reaction assay with 15 ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 
1-8 were time pointes: 0.5, 1, 3, 5, 20, 60 and 120 minutes, respectively. Also labelled were the 20Top 
and 50Top bands, representing free DNA and ligated DNA, respectively. The concentration of DNA 
substrate was 100 nM and NAD+ was 25 µM. Panel B) Table shows the corrected data of the initial 
rate (V0) for all the varying NAD+ cofactor. Panel C) Graph shows plotted the initial rate against 
different temperatures. 
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4.3.4. Varying [NMN] 
A master solution of NMN was prepared from a different stock nicotinamide mononucleotide 
(NMN). NMN was obtained from Sigma-Aldrich in a powdered form and the required amount 
(grams) needed to make the stock was determined by the same calculation as the one used 
above for NAD+. NMN experiments were only conducted for LigA not LigB, because the 
difficult and limited solubility of LigB prep. The varying NMN was 25, 50, 100, 200 and 400 
µM and the concentration of DNA substrate was 100 nM. Figure 4.10A shows a 15% (w/v) 
denaturing gel with eight timepoints at a [NMN] cofactor concentration of 400 µM as an 
example of a lots of denaturing gels. All the gels corresponding to the experiments of varying 
[NMN] cofactor are (for space reasons) given as high resolution .tif files on the attached CD. 
The band intensity of free DNA (20Top) and the nicked DNA (50Top) were analysed using 
ImageJ and plotted in the Excel programme to get the V0 for each time-course of NMN. 
Increasing NMN concentrations does have an effect on LigA, as the rate of ligation catalysed 
by LigA shows an overall decrease.  
The NMN appears to inhibit the ligase reaction. Initially the rate decreases sharply 
between 0 and 50 μM. At higher NMN concentrations up to 400 µM of NMN the increase in 
inhibition is less rapid. Figure 4.10B shows the corrected data of the initial rate (V0) for all the 
varying NMN concentrations by using the single exponential fit in GraFit programme. Figure 
4.10C shows a graph of initial rate against NMN concentration. Because these data showed 
inhibition of LigA, it was fitted in GraFit using an IC50 inhibition equation. This equation gives 
three parameters: Yrange (the difference in initial rate between theoretical maximum and 
minimum), IC50 (the concentration of NMN that given a half-maximal inhibition 
concentration), slope factor (the angle of the curve).  From Figure 4.x the Yrange for NMN was 
13.89±0.56 µM/min, and the inhibition IC50 was 31.34±1.56 µM.  
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Figure 4.10. Ligase A Reaction with Varying NMN Concentrations
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with [NMN] at 200 µM. Lanes are labelled with loaded quenched timecourse samples (10μl), 
lanes 1-7 were time pointes: 0.5, 1, 3, 5, 10, 30 and 60 minutes, respectively. Also labelled were the 
20Top and 50Top bands, representing free DNA and ligated DNA, respectively. The concentration of 
DNA substrate was 100 nM and NAD+ was 25 µM. Panel B) Table shows the corrected data of the 
initial rate (V0) for all the varying NMN. Panel C) shows a graph of initial rate against NMN, Yrange is 
the difference in initial rate between theoretical maximum and minimum, and IC50 is the concentration 
of NMN that given a half-maximal inhibition concentration. Yrange for NMN that inhibit the LigA protein 
was 13.89±0.56 µM/min, and the inhibition IC50 was 31.34±1.56 µM. 
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4.3.5. Varying [Ammonium Sulphate]. 
Ammonium sulphate (NH4SO4) is an ionic salt which dissociates into an ammonium cation 
(NH4+) and a sulphate (SO4-) anion. It has been previously reported (Modrich & Lehman, 1973, 
Chauleau & Shuman, 2016) that low concentrations of NH4SO4 increased the rate of nick 
ligation, possibly by speeding up either step 2 or step 3 in the mechanism (see Figure 1.7).  
Figure 4.11A shows a 15% (w/v) denaturing gel with eight timepoints at a [NH4SO4] 
concentration of 10 mM as an example of twelve of denaturing gels. All the gels corresponding 
to the experiments of varying [NH4SO4] are (for space reasons) given as high resolution .tif 
files on the attached CD. The band intensity of free DNA (20Top) and the nicked DNA (50Top) 
were analysed using ImageJ and plotted in the Excel programme to get the V0 for each time-
course of NH4SO4. The concentration of nicked DNA that used in this experiment was 100 nM. 
Increasing NH4SO4 concentrations does have an effect on LigA, as the rate of ligation
catalysed by LigA shows an overall increased. The NH4SO4 concentration appears to stimulate 
the ligase reaction. Initially the rate sharply increased between 0 and 500 μM. At higher 
NH4SO4 concentrations up to 5 mM of NH4SO4 the ligase increase less rapid and showing 
saturated at 10 mM of NH4SO4. Figure 4.11B shows the corrected data of the initial rate (V0) 
for all the varying NH4SO4 concentration by using the single exponential fit in GraFit 
programme. Figure 4.11C shows a graph of initial rate for all varying [NH4SO4] against the 
time by using LigA protein, which contained the Vmax and the Km. The Vmax obtained was 
48.67±8.0 µM/min and the apparent Km was 37.63±40.63 µM. This data has a large error and 
will need further measurement to be more accurate. 
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Figure 4.11. Ligase A Reaction with Varying [NH4SO4] Cofactor Concentration.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 10 mM of [NH4SO4]. Lanes are labelled with loaded quenched timecourse samples (10μl), 
lanes 1-6 were time pointes: 0.5, 1, 3, 5, 20 and 60 minutes, respectively. Also labelled were the 20Top 
and 50Top bands, representing free DNA and ligated DNA, respectively. The concentration of DNA 
substrate was 100 nM and NAD+ was 25 µM. Panel B) Table shows the corrected data of the initial 
rate (V0) for all the varying [NH4SO4]. Panel C) Graph shows plotted percent (nM) of varying 
[NH4SO4], which stimulated the reaction, converted to ligated product against time (V0), using GraFit 
programme, the graph also shows maximum speed of varying [NH4SO4 ] cofactor which was Vmax
48.67±8.00 µM/min and apparent Km  was 37.63±40.63 µM. 
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4.4. Initial Experiments of Electrophoretic Mobility Shift Assay (EMSA) on Native 
LigA and LigB  
4.4.1.      EMSA with Nicked DNA LigA.  
In order to assess the binding between LigA and nicked DNA substrate, an EMSA was 
performed using  LigA protein with 50 nM of nicked DNA (50 bp, Substrate B) by using  
binding buffer which contain 0.5 mM EDTA (see details in Section 2.4 in Materials 
and Methods). Native polyacralmide gel 6% (w/v) with 0.5 × TBE was used, and cassette was 
prepared for 10 lanes. The concentration of LigA were 0 nM, 8 nM, 16 nM, 32 nM, 64 nM, 
125 nM, 250 nM, 500 nM, 1000 nM and 2000 nM. Figure 4.12A shows these samples on a 
native gel.  The extreme left lane (lane 1) for only free nicked DNA, 100%, which is represented 
by the red arrow labeled free DNA. The observation in the gel shows that as the concentration 
of LigA increased the intensity of free DNA decreased. The lanes between 2-10 correspond to 
an increasing concentration of LigA (7 to 2000 nM).  
The band corresponding to bound DNA displayed reduced electrophoretic mobility 
with increasing concentrations of LigA (indicated by the blue arrow on the right side). This 
result shows LigA can form a complex with nicked DNA in 0.5 mM EDTA. Only one bound 
species was formed. The LigA appears to produce stable complex with the 50 bp nicked DNA.  
Since EDTA was present in the buffer it will chelate Mg2+ from the enzyme and inhibit the 
LigA from fixing the nick. The gel shows that the enzyme forms a stable complex with the 
DNA without fixing the nick. Figure 4.12B shows a graph of the percentage of bound DNA at 
each LigA concentration. The method for quantitating the gel is described in Section 2.4 in 
material and method Chapter. This plot showed a rising curve that had maximum value (Bmax) 
at 51.1%. The concentration of LigA at half Bmax correspond to Kd and this value was 
661.15±142.21 nM. 
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Figure 4.12.        EDTA-Containing Buffer Used for LigA Bandshift. 
Panel A) 6% (w/v) polyacrylamide gel is shown the band-shift assay of LigA concentration at 0 nM, 8 
nM, 16 nM, 32 nM, 62.50 nM, 125 nM, 250 nM, 500 nM, 1000 nM and 2000 nM from lanes 1-10, 
respectively by using buffer1 (Section 2.4.1). The bound DNA is shown in blue arrow, and free DNA 
and bromophenol blue are shown by red colour. Panel B) The binding curve of total bound LigA in 
EDTA-containing buffer gave a capacity (Bmax) of 51.09±4.71 % bound and a Kd of 661.15±142.22 nM.  
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4.4.2.         Nicked DNA LigB Experiment. 
EMSA was carried out on recombinant LigB protein with 50 nM of nicked DNA by using  
binding buffer  (1× EDTA). Native polyacralmide gel 6% with 9 lanes was used. The 
concentration of LigB that purified from second strategy (see Section 3.4.2) were 30 nM, 62 
nM, 125 nM, 250 nM, 500 nM, 1000 nM, 2000 nM, 4000 nM and 6000 nM respectively.  
Figure 4.13A shows lane 1 was free nicked DNA and lanes 2-9 were coresponding to the 
concentration of native LigB (31-6000 nM).  Noticeably on the gel, at higher concentrations 
more bound species appeared. Indicated by the blue arrows, a bandshift emerged that showed 
one, two and three bound species as the concentration of LigB increased. However, when the 
area of each lane was calculated using Image J, there were bound species identified at lower 
concentrations. The results in this figure show that LigB can form a complex with nicked DNA 
in the present 0.5 mM EDTA. Three bound species were formed, which was different in LigA. 
The bromophenol blue and free DNA, indicated by the red arrow was used as a tracking dye to 
show when the migration of the free DNA was near the bottom. Figure 4.13B shows a corrected 
counts table showing the percentage of total three bound species. Figure 4.13C shows a graph of 
the percentage of bound DNA at each LigB concentration. The method for quantitating the gel 
was described in Section 2.4. This plot showed a rising curve that had maximum value (Bmax) 
(capacity) at ~170%. This total comes from adding together the percentage of each of the three 
species. It is clear that this method of fitting the data is too simple to account for what appear 
to be multiple LigB proteins bound to nicked DNA; futher studies using LigB are required. The 
concentration of LigB at half Bmax correspond to Kd and this value was  4566.29±1146.70 nM. 
4.5.      Iinitial β-clamp and Gamma-Loader Experiments. 
The main aim of this section was to test a potential interaction between LigA and the ring-
shaped E.coli beta sliding-clamp (see Figure 1.12). During bacterial DNA replication, the beta 
sliding-clamp component is a ring shaped protein that encircles the duplex and binds the DNA 
polymerase, tethering it to DNA for high processivity (Levin et al., 1997). In 2001 Prof.  
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Figure 4.13.         EDTA -Containing Buffer Used for LigB Bandshift. 
Panel A)  0.5% polyacralamide gel is shown the bandshift assay of increasing LigB concentrations 
from lanes 1-9 at 31 nM, 62 nM, 125 nM, 250 nM, 500 nM, 1000 nM, 2000 nM, 4000.00 nM and 6000 
nM respectively by using buffer1 (see Section 3.4.2). The bound species (I, II and III) DNA is shown 
in blue arrow, and free DNA and bromophenol blue are shown by red colour. Panel B) A corrected 
counts table showing the percentage of total three bound species. Panel C) The total species of a LigB 
binding curve that read a capacity (Bmax) of 169.92±23.16 % bound and a Kd of 4566.29±1146.69 nM. 
Bound species III
Bound species II
Bound species I
Free nicked 
DNA
Bromophenol
Blue
1         2       3        4       5       6       7       8       9        
A
B
LigB
C
143 
Michael ODonnell with his group stated that the polymerase sliding clamp (beta-clamp) 
associated with E.coli LigA (López et al. 2001). In this section, preliminary experiments were 
conducted to determine if native LigA formed a protein: protein interaction on nicked DNA 
with the beta-clamp protein to improve the processivity of the enzyme.  
Initial timecourse reactions were carried out in the precence of E.coli DNA ligase (LigA) (see 
Section 4.3). A separate tube of 50 µl of β-clamp and gamma clamp-loader protein (required 
to load the clamp on to the DNA) were made in β-clamp reaction buffer, which contained 100 
nM of double strand of three nicked DNA (100 bp) (30Top with phos1, 20Top with phos, 
30Top with phos2, 20Top with Hex and 100Bot) (see all details about the oligos in Section 
2.6) and single nicked-DNA 50 bp (see Section 2.3.2), 1× Beta-clamp buffer reaction, 500 nM 
of each Beta and Gamma proteins and 30-40 nM of purified LigA protein. All these compounds 
required for both ligase and sliding-clamp proteins to contact and work efficiently (see Section 
2.3.4). The substrate that used in this experiment had 3 NICKS as follow in this diagram:  
3GTAATGCATATGGTCCACAGGACACTCGTCGCTTCCGGGTGACACTCGTCGCTTCCGGGTGATCGA
ACGCGACACTCGTCGCTTCCGGGTATGCGCTCTA 5
5CATTACGTATACCAGGTGTCCTGTGAGCAGCGAAGGCCCACTGTGAGCAGCGAAGGCCCACTAGCT
TGCGCTGTGAGCAGCGAAGGCCCATACGCGAGAT3
The components for each reaction were mixed very well before doing timecourse 
experiment at 15ºC. Time points were interval at (0, 0.5, 1, 3, 5, 10, 20, and 60 min) aliquots 
of reaction mix were added to STOP buffer to terminate the reaction. Single strand of DNA 
was run on 15% denaturing polyacrylamide gels, 70 W for 90 min was used, and then exposed, 
scanned and visualised, as previously described in material and method in Section 2.3.4.  
20 Top- HEX
30 Top- Phos 20 Top- Phos 30 Top- Phos1 NICK 2 NICK
3 NICK
100 Bot
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The first set of experiments were to test the β-clamp, ligase and DNA together and also 
the gamma-loader, ligase and DNA together. To ensure that the DNA ligase LigA will associate 
and increase the activity within the new β-clamp reaction buffer and β-clamp and gamma 
clamp-loader proteins (to check if the LigA interact with β-clamp to speed up the nick ligation 
or not), a ligase reaction timecourse was conducted in beta reaction buffer with ligase, but 
without β-clamp and gamma clamp-loader proteins to make comparison between them. Adding 
beta-clamp alone to a Ligase reaction does not affect the reaction rate as the clamp requires 
gamma clamp-loader to load beta-clamp onto a DNA molecule (data not shown). In the second 
set of experiments, β-clamp, gamma-loader, ligase and DNA were added together. 
Figure 4.14A shows a 15% (w/v) denaturing gel with two timecourses, lanes from 1-
7 adding sliding-clamp component (β-clamp and gamma loader complex) to the reaction of 
DNA ligase at time points 0, 0.5, 1, 3, 5, 10, 20, and 60 min, respectively. Lanes 8-14 were 
without adding sliding-clamp proteins at time points 0, 0.5, 1, 3, 5, 10, 20, and 60 min, 
respectively. DNA fragments were clearly visible on each denaturing gel, the migration of 
single strand DNA from 20Top to 50, 70 and 100Top and the size was indicated by purple 
arrows in the gel. The intensity of each band was plotted in Excel programme to calculate the 
initial rates. Figure 4.14B shows the corrected data of the initial rate (V0) just for 50Top for 
the β-clamp concentration by using the single exponential fit in GraFit programme.  
Figure 4.14C graph shows that the activity of DNA ligase LigA to fix the three nicked 
DNA in the presence of β-clamp and gamma clamp-loader protein did not make the reaction 
faster and the V0 for β-clamp reaction look the same as no β-clamp (normal reaction as in 
4.3.1). 
145 
Figure 4.14. B-clamp Protein Interaction with LigA Protein. 
Panel A) Denaturing gel 15% (w/v) is showing two timecourses, lanes 1-7 adding sliding-clamp 
component to the reaction of DNA ligase at time points 0.5, 1, 3, 5, 10, 20 and 60 min. Lanes 8-14 
without adding sliding-clamp proteins at time points 0.5, 1, 3, 5, 10, 20 and 60 min, the concentration 
of DNA substrate was 100 nM of double strand three nicked DNA in this gel. Panels B) Table shows 
the corrected data of the initial rate (V0) that plotted with % intensity against time for the complex 
reaction of β-clamp and without β-clamp. Panel C) Graphs showing results of the average of initial 
rates of each DNA fragment that pointed in arrows (50, 70 and 100Top), the initial rate for β-clamp 
proteins interaction with LigA was 33.128 and the initial rate for just LigA protein (no adding β-clamp) 
was 31.201. 
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4.6. Discussion. 
In this Chapter, a large number of kinetics and binding experiments were performed. In this 
Discussion I will explain these results by comparing most of experiments of native LigA and 
LigB. In Section 4.2 the aim was to develop a new ligation assay. This involved firstly 
designing and annealing oligonucleotides to make suitable DNA ligase substrate. In this study 
the length of double strand of nicked DNA that used was 50 base pair and the nick was between 
bases 30 and 20 TOP. This length was similar to previous studies (Wilkinson et al., 2005).  
In this study the nicked DNA was checked by commercial LigA first to determine the 
best concentration.  A hexachlorofluorescein (Hex) group was attached to 5-end at 20 base 
pair was used in this study, which had an excitation wavelength of 535 nm ( which allowed to 
be easily image), easy and safe, to determine and plot the ligation strand (50Top) of nicked 
DNA at 100 nM concentration as used in this experiments. These was similar to Mills et al. 
2011 used tetramethyl carboxyrhodamine fluorescent (TAMRA) that labelled at the 3-end. 
Whereas Liu et al. in 2004 was used radiolabelling P32 at 5-end of oligonucleotides.  
Next, in Section 4.3, I provided the first side-by-side comparison of native LigA and 
LigB for three out of five parameters: [DNA], [NAD+] and Temperature. Michaelis-Menten 
kinetics for native LigA and LigB showed that the Vmax of LigA and LigB for a singly-nicked 
DNA substrate were different, at 62.10± 8.56 and 9.73±0.58 nM/min, respectively. The Km
values for LigA and LigB (how tightly they bound the nicked DNA) were slightly similar, at 
12.22±6.42 and 3.50±1.34 nM, respectively. LigB bound nicked DNA ~ 4-fold tighter than 
LigA, which is a new results. It is possible that LigA and LigB have different function in the 
cell with different affinities for nicked DNA for example it would interesting to observe with 
microscope where in the bacteria LigA and LigB are. There no studies on this before. As well 
more discussions with others studies was added in the final discussion (Chapter 7).   
Both enzymes required NAD+ as cofactor, but showed different Vmax values 
(61.14±3.22 and 15.37±0.60 µM/min, respectively), as well their Km values were sharply 
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different (1.55±0.33 and 0.16±0.03 µM), and showing that LigB bound NAD+ obviously tighter 
than LigA. The Vmax values showed that LigA was 4-fold faster than LigB. Similar to the result 
for [DNA], perhaps there is a different role in the cell of LigA and LigB.  
The other parameter that was compared for LigA and LigB was incubation temperature. 
This showed that both native enzymes had a slightly different optimum temperature for 
activity. For LigA this was ~20ºC, and for LigB approximately ~16ºC. Most DNA ligases are 
used at 16ºC or room temperature and can be denatured by heat (Lohman et al., 2011B). Also, 
we found LigA if left at room temperature overnight lost almost its activity. Therefore, 
although some DNA ligases such as the three ATP-dependent ligases from bacteriophage T4 
that required 37ºC for optimum activity (Bullard and Bowater, 2006).  The temperature used 
in every LigA and LigB reaction (kinetics study) was 16ºC, which was closed to the optimum 
temperature for each enzyme.  
The remaining two parameters [NMN] and [NH4SO4] were only studied for LigA. Data 
for LigB were not obtained because the difficult and limited solubility of LigB prep. The 
interesting result for NMN was that inhibited the reaction of LigA. The Yrange for [NMN] was 
13.89±0.56 µM/min, and the inhibition IC50 was 31.34±1.56 µM. As seen in the previous 
kinetics experiments, the ligation catalysed by LigA or LigB doesnt go to completion even at 
ideal reaction conditions. We hypothesised that the NMN, which is released during ligation as 
a by-product, could somehow be involved in this ligation.  
The ammonium sulphate experiment on LigA confirms previous papers that have 
reported this effect and stimulate the reaction of the LigA enzyme (Modrich & Lehman, 1973; 
Chauleau & Shuman, 2016). The Km for [NH4SO4] was 37.64±40.64 µM, but this has a large 
error and will need further measurement to be more accurate. In the crystal structure of 2OWO 
(see Figure 1.5) there are four sulphate anions but no ammonium cation.  
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In Section 4.4, comparative gel-shift studies in EDTA containing buffers (no Mg2+ 
added) showed that LigA bound the 50 bp nicked DNA with a Kd of 661.15±142.22 nM and 
LigB 4,566.30±1146.70 nM. This showed that LigA bound approximately 6.9-fold tighter than 
LigB. Interestingly, LigA only formed one type of protein-DNA complex since there was only 
one bound species on the gel. Otherwise, for LigB there were three types of protein-DNA 
complex, which shows possibly multiple LigB monomeric in the 50 bp nicked DNA or the 
LigB bend the nick DNA to form different species. Further studies on LigA and LigB, could 
include mass spec and Western blot analysis (Kneale, 1994).     
In Section 4.5, to determine the processivity of DNA ligase LigA in E.coli, we 
predicted here that the β-clamp complex interact directly with Lig1 eubacteria (Levin et al, 
1997). Improving the interacting between DNA ligase and sliding-clamp (β-clamp and gamma 
loader complex) will be increasing the attention as a therapeutic target. We found here in this 
study that DNA ligase E.coli LigA did not interact with β-clamp complex in vitro (all the 
conditions of studied in this experiment explained in Section 4.5). More discussions with others 
studies was added in the final discussion in Chapter 7. 
 Overall, these studies show that the two ligase enzymes in E.coli have different kinetic 
and binding profiles. Possibly this means that they have different functional roles within the 
bacteria cell. For the two parameters [DNA] and [NAD+], the Vmax values for LigA were ~7 
and 4-fold faster than LigB. All five parameters taken together show these two enzymes that 
do the same reaction may have different roles in the cell, such as replication or repair.  
Further experiment would be needed to examine this idea, for example separate 
mutation studies for native LigA and LigB in vivo would help locate and explain the function 
for each protein. For example, gene knockout experiments would help greatly. The LigA gene 
has been examined before (Rychta et al., 2007) and when inactivated, appeared to cause the 
E.coli to die.  
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In 2017, Bodine with his group reported that E.coli LigB play a potential role in the 
base excision repair pathway or the mismatch repair pathway by deletion of LigB gene study 
(Bodine at al., 2017).  Another approach would be to use fluorescent-tagged LigA or LigB and 
image in fluorescence microscope to find which part in E. coli they are located. Table 4.1
shows the overall studies and comparison of kinetics and DNA binding experiments on native 
LigA and LigB.
 Native LigA     Native LigB 
Kinetics  Vmax  Km  kcat  Vmax  Km  kcat
[DNA]  62.10±8.56 12.22±6.42 2.07  9.73±0.58 3.50±1.34 0.32
[NAD+]  61.14±3.22 1.55±0.33 2.038  15.37±0.52 0.16±0.03 0.51 
Temp. 20ºC      16ºC
Binding  Bmax  Kd    Bmax          Kd 
51.09±4.71  661.15±142.22    169.92±23.16         4566.29±1146.69  
Vmax in nM/min for [DNA], but µM/min for [NAD+]. 
Km in nM for [DNA], but µM/min for [NAD+].  
kcat in min-1
Bmax is in % bound  
Kd in nM 
Table 4.1. The Overview of Studies and Comparison of Kinetics and DNA Binding 
Experiments on Native LigA and LigB, the standard condition for each set of measurements for 
each variables were mentioned in Section 2.3.6 in Chapter 2 in details. 
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Chapter 5: In Silico Molecular Docking
One of the main objectives of this PhD study was to clone and investigate the activity of native 
LigA and LigB (Chapters 3 and 4). Another key objective was to explore the potential of DNA 
ligases as possible antibiotic targets. The reason they might be attractive targets for new 
inhibitors is that DNA ligases are essential enzymes in DNA repair and replication (as 
described in Chapter 1). Work in this chapter describes using a molecular docking programme 
called Molecular Operating Environment (MOE). This software was used to identify chemical 
compounds from a large library of possible small molecular inhibitors. 
5.1. Preparation of Native LigA Structure in MOE. 
All the computational processes for native LigA were performed within the molecular docking 
program MOE, version 7.0 (Chemical Computing Group, 2013). Figure 5.1A shows a flow 
diagram of the key processes that were performed to discover new potential inhibitors of LigA. 
The first stage was to prepare the LigA structure. The crystal structure of native LigA was 
downloaded from the PDB (2OWO) as text file and opened using MOE. The crystal structure 
was input and checked by using MOE for additional information within the pdb.txt files, such 
as the binding of the DNA.  
The double strand DNA chain was removed to reduce the computation requirements. 
The domains of LigA have different functions, generally, Ia is involved with the capture of 
NAD+, NTase provides a scaffold for the catalysis Adenylate transfer reaction and OB, Znf and 
HhH domains assist with DNA binding and structural conformation changes (see Chapter 1.4). 
The sequence of LigA (amino acids 1-586, not including BRCT domain 587-671) was chosen 
to select all the amino acids chain by docking in MOE.
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Figure 5.1B shows the structure of LigA (Nandakumar et al, 2007) with the five 
domains: Ia, NTase, OB, Znf and HhH. Also shown is the AMP group which is actually 
attached to the 5 phosphate at the nick (the nicked DNA its self has been removed). Since the 
LigA-DNA co-crystal (Nandakumar et al, 2007) was prepared in the presence of EDTA, it was 
speculated that co-ordinated divalent cations are required to provide structure and complete the 
second and third reactions described below in Figure 5.2A (mechanism of LigA). As these are 
absent in the structure, the reaction has effectively been halted just before the 3OH attacks the 
adenylated DNA to complete the ligation step (Wilkinson et al, 2001). Priming (prior to DNA 
binding). 
5.2. Positive Control Simulation for rAMP Docking. 
Prior to commencing the key site finding and docking, a positive control experiment was 
performed where the AMP group (shown in cyan in Figure 5.1B) was removed from the 
2OWO structure in MOE file. The purpose of this docking control experiment was to test the 
MOE programme if it was able to identify the binding site for AMP by docking ribose AMP 
(rAMP) with the whole sequence of LigA protein (four sites).  
The rAMP molecule was selected from the ZINC library of molecules (ZINC library 
03860159), downloaded and saved as a MOL file in a biologically relevant conformation (Irwin 
et al., 2012). MOE was then instructed to dock rAMP into any site on LigA. MOE successfully 
identified the AMP binding site and correctly orientated the rAMP molecule. Figure 5.2B
shows diagrams of 2-D representation of the rAMP ligand bound in the active site of LigA as 
shown in 2OWO. The docking position of rAMP was the same as in 2OWO with AMP bound 
to the nicked DNA by re-docking the rAMP in MOE technique.
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Domain  Colour  Amino acids 
Ia  Blue  1-71
NTase  Green  72-316
OB  Yellow  317-407 
Znf  Orange  408-435 
(HhH)   Red  436-586 
BRCT  Not Shown 587-671 
AMP shown in cyan. 
Nicked DNA not shown. 
Figure 5.1. The Flow Diagram of MOE and the Crystal Structure of LigA. 
Panel A) shows the stages of in silico MOE docking (Molecular Operating Environment, 2013), from 
downloading PDB files of LigA protein (2OWO). Panel B) PDB 2OWO of LigA is showing docking 
site 1 in yellow (OB), docking site 2 in red (HhH and Zn), docking site 3 in green (NTase) and docking 
site 4 in magenta (Ia). 
Docking Results 
for sites 1-4
Calculation the 
Average of S Value  
Uploading File in MOE 
Positive control simulation 
Identify key amino 
acids
Select docking sites
Preparation of LigA 
structure
Ia
NTase
OB
Znf
(HhH
AMP
A
B
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1) Adenylation of Ligase  
LigA + NAD+    LigA-(lysyl-N-)-AMP + NMN 
2) Adenylation of nicked DNA 
LigA-(lysyl-N-)-AMP + 5PO4  LigA + AppDNA 
3) Ligation 
(AppDNA)-5PO4  + 3OH   DNA + AMP 
Figure 5.2. The Mechanism of E.coli DNA Ligase LigA and the Docking position of rAMP in 
2OWO. 
Panel A) shows the catalyses of LigA three distinct reaction steps. Panel B) shows 2-D representation 
of the AMP ligand bound in the active site of LigA as shown in 2OWO, ligand exposure means the 
position of compound that interact with the amino acid and receptor exposure means the position of 
water in the protein.
A
B
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5.3. Identifying key Amino Acids in LigA from Mutagenesis Studies.
To identify the key amino acids in LigA structure, two steps were used: the first was to map all 
the amino acids from previous mutagenesis studies on the LigA structure. The second step was 
to use the site finder function in MOE to map all the accessible binding sites for small chemical 
compounds. To select the most appropriate sites, information on which residues were essential 
for catalytic activity needed to be found. These were determined from previous publications 
(Sriskanda & Shuman, 2002a; Zhu & Shuman, 2005; Wang et al., 2008; Wang et al., 2009). 
Helpfully, the Uniprot database (www.uniprot.org) included all these single mutation studies 
on LigA.  
Table 5.1 shows the mutagenesis studies of different amino acids found within LigA. 
Amino acid mutations that had little or no effect are shown in pink and white, and the amino 
acids that are critical are shown in green. Figure 5.3A shows a PyMOL image of PDB 2OWO 
with the protein backbone shown in white. Shown in red are all the amino acid residues from 
Table 5.1 that when mutated gave a > 95% reduction in activity. 
For the second stage, once the crystal structure of LigA protein was prepared, the Site 
Finder function panel in MOE was used to predict possible binding sites (Galli et al., 2014).  
Depending on the previous survey of mutagenesis studies of different amino acids on LigA, a 
large number of possible docking sites were found using the same mutagenesis position for all 
domains of LigA protein. (Not all of these were used). Figure 5.3B shows an MOE image of 
2OWO with all the detected drug-able sites shown with red and white spheres and the LigA 
main chain in ribbon format. 
5.4. Select Docking Sites Using MOE. 
The key results from section 5.3 was to map where the essential amino acids were (Figure 
5.3A) and where the drug-able sites were (Figure 5.3B). Based on these maps, four 
potential docking sites were chosen.
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A.A. position Mutation % Ligation inhibition
334 T → A 100
521 G → D or V 100
22 Y → A or S 99.9
35 Y → S 99.9
115 K → Q or R 99.9
117 D → N 99.9
118 G → A 99.9
173 E → A, D or Q 99.9
200 R → A, K or Q 99.9
36 D → A 99.8
32 D → A or E 99
208 R → A, K or Q 99
277 R → A 99
285 D → N 99
314 K → Q 99
35 Y → A 98
117 D → E 97
36 D → E 96
285 D → E 96
314 K → R 95
333 R → A or Q 95
379 R → A or Q 95
383  384 VI → AA 95
446  447 RR → AA 95
455 G → D or V 95
489 G → D or V 95
521 G → A 95
553 G → D or V 95
22 Y → F 91
32 D → N 91
23 H → A or Y 90
487 R → A 90
36 D → N 88
290 K → A 87
286 G → A 86
614 R → A 85
342 R → A 80
35 Y → F 77
198 N → A 74
172 G → A 64
138 D → A 63
455 G → A 50
143 E → A 48
288 V → A 25
10 E → A 0
Table 5.1.   Shows the collected Mutagenesis studies of different amino acids found within LigA 
using Uniprot database. These have been ranked according to the percentage inhibition for each 
mutation. Lysine 115 which forms the LigA-(lysyl-N-)-AMP intermediate is shown in red. 
References in main text. 
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Figure 5.3.      Identifying key Amino Acids in 2OWO from Mutagenesis Studies.  
Panel A) shows Pymol image of PDB 2OWO with the protein structure shown in White, AMP in 
Cyan and all residues that when mutated induce a > 95% reduction in activity shown in Red. Panel 
B) An MOE image showing the ribbon structure of 2OWO with all the detected drug-able sites 
shown with spheres. 
B A
B
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Sites were selected based on four factors; accessibility, pocket size and proximity 
to essential amino acids (Table 5.1) and sites of structural interest (Figure 5.1B). Figure 
5.4 shows the four selected docking sites of LigA. These are called Docking site 1 (OB 
domain) in Red, Docking site 2 (Znf and HhH domain) in Yellow, Docking site 3 (NTase 
domain) in Green and Docking site 4 (Ia domain) in Magenta. The coloured spheres 
represent dummy atoms which show the pocket at the selected binding sites. Site 1 is the 
smallest and most accessible site. It is located on the OB domain. This region acts as the 
hinge for the clamping mechanism of LigA. The OB domain is also involved in DNA 
binding.  
             In Table 5.2 is a summary table of the amino acids of each sites (1-4) explains 
only the key sites that selected for molecular docking in MOE (in silico). The key amino 
acids that selected for molecular docking in Site 1 was Arg 325, Ile 371, Gly 372, Asp 
398, Thr 399, Arg 400, Asp 326 Val 324, Glu 328, Val 408, Glu 397, Pro 396 and Val 327 
(see Table 5.2). Site 2 is found in the HhH DNA binding Domain. This site contains the 
essential amino acid Arg 487. The mutation of this residue can inhibit overall enzyme 
function by 90% (see Table 5.1 above).  
             Also, this region is flanked by residues at positions 455 and 489 both of which, 
when mutated, can inhibit nick ligation by 95% (Table 5.1). The site is also quite 
accessible as it is exposed on the surface of the enzyme. The key amino acids in this site 
(site 2) includes Lys 457, Ile 458, Asp 460, Gln 461, Leu 485, Glu 486, Arg 487, Met 488, 
Lys 465, Glu 464, Gly 455, Asp 456 and Gly 453 (see Table 5.2). Site 3 was located on 
the NTase domain, which is the active site of the enzyme. This is the location of reactions 
1, 2 and 3 listed above (Figure 5.2A). This site contains the essential amino acids Asp 117 
and Arg 200. The mutation of these residue can inhibit overall the enzyme by 99.9% 
(Table 5.1).  
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Figure 5.4.  The Descriptions of the Sites Selected for Molecular Docking in MOE.
Panel A) The first image was the domain map of LigA showing the protein structure and the 
binding site of compounds, Site 1 (OB domain) in Red, Docking Site 2 (Znf and HhH domain) in 
Yellow, Docking Site 3 (NTase domain) in Green and Docking Site 4 (Ia domain) in Magenta For 
clarity the nicked DNA is not shown.
Table 5.2     A summary of the key amino acids that selected for molecular docking in Site 1-
4 in MOE. 
12 Å 19 Å 32 Å 41 Å
PDB 2OWO PDB 2OWO PDB 2OWO PDB 2OWO
Site Site Site Site
Domain OB Domain HhH Domain NTase Domain NTase/1a
amino acid Arg 325 amino acid Lys 457 amino acid Leu 116 amino acid Tyr 35
Ile 371 Ile 458 Asp 117 Asp 36
Gly 372 Asp 460 Gly 118 Ala 65
Asp 398 Gln 461 Val 174 Pro 66
Thr 399 Leu 485 Phe 175 Leu 67
Arg 400 Glu 486 Leu 176 Ala 68
Asp 326 Arg 487 Pro 177 Ala 69
Val 324 Met 488 Gln 178 Phe 70
Glu 328 Lys 465 Pro 199 Asp 144
Val 403 Glu 464 Arg 200 Ile 145
Glu 397 Gly 455 Ala 203 Thr 146
Pro 396 Asp 456 Phe 282 Ser 147
Val 327 Gly 453 Asp 283 Asn 148
Lys 290 Gln 209
Glu 113 Leu 210
Val 288 Pro 212
Glu 173 Pro 58
Tyr 225 Arg 213
Leu 80 Asp 211
Ala 120 Ala 64
Ser 81 Arg 61
Arg 136 Met 39
Leu 82 Arg 43
Lys 115
Leu 114
Glu 113
Arg 136
Docking site 1 Docking site 2 Docking site 3 Docking site 4
1 2 3 4
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The key amino acids that selected for molecular docking in Site 3 are listed in 
table 5.2. Site 4 is composed of amino acid from both the Ia and NTase domains, which 
essential domains in the mechanism steps of LigA in the first reaction. The mutation of 
these residue can inhibit the enzyme by 99.9% and 97%, respectively (Table 5.1). This 
site includes a lots of amino acids that are listed in Table 5.2 above. 
5.5. Docking Results for Sites 1 to 4. 
Into each of the four chosen docking sites (Table 5.2) was docked putative inhibitor 
molecules from a ZINC library of 800 compounds, which had 3995 different structural 
conformations. The aim with this was to use MOE to determine the most likely compounds 
to bind and inhibit the protein (Vilar et al., 2008). Docking calculations were achieved 
using the docking module of MOE. Specifically, the interactions between protein-small 
molecules was recommended to select the parameters (inhibitors) by docking using MOE 
software. The new compounds was set as ligand and correct site (sites 1-4) was fixed as 
receptors. In this situation the new compounds were docked into the site. Each of these 
new inhibitors were tested in the selected site and a score is given. The S-value is a 
simulated approximation of the ΔG of the binding.  
             The larger and more negative the S-value, the tighter the theoretical binding. 
Larger docking molecules tend to form more interactions and therefore produce larger 
more negative S-values. All the compounds were chosen based on the tightness of the 
binding by using MOE (in silico) and ordered for in vitro experiments where their IC50
values were measured and the most successful with the greatest potential would be used 
for future drug studies. A total of eight compounds were chosen from the four sites on 
LigA depending on the high negative number of S-value. Figure 5.5A shows the four 
selected docking sites of LigA. Figure 5.5B shows the eight compound that had largest 
negative number of S-value and site position. 
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Name Site S value 
1. Oxidised Glutathione 2 -47.764
2. 5-Azacytidine 3 -43.4276
3. Geneticin (G418) 1 -40.101
4. Chlorhexidine 1 -39.0645
5. Bestatin/ Ubenimex 4 -36.7435
6. 2-(Aminomethyl) imidazole 4 -36.1202
7. Imidazolidinyl Urea 2 -35.1460
8. Imidazo [1,2-a] pyridine-7-carboxylic acid 3 -29.5067
Site 2
(HhH domain)
Site 1
(OB domain)
Site 4 NTase/Ia 
domain
Site 3 NTase 
domain
A
Figure 5.5.         The Docking Results Sites (1-4) and the Eight Compounds that were Identified.
Panel A) shows the four selected docking sites of LigA. These are called Docking site 1 (OB domain) 
in Red, Docking site 2 (Znf and HhH domain) in Yellow, Docking site 3 (NTase domain) in Green and 
Docking site 4 (Ia domain) in Magenta. Panel B) shows the eight compounds that had highest negative 
number of S-value with their site position. 
B
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5.5.1. Binding of MOE Library Arcos 800 into Site 1. 
The simulated docking of the molecule library into Site 1 produced a large number of potential 
compounds, with a range of S-values from -40.101 to -6.0691. The strongest binding molecule, 
with an S-value of -40.101 was the antibiotic G418, also known as Geneticin (#A1720 Sigma 
Aldrich). Figure 5.6A shows a 2D ligand interaction diagram of Geneticin docked into Site 1. 
This interaction showed very high ligand exposure as the molecule was sitting on the surface 
of the OB domain. The molecule formed hydrogen-bond interactions with residues Asp 398, 
Arg 400, Arg 325 and Asp 326 and was therefore successfully linking two formerly free-to-
move peptide sequences.   
The second strongest binder (S-value = -39.0645) was the antibacterial Chlorhexidine 
(#282227 Sigma Aldrich). This is shown in Figure 5.6B. This molecule was forming 
interactions with residues Asp 326 and Asp 398. This bound in a similar way to Geneticin, 
straddling two peptide chains. This may mean it is a good inhibitor for ligases. 
It was interesting that the two compounds were already known as antibacterial drugs. 
These two compounds were the primary candidates for this site, as many of the other candidate 
conformations had a high level of ligand exposure. These molecules were both relatively large 
and formed multiple interactions with the OB domain (Site 1). 
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Figure 5.6. Binding of MOE Library Arcos 800 into Site1.  
Panel A) 2D ligand interaction diagrams showing the interactions at binding site 1 of Geneticin (A1720 
Sigma). Panel B) 2D ligand interaction diagrams showing the interactions at binding site 1 of 
Chlorhexidine (282227 Aldrich). 
Geneticin
ChlorhexidineB
A
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5.5.2. Binding of MOE Library Arcos 800 into Site 2. 
Docking at this site produced a rage of S-values from -47.7664 to -7.5062. The strongest 
binding candidate (S-value = -47.764) was Oxidised Glutathione (Glutathione disulphide) 
(#49740 Sigma). Figure 5.7A shows a 2D ligand interaction diagram of Oxidised Glutathione 
docked into Site 2. This molecule forms multiple interactions with various sections of the 
binding pocket. It is relatively large and in an accessible region, it remains exposed. 
This candidate molecule was selected as the strongest binding, which interactions with 
residues 465, 486, 460, 457 and 458. The next candidate inhibitor was Imidazolidinyl urea 
(#l5133 Aldrich), which had a higher S-value (S value = -35.1460). Figure 5.7B shows a 2D 
ligand interaction diagram of Imidazolidinyl urea docked into Site 2. It showed an interaction 
and displacement with 486, 457, 487 and 488. (see Figure 1.2 in Chapter 1). Imidazolidinyl 
urea also fitted well into the binding pocket with minimal exposure. 
5.5.3. Binding of MOE Library Arcos 800 into Site 3. 
Site 3 is the active site of the enzyme. This is the location of reactions 1, 2 and 3 listed above. 
The docking run produced a range of S-values from -47.3090 to 448.9537. This much greater 
range indicates that this binding pocket is less exposed and accessible than those described 
previously. As binding site 3 is an AMP binding site, it is expected that nucleotide and 
nucleoside analogues will bind this site also. The strongest binding molecule was 5-
Azacytidine (S-value = -43.4276) (#A2385 Sigma) a chemotherapeutic nucleoside analogue 
which form a direct sidechain hydrogen bind with Lys 115, Glu 113 and Leu 116. Figure 5.8A
shows a 2D ligand interaction diagram of 5-Azacytidine docked into Site 3. Imidazo[1,2-
a]pyridine-7-carboxylic acid was the second candidate with S-value -29.5067 (#CDS017300 
Aldrich). Figure 5.8B shows a 2D ligand interaction diagram of Imidazo[1,2-a]pyridine-7-
carboxylic acid docked into Site 3.  
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Figure 5.7. Binding of MOE Library Arcos 800 into Site2.  
Panel A) 2D ligand interaction diagrams showing the interactions at binding site 2 of Oxidised 
Glutathione (#49740 Sigma). Panel B) 2D ligand interaction diagrams showing the interactions at 
binding site 2 of Imidazolidinyl urea (#l5133 Aldrich). 
Oxidised Glutathione
Imidazolidinyl urea
A
B
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Figure 5.8. Binding of MOE Library Arcos 800 into Site3.  
Panel A) 2D ligand interaction diagrams showing the interactions at binding site 3 of 5-Azacytidine 
(#A2385 Sigma). Panel B) 2D ligand interaction diagrams showing the interactions at binding site 3 
of Imidazo[1,2-a]pyridine-7-carboxylic acid(#CDS017300 Aldrich).
5-Azacytidine
Imidazo[1,2-a]pyridine-7-carboxylic 
A
B
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5.5.4. Binding of MOE Library Arcos 800 into Site 4. 
Site 4 is composed of amino acid residues from both the Ia and NTase domains. It is speculated 
that this region is essential to the priming reaction 1. The site also contains residues 35 and 36 
both of which, when mutated induce a ≥ 99.8% reduction in nick ligation.  
(Table 5.1 above). For this site, the first candidate was Bestatin/Ubenimex (S-value = -
36.7435) (#482609 Aldrich).  
Figure 5.9A shows a 2D ligand interaction diagram of Bestatin/Ubenimex docked into 
Site 4. This molecule formed hydrogen-bond interactions with residues Arg 43, Asp 36, Ala 
65 and Ser 147. 2-(Aminometyl) imidazole (S-value = - 36.1202) (#723340 Aldrich) have been 
selected. These have been selected as they both interact directly with Asp 36 and fit well in the 
binding pore, Ser 147, Leu 210, Phe 70 and Ala 68. Figure 5.9B shows a 2D ligand interaction 
diagram of 2-(Aminometyl) imidazole docked into Site 4.  
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Figure 5.9. Binding of MOE Library Arcos 800 into Site4.  
Panel A) 2D ligand interaction diagrams showing the interactions at binding site 4 of
Bestatin/Ubenimex (482609 Aldrich). Panel B) 2D ligand interaction diagrams showing the 
interactions at binding site 4 of2-(Aminometyl) imidazole (723340 Aldrich). 
Bestatin/Ubenime
2-(Aminomethyl) imidazole
A
B
168 
5.6. Discussion.  
In this Chapter, the molecular docking software MOE was used to see if there were compounds 
that could attach to the structure of LigA enzyme. Eight compounds were chosen from four 
sites on LigA via using MOE software. These compounds have been chosen depending on the 
large negative number of S-value by using ZINC database in silico docking runs. These 
compounds were: Glutathione disulphide (#49740 Sigma), 5-Azacytidine (#A2385 Sigma), 
Geneticin (G418) (#A1270 Sigma), Chlorhexidine (#282227 Aldrich), Bestatin/Ubenimex 
(#482609 Aldrich), 2-(Aminometyl) imidazole (#738840 Aldrich), Imidazolidinyl Urea 
(#I5133 Aldrich), and Imidazo [1,2-a]pyridine-7-carboxylic acid (#CDD017300 Aldrich). 
The largest negative number of S-value of these compounds were Glutathione 
disulphide (Site 2) and 5-Azacytidine (Site 3) with S-value -47.764 and -43.4276, respectively. 
5-Azacytidine was formed a hydrogen bond interactions with residues Lys 115, which is the 
active residue in LigA protein to form the covalent intermediate bound. Imidazolidinyl urea, 
which had a higher S-value (-35.1460) in Site 2 was forming interaction and displacement with 
residue Arg 487 that considers one of the essential amino acid that penetrates the minor groove 
at the outer edge of 3-OH side of the nick in HhH domain and contact to the 
nuclotidyltransferase domain, which involved with DNA binding (Wang et al., 2008). 
Imidazo[1,2-a]pyridine-7-carboxylic acid was the second candidate with S-value -29.5067 in 
Site 3 and this molecules interact just with Lys 115 and Lys 290. Lys 290 is as an essential 
residue for E coli LigA functions to contact the AMP adenine (Wang et al., 2009; Sriskanda & 
Shuman, 2002a).  
2-(Aminometyl) imidazole had S-value - 36.1202 in Site 3, which showing interaction 
with  residue Asp 36 that involved specifically in adenylating and AMP transfer in Ia domain 
of LigA structure (Sriskanda & Shuman, 2002b). 
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The further MOE experiments that I suggest is to do the homologous sites in different 
bacteria to see if the compounds that bind that site regardless of any S-value will inhibit the 
different bacteria in vitro and in vivo and inhibit the growing of bacteria (see Figure 1.4 in 
Chapter 1). Because of the crystal structure of LigB protein was not solved yet, LigB has 
limitation in MOE techniques. However, the manually alignment of the primary and secondary 
structures of LigB and LigA was done by Clustal programme (see Figure 1.3 in Chapter1). 
The next Chapter (Chapter 6) explores these eight compounds tested firstly in vitro by ligation 
assays with LigA using denaturing gel and in vivo using Kirby Bauer technique.   
The biological activities of some of these eight compounds are already known, for 
example: 5-Azacytidine is a chemical analogue of cytidine in DNA or RNA. It is effects on 
DNA and protein synthesis in embryonic tissues, cells in tissue culture, regenerating livers, 
bacteria and phages (Čihák, 1974).  It is used in the treatment of myelodysplastic syndrome 
and sometimes used for acute myeloid leukaemia (Estey, 2013). Geneticin blocks polypeptide 
synthesise by inhibiting the elongation step in both prokaryotic and eukaryotic cells (Vicens et 
al., 2003). Chlorhexidine is an antiseptic that is used for skin disinfection before surgery in 
hospital. It has a positive charge that allows to interact with the cell wall of bacteria as negative 
charge and inhibit it (Davis et al., 2010). Bestatin (Ubenimex) is known as protease inhibitor 
and is being studied for use in the treatment of acute myelocytic leukemia (Hirayama, et al., 
2003) and lymphedema (Tian, et al., 2017). More discussion about their inhibitions in vitro on 
E.coli DNA ligase LigA and in vivo are shown in Chapter 6.  
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Chapter 6: In vitro and In vivo inhibition  
Assay of native LigA protein. 
The previous study and data of Molecular Operating Environment in Chapter 5 described the 
successful docking of the compounds on native LigA protein using in silico technique. 
Accordingly, this results chapter utilises this enzyme (native LigA) for inhibition studies with 
the different compounds and different concentrations. Compounds were selected based on the 
tightness of the binding and ordered for in vitro testing where their IC5o values were measured 
and the most successful with the greatest potential for future drug studies. Key questions 
addressed in this chapter within this work include, whether these compounds or inhibitors can 
inhibit the LigA protein in vitro or in vivo as well.  
Here in this chapter we will describe the various in vitro (denaturing gel) and in vivo 
(Kirby-Bauer) experiments that were used to investigate whether these different compounds 
that have a high negative number of S-value (MOE) can bind to LigA and affect its activity 
through a combination of in silico, in vitro and in vivo techniques. The resulting data in this 
chapter will provide information about which compound or inhibitor that can use and inhibit 
the LigA protein making it a promising antibiotic target in the future. This will be a building 
block towards potential future studies of inhibitions that could then explore and exploit small-
molecule chemical libraries for compounds that affect and kill the bacteria.  
6.1. Design of in vitro Assays.
In this study the powerful combination was to identify new compounds or inhibitor that 
selected via using MOE technique with the ability to bind to the LigA enzyme. Eight starting 
compounds were filtered out of 800 potential compounds that showed the ability to limit or 
stop the function of LigA in the process of nick repairing in DNA by using molecular docking 
(in silico) (previous chapter).  
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MOE software allowed us to choose eight compounds from four sites on LigA. These 
compounds had a high negative number of S-value (please see Table 5.2) that purchased by 
using ZINC data base in silico docking runs (MOE, previous chapter). The eight compounds 
were; Glutathione disulphide (#49740 Sigma), 5-Azacytidine (#A2385 Sigma), Geneticin 
(G418) (#A1270 Sigma), Chlorhexidine (#282227 Aldrich), Bestatin/Ubenimex (#482609 
Aldrich), 2-(Aminomethyl) imidazole (#738840 Aldrich), Imidazolidinyl Urea (#I5133 
Aldrich), and Imidazo [1,2-a]pyridine-7-carboxylic acid (#CDD017300 Aldrich). 
Figure 6.1 down shows the chemical structure of the eight candidate compounds. Four 
out of the eight compounds were shown very potent inhibition of the enzyme ability to repair 
nicked DNA; Geneticin (G418) (site1) the s-value was -40.101, 5-Azacytidine (site4) with s-
value -43.4276, Chlorhexidine (site 1) s-value was -39.0645 and Imidazolidinyl Urea (site 2) 
the s-value was -35.1460.  They were ordered from Sigma Aldrich in powder form and 
suspended in nuclease-free water. 
 The concentrations of all these compounds that used in this experiment were 40 nM  
400 µM to quantify their inhibition on LigA nick ligation of DNA. The reaction mixture for 
each tube was 50 µl that contained 100 nM DNA, 30-40 nM LigA, 1× DNA Ligase buffer and 
the required compound concentration. Timepoints that used were between 0.25-60 or 0.5-20 
minutes for each reaction mixture.  
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Figure 6.1. showing the chemical structure of the eight compounds that had large number of 
S-value via using MOE programme (see Figure 5.5B in Chapter 5). 
    G418 
Chlorhexidine
Glutathione disulphide
Imidazolidinyl Urea
5-Azacytidine
Imidazo [1,2-a]pyridine-7-
carboxylic acid 
Bestatin/Ubenimex 
2-(Aminometyl) Imidazole 
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6.2. In vitro Assays Results. 
The following eight sections (6.2.1 to 6.2.8) give the in vitro ligation assay results for the eight 
compounds that were tested. These are described in the order of the S-values (Figure 5.5 in 
Chapter 5), starting with most negative S-value.  
6.2.1. Glutathione Disulphide. 
The largest S-value (-47.764) from MOE prediction as an inhibitor on E.coli DNA ligase LigA 
was for glutathione disulphide. The experiment was carried out at substrate concentration 100 
nM of nicked DNA and 30 nM of ligase LigA. The varying glutathione disulphide compound 
was 0, 0.004, 0.040, 0.2, 0.4, 1, 2, 4, 20, 50, 200 and 400 µM. Figure 6.2A shows a denaturing 
gel 15% (w/v) with three timecourses at 10, 50 and 100 µM of glutathione disulphide as an 
example of three denaturing gels. All the gels corresponding to the experiments of varying 
[glutathione disulphide] substrate are shown in Appendix 6.1. The band intensity of nicked 
DNA (20Top) and the ligated DNA (50Top) were analysed using ImageJ and plotted in the 
Excel programme to get the V0 for each timecourse of glutathione disulphide at different 
inhibitor concentrations. The gel shows that the band of nicked DNA (20Top) over the time 
(0.5, 1, 1.5, 3 and 20 min) decreased slightly and the band of 50Top increased slightly over the 
time. But over all there are no any disruption on the DNA (50Top) present on the gel at the 
lowest concentration even at the highest concentration of glutathione disulphide (100 µM).  
Figure 6.1B shows the corrected data of the initial rate (V0) for glutathione disulphide 
at different concentrations. The V0 values were calculated in Excel software using a linear fit 
to about the first 20-30% of the reaction. Figure 6.2C shows a curve of IC50 inhibition of 
glutathione disulphide. The initial rate data from Panel B was in put in Grafit software along 
with the glutathione disulphide concentration and an inhibition (IC50) fit added to the data. The 
flat line did not shows any effect on LigA protein at any glutathione disulphide.  
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Figure 6.2. The Inhibition of LigA with Varying Glutathione Disulphide Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate time-course samples collected from ligation 
reaction assay at 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 1-5, 
6-10 and 11-15 were time points: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of glutathione 
disulphide (20, 50 and 100 µM), respectively. Also labelled were the 20Top and 50Top bands, 
representing nicked DNA and ligated DNA, respectively. Panel B) Table shows the corrected data of 
the initial rate (V0) for all the varying [glutathione disulphide]. Panel C) shows a graph of initial rate 
against [glutathione disulphide]. The flat line did not shows any inhibition. 
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6.2.2. 5-Azacytidine.   
The second largest S-value (-43.4276) from MOE prediction as an inhibitor on E.coli DNA 
ligase LigA was for a 5-Azacytidine. The experiment was carried out at substrate concentration 
100 nM of nicked DNA. The varying 5-Azacytidine compound was 0, 0.040, 0.400, 4, 10, 50, 
100 and 400 µM. Figure 6.3A shows a denaturing gel 15% (w/v) with four timecourses at 10, 
50, 100 and 400 µM of 5-Azacytidine as an example. Another gel corresponding to the 
experiments of varying [5-Azacytidine] substrate are shown in Appendix 6.2. The gel shows 
that the band of nicked DNA (20Top) over the time (0.5, 1, 1.5, 3 and 20 min) decreased 
slightly and the band of 50Top decreased sharply over the time. Over all there are huge 
inhibition on the DNA (50Top) present on the gel at the lowest concentration (10 µM) and as 
well at the highest concentration of glutathione disulphide (400 µM) on this gel. 
Figure 6.3B shows the corrected data of the initial rate (V0) for 5-Azacytidine at 
different concentrations. The V0 values were calculated in Excel software using a linear fit to 
about the first 20-30% of the reaction. Figure 6.3C shows a curve of IC50 inhibition of 5-
Azacytidine. The initial rate against 5-Azacytidine concentrations from Panel B was put in 
Grafit software along with the 5-Azacytidine concentration and an inhibition (IC50) fit added 
to the data using an IC50 inhibition equation. The curve did show inhibition on LigA protein at 
50, 100 and 400 µM of 5-Azacytidine concentration. This equation gives four parameters: 
Yrange (the difference in initial rate between theoretical maximum and minimum), IC50 (the 
concentration of 5-Azacytidine that given a half-maximal inhibition concentration), slope 
factor (the steepness of the curve) and background (theoretical minimum of the curve).  From 
Figure 6.3C the Yrange for 5-Azacytidine was 30.72±5.40 µM/min, and the inhibition IC50 was 
10.34±4.14 µM.  
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Figure 6.3. The Inhibition of LigA with 5-Azacytidine Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 1-5, 6-10, 
11-15 and 16-20 were time pointes: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of 5-Azacytidine 
(10, 50, 100 and 400 µM), respectively. Also labelled were the 20Top and 50Top bands, representing 
free DNA and ligated DNA, respectively. Panel B) Table shows the corrected data of the initial rate 
(V0) for all the varying 5-Azacytidine. Panel C) shows a graph of initial rate against 5-Azacytidine, 
Yrange is the difference in initial rate between theoretical maximum and minimum, and IC50 is the 
concentration of 5-Azacytidine hat given a half-maximal inhibition concentration. Yrange for 5-
Azacytidine that inhibit the LigA protein was30.72±5.40 µM/min, and the inhibition IC50 was 
10.34±37.97 µM. 
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6.2.3. Geneticin (G418).  
The third largest S-value (-40.101) from MOE prediction as an inhibitor on E.coli DNA ligase 
LigA was for a G418. The experiment was carried out at substrate concentration 100 nM of 
nicked DNA. The varying G418 compound was 0, 0.400, 4, 10, 20, 50, 100, 200 and 400 µM.
Figure 6.4A shows a denaturing gel 15% (w/v) with four timecourses at 0.4, 10, 20 and 50 µM 
of G418 as an example of three denaturing gels. All the gels corresponding to the experiments 
of varying [G418] substrate are shown in Appendix 6.3. The gel shows that the band of nicked 
DNA (20Top) over the time (0.5, 1, 1.5, 3 and 20 min) decreased slightly and the band of 
50Top decreased sharply over the time. Over all there are huge inhibition on the DNA (50) that 
present on the gel at the lowest concentration (400 nM) and as well at the highest concentration 
of glutathione disulphide (50 µM). 
Figure 6.4B shows the corrected data of the initial rate (V0) for G418 at different 
concentrations. The V0 values were calculated in Excel software using a linear fit to about the 
first 20-30% of the reaction. Figure 6.4C shows a curve of IC50 inhibition of G418. The initial 
rate against G418 concentrations from Panel B was put in Grafit software along with the G418 
concentration and an inhibition (IC50) fit added to the data by using an IC50 inhibition equation. 
The same four parameters were calculated as before. The curve in Figure 6.xC did show 
inhibition or effect on LigA protein at 400 nM, 10, 20 and 50 µM of G418 concentrations. 
From Figure 6.4C the Yrange for G418 was 29.68±5.62 µM/min, and the inhibition IC50 of G418 
was 45.31±13.81 µM.  
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Figure 6.4. The Inhibition of LigA with Varying G418 Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 1-5, 6-10, 
11-15 and 16-20 were time points: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of G418 (400 
nM, 10, 20 and 50 µM), respectively. Also labelled were the 20Top and bands, representing free DNA 
and ligated DNA, respectively. Panel B) Table shows the corrected data of the initial rate (V0) for all 
the varying 5-Azacytidine. Panel C) shows a graph of initial rate against G418, Yrange is the difference 
in initial rate between theoretical maximum and minimum, and IC50 is the concentration of G418 hat 
given a half-maximal inhibition concentration. Yrange for G418 that inhibit the LigA protein was 
29.68±5.62 µM/min, and the inhibition IC50 of G418 was 45.31±13.81 µM. 
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6.2.4. Chlorhexidine. 
The fourth largest S-value (-39.0645) from MOE prediction as an inhibitor on E.coli DNA 
ligase LigA was for Chlorhexidine. The experiment was carried out at substrate concentration 
100 nM of nicked DNA. The varying Chlorhexidine compound was 0, 0.040, 0.400, 4, 20, 50, 
100 and 400 µM. Figure 6.5A shows a denaturing gel 15% (w/v) with four timecourses at 50, 
100, 200 and 400 µM of a Chlorhexidine as an example. Another gel corresponding to the 
experiments of varying [Chlorhexidine] substrate are shown in Appendix 6.4.
The gel shows that the band of nicked DNA (20Top) over the time (0.5, 1, 1.5, 3 and 20 min) 
decreased sharply especially at 400 µM, and chlorhexidine visually showed the largest 
disruption to nick repair (Figure 6.5A). At the 100, 200 and 400 µM concentrations there was 
no visible 50 base DNA present on the gel, showing its apparent complete disruption to DNA 
repair. This was not shown on the other compounds tested.
Figure 6.5B shows the corrected data of the initial rate (V0) for chlorhexidine at 
different concentrations. Figure 6.5C shows a curve of IC50 inhibition of chlorhexidine. The 
curve did show inhibition on LigA protein at 50, 100, 200 and 400 µM of chlorhexidine 
concentration. From Figure 6.5C the Yrange for chlorhexidine was 27.98±2.73 µM/min, and the 
inhibition IC50 was 20.66±6.11 µM.  
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Figure 6.5. The Inhibition of LigA with Varying Chlorhexidine Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 1-5, 6-10, 
11-15 and 16-20 were time points: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of  chlorhexidine 
(50, 100, 200 and 400 µM), respectively. Also labelled were the 20Top and 50Top bands, representing 
free DNA and ligated DNA, respectively. Panel B) Table shows the corrected data of the initial rate 
(V0) for all the varying chlorhexidine. Panel C) shows a graph of initial rate against chlorhexidine, 
Yrange is the difference in initial rate between theoretical maximum and minimum, and IC50 is the 
concentration of chlorhexidine that given a half-maximal inhibition concentration. Yrange for 
chlorhexidine that inhibit the LigA protein was 27.98±2.73 µM/min, and the inhibition IC50 of 
chlorhexidine was 20.66±6.11 µM. 
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6.2.5. Bestatin. 
The fifth largest S-value (-36.7435) from MOE prediction as an inhibitor on E.coli DNA ligase 
LigA was for Bestatin. The experiment was carried out at substrate concentration 100 nM of 
nicked DNA. The varying Bestatin compound was 0, 0.040, 0.4, 4, 10, 20, 50, 100 and 400 
µM. Figure 6.6A shows a denaturing gel 15% (w/v) with two timecourses at 40 and 400 nM 
of Bestatin as an example of two denaturing gels. All the gels corresponding to the experiments 
of varying [Bestatin] substrate are shown in Appendix 6.5. The band intensity of nicked DNA 
(20Top) and the ligated DNA (50Top) were analysed using ImageJ and plotted in the Excel 
programme to get the V0 for each timecourse of Bestatin at different inhibitor concentrations. 
The gel shows that the band of nicked DNA (20Top) over the time (0.5, 1, 1.5, 3 and 20 min) 
decreased slightly and the band of 50Top increased slightly over the time. But over all there 
are no disruption on the DNA (50Top) present on this gel at the lowest concentration even at 
the highest concentration of Bestatin (100 µM). 
Figure 6.6B shows the corrected data of the initial rate (V0) for Bestatin at different 
concentrations. The V0 values were calculated in Excel software using a linear fit to about the 
first 30% of the reaction. Figure 6.6C shows a curve of IC50 inhibition of Bestatin. The initial 
rate data from Panel B was in put in Grafit software along with the Bestatin concentration and 
an inhibition (IC50) fit added to the data. The flat line did not shows any inhibition or effect on 
LigA protein at any Bestatin.  
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Figure 6.6. The inhibition of LigA with varying Bestatin concentrations.
Panel A) Denaturing gel 15 % (w/v) shows separate time-course samples collected from ligation 
reaction assay with 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 
1-5 and 6-10 were time points: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of Bestatin (40 and 
400 nM), respectively. Also labelled were the 50 Top and 20 Top bands, representing free DNA and 
ligated DNA, respectively. Panel B) Table shows the corrected data of the initial rate (V0) for all the 
varying Bestatin. Panel C) shows a graph of initial rate against Bestatin, Yrange is the difference in initial 
rate between theoretical maximum and minimum, and IC50 is the concentration of Bestatin that given a 
half-maximal inhibition concentration. The flat line did not shows any inhibition. 
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6.2.6. Imidazolidinyl Urea. 
The seventh largest S-value (-35.1460) from MOE prediction as an inhibitor on E.coli DNA 
ligase LigA was for an Imidazolidinyl Urea. The experiment was carried out at substrate 
concentration 100 nM of nicked DNA. The varying Imidazolidinyl Urea compound was 0.04, 
0.400, 4, 10, 50, 200 and 400 µM. Figure 6.8A shows a denaturing gel 15% (w/v) with four 
timecourses at 10, 50 and 200 µM of Imidazolidinyl Urea as an example of three denaturing 
gels. All the gels corresponding to the experiments of varying [Imidazolidinyl Urea] substrate 
are shown in Appendix 6.6. The gel shows that the band of nicked DNA (20Top) over the time 
(0.5, 1, 1.5, 3 and 20 min) decreased slightly and the band of 50Top decreased slightly over the 
time with 10 and 50 µM, but decreased sharply with 200 µM. Over all there are high inhibition 
on the DNA (50Top) that present on the gel at the high concentration (200 µM).  
Figure 6.8B shows the corrected data of the initial rate (V0) for Imidazolidinyl Urea at 
different concentrations. The V0 values were calculated in Excel software using a linear fit to 
about the first 30% of the reaction. Figure 6.8C shows a curve of IC50 inhibition of 
Imidazolidinyl Urea. The initial rate against Imidazolidinyl Urea concentrations from Panel B 
was put in Grafit software and an inhibition (IC50) fit added to the data by using an IC50 
inhibition equation. The same four parameters were calculated as before. The curve in Figure 
6.8C did show inhibition on LigA protein at 50, 200 and 400 µM of Imidazolidinyl Urea 
concentrations. From Figure 6.4C the Yrange for Imidazolidinyl Urea was 18.99±9.75 µM/min, 
and the inhibition IC50 of Imidazolidinyl Urea was 7.56±14.48 µM.  
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Figure 6.7. The Inhibition of LigA with Varying Imidazolidinyl Urea Concentrations.
Panel A) Denaturing gel 15% (w/v) shows separate timecourse samples collected from ligation reaction 
assay with 15ºC. Lanes are labelled with loaded quenched time-course samples (10μl), lanes 1-5, 6-10 
and 11-15 were time points: 0.5, 1, 1.5, 3 and 20 minutes for each concentration of Imidazolidinyl Urea 
(10, 50 and 200 µM), respectively. Also labelled were the 20 Top and 50Top bands, representing free 
DNA and ligated DNA, respectively. Panel B) Table shows the corrected data of the initial rate (V0) 
for all the varying Imidazolidinyl Urea. Panel C) shows a graph of initial rate against Imidazolidinyl 
Urea, Yrange is the difference in initial rate between theoretical maximum and minimum, and IC50 is the 
concentration of Imidazolidinyl Urea that given a half-maximal inhibition concentration. Yrange for 
Imidazolidinyl Urea that inhibit the LigA protein was 18.99±9.75 µM/min, and the inhibition IC50 of 
Imidazolidinyl Urea was 7.56±14.48 µM. 
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6.3. In vivo Assay Results. 
The following section gives the in vivo (Kirby Bauer technique) ligation assay results for the 
eight compounds that were tested in vitro above. These are described in the order of the S-
values (Figure 5.5 in Chapter 5), starting with the largest negative S-value.  
Mueller-Hinton agar was used to prepare plates which were streaked using wild type E. 
coli and incubated at 37oC for 18 hours. A small colony was suspended in 1ml of LB broth in 
a cuvette to a 0.5 McFarland standard, which is the measure of the absorbance using a 
spectrophotometer at 625 nm until the OD600 of the broth was between 0.08-0.13 (26). This 
concentration was streaked across fresh Mueller-Hinton plates using a sterile swab, covering 
the plates three times. Five or six sterile disks were placed on the plate using tweezers, they 
were soaked in either a control or a compound. These plates were left to incubate for 18 hours 
and were analysed. A disk soaked in H2O reaction buffer was used as a negative control and 
2.5 mg/ml Ampicillin as a positive control. The Kirby Bauer experiment (in vivo) was carried 
at varying concentrations of the compound tested as follow in the table below: 
Compounds Concentrations in mM 
Glutathione Disulphide (-47.764) 40 80 100 200
5-Azacytidine (-43.4276) 10 20 40 100 200
Geneticin (G418) (-40.101) 0.1 0.2 0.4 0.6 0.8 1 2 4
Chlorhexidine (-39.0645) 0.01 0.05 0.1 0.4 0.6 0.8 1 2 4
Bestatin (-36.7435) 4 10 20
2-(Aminomethyl)Imidazole (-36.1202) 100 150 200
Imidazolidinyl Urea (-35.1460) 1 2 4 20 40 80 100 150 200
Imidazo [1,2-a] pyridine-7-
carboxylic acid (-29.5067)
200
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The largest S-value (-47.764) from MOE prediction as an inhibitor on E.coli DNA ligase LigA 
was for glutathione disulphide. Figure 6.8A shows a Mueller-Hinton agar plate with three 
concentrations 40, 80 and 100 mM of glutathione disulphide as one example of two Mueller-
Hinton agar plates. Another agar plate that corresponding to this experiment is shown in 
Appendix 6.7. The agar plate shows five discs: negative control (just H2O), 5 mg/ml 
Ampicillin as a positive control, 40 mM, 80 mM and 100 mM of glutathione disulphide that 
dissolved in free water (all the discs were labelled down in the agar plate). This agar plate 
shows there is no inhibition zone of glutathione disulphide even the highest concentration (200 
mM). Figure 6.8B shows the data of the inhibition zones by measuring the diameter of the 
zone around the disk for all the concentrations of glutathione disulphide. The diameter values 
were measured in ImageJ software. Figure 6.8C shows a curve of IC50 inhibition of glutathione 
disulphide. The data were fit to a modified Michaelis-Menten equation using Grafit software. 
The Vmax and Km were modified to Imax (Maximum Inhibition, in mm) and IC50 (like Km, in 
mM). The curve did not show any inhibition on the growth of the bacteria at 0, 40, 80, 100 and 
200 mM concentration of glutathione disulphide. This equation gives two parameters: Imax (the 
theoretical maximum diameter) and IC50 (the concentration of glutathione disulphide that give 
a half-maximal Imax). From Figure 6.8C the flat line did not shows any inhibition or effect on 
the growth of E.coli at any concentration of glutathione disulphide. This compares to in vitro
results (see Section 6.2.1), which showed the glutathione disulphide did not inhibit LigA 
enzyme.
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The second largest S-value (-43.4276) from MOE prediction as an inhibitor on E.coli
DNA ligase LigA was for a 5-Azacytidine. Figure 6.9A shows a Mueller-Hinton agar plate 
with three concentrations 10, 20 and 40 mM of 5-Azacytidine as one example of two Mueller-
Hinton agar plates. Another agar plate that corresponding to this experiment is shown in 
Appendix 6.8. The agar plate shows five disks: negative control (just H2O), 5 mg/ml 
Ampicillin as a positive control, 10, 20 and 40 mM of 5-Azacytidine (all the disks were labelled 
down in the agar plate). This agar plate shows there is no inhibition zone of 5-Azacytidine even 
at high concentration (200 mM). Figure 6.9B shows the data of the inhibition zones by 
measuring the diameter of the zone around the disk for all the concentrations of 5-Azacytidine. 
The diameter values were measured in ImageJ software. 
Figure 6.9C shows a curve of IC50 inhibition of 5-Azacytidine. The data were fit to a 
modified Michaelis-Menten equation using Grafit software. The Vmax and Km were modified 
to Imax (Maximum Inhibition) and IC50 (like Km). The curve did not show any inhibition on the 
growth of the bacteria at 0, 40, 80, 100 and 200 mM concentration of 5-Azacytidine. This 
equation gives two parameters: Imax (the theoretical maximum diameter in mm) and IC50 (the 
concentration of glutathione disulphide that give a half-maximal Imax in mM). From Figure 
6.9C above the flat line did not shows any inhibition or effect on the growth of E.coli at any 
concentration of 5-Azacytidine. This different to in vitro results (see Section 6.2.2), which 
showed the 5-Azacytidine did inhibit LigA enzyme or the growth of bacteria. 
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Figure 6.8. The in vivo Inhibition of glutathione disulphide on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of glutathione disulphide were used in this plate: 80, 100 and 200 mM. The 
agar plate shows five discs were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a negative 
control just H2O, 3 is 40 mM of glutathione disulphide, 4 is 80 mM of glutathione disulphide and 5 is 
100 mM of glutathione disulphide. Panel B) shows the data of the inhibition zones (diameter) for 
different concentrations of glutathione disulphide. The data were fit to a Michaelis-Menten kinetics fit 
using Grafit software, and the Vmax and Km modified to Imax and IC50. Panel C) shows a curve of IC50
inhibition of glutathione disulphide. The diameter data of glutathione disulphide concentrations from 
Panel B was put in Grafit software along with the glutathione disulphide concentration and an inhibition 
(IC50) fit added to the data using an IC50 inhibition equation. The curve did not show any inhibition on 
the growth of the bacteria at 0, 40, 80, 100 and 200 mM concentration of glutathione disulphide. 
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Figure 6.9. The in vivo Inhibition of 5-Azacytidine on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of 5-Azacytidine were used in this plate: 10, 20 and 40 mM. The agar plate 
shows five disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a negative control just 
H2O, 3 is 10 mM of 5-Azacytidine, 4 is 20 mM of 5-Azacytidine and 5 is 40 mM of 5-Azacytidine. 
Panel B) shows the data of the inhibition zones (diameter) for different concentrations of 5-
Azacytidine. The data were fit to a Michaelis-Menten kinetics fit using Grafit software, and the Vmax
and Km modified to Imax and IC50. Panel C) shows a curve of IC50 inhibition of 5-Azacytidine. The 
diameter data of 5-Azacytidine concentrations from Panel B was put in Grafit software along with the
5-Azacytidine concentration and an inhibition (IC50) fit added to the data using an IC50 inhibition 
equation. The curve did not show any inhibition on the growth of the bacteria at 0, 40, 80, 100 and 200 
mM concentration of 5-Azacytidine. 
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The third largest S-value (-40.101) from MOE prediction as an inhibitor on E.coli DNA ligase 
LigA was for a G418. Figure 6.10A shows a Mueller-Hinton agar plate with three 
concentrations 1, 2 and 4 mM of G418 as one example of three Mueller-Hinton agar plates. 
Another two agar plates that corresponding to this experiment are shown in Appendix 6.9. This 
agar plate shows a huge inhibition zone with all three concentrations. Comparing with another 
compounds small concentration of G418 did the inhibition very well. Figure 6.10B shows the 
data of the inhibition zones by measuring the diameter of the zone around the disk for all the 
concentrations of G418. Figure 6.10C shows a curve of IC50 inhibition of G418. The curve did 
show very nice inhibition on the growth of the bacteria at all the concentration except the 0.01 
mM of G418. From Figure 6.10C the Imax for G418 was 20.59 ± 1.96 mM/min, and the 
inhibition IC50 of G418 was 0.63± 0.17mM. This compares to in vitro results (see Section 
6.2.3), which showed that the G418 did inhibit LigA enzyme. 
The fourth largest S-value (-39.0645) from MOE prediction as an inhibitor on E.coli
DNA ligase LigA was for a chlorohexidine. Figure 6.11A shows a Mueller-Hinton agar plate 
with three concentrations 1, 2 and 4 mM of chlorhexidine as one example of three Mueller-
Hinton agar plates. Another two agar plates that corresponding to this experiment are shown in 
Appendix 6.10. The agar plate shows five disks: 1 is 5 mg/ml Ampicillin as a positive control, 
2 is control (just H2O), 3 is 1 mM of chlorohexidine, 3 is 2 mM of chlorohexidine and 5 is 4 
mM of chlorohexidine (all the discs were labelled down in the agar plate). This agar plate 
shows a huge inhibition zone with all three concentrations. Comparing with another 
compounds small concentration of chlorhexidine did the inhibition very well even at 0.01 mM. 
Figure 6.11B shows the data of the inhibition zones by measuring the diameter of the zone 
around the disk for all the concentrations of. Figure 6.11C shows a curve of IC50 inhibition of 
chlorhexidine.  
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Figure 6.10. The in vivo Inhibition of Geneticin (G418) on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of G418 were used in this plate: 1, 2 and 4 mM. The agar plate shows five 
disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a negative control just H2O, 3 is 
1 mM of G418, 4 is 2 mM of G418 and 5 is 4 mM of G418. Panel B) shows the data of the inhibition 
zones (diameter) for different concentrations of G418. The data were fit to a Michaelis-Menten kinetics 
fit using Grafit software, and the Vmax and Km modified to Imax and IC50. Panel C) shows a curve of IC50
inhibition of G418. The diameter data of G418 concentrations from Panel B was put in Grafit software 
along with the G418 concentration and an inhibition (IC50) fit added to the data using an IC50 inhibition 
equation. The curve did show very potent inhibition on the growth of the bacteria at all the 
concentrations of G418. The Imax for G418 was 20.59±1.96 mM/min, and the inhibition IC50 of 
G418 was 0.63±0.17mM. 
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Figure 6.11. The in vivo Inhibition of Chlorhexidine on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of chlorhexidine were used in this plate: 1, 2 and 4 mM. The agar plate 
shows five disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a negative control just 
H2O, 3 is 1 mM of chlorhexidine, 4 is 2 mM of chlorhexidine and 5 is 4 mM of chlorhexidine. Panel
B) shows the data of the inhibition zones (diameter) for different concentrations of chlorhexidine 
using ImageJ. The data were fit to a Michaelis-Menten kinetics fit using Grafit software, and the Vmax
and Km modified to Imax and IC50. Panel C) shows a curve of IC50 inhibition of chlorhexidine. The 
diameter data of chlorhexidine concentrations from Panel B was put in Grafit software along with the
chlorhexidine concentration and an inhibition (IC50) fit added to the data using an IC50 inhibition 
equation. The curve did show very potent inhibition on the growth of the bacteria at all the 
concentrations of chlorhexidine. The Imax for chlorhexidine was 11.22±0.43 mM/min, and the 
inhibition IC50 of chlorhexidine was 0.17±0.03 mM. 
2
34
Chlorhexidine
conc (mM) 0 0.01 0.05 0.1 0.4 0.6 0.8 1 2 4
DIA (mm) 0 1.44 2.45 4.07 7.95 9.8 9.67 9.49 10.38 10.86
Example inhibition of Chlorhexidine
in vivo 
1
5
B
C
A
[Chlorhexidine] in mM
0 1 2 3 4 5
A
ve
ra
ge
 d
ia
m
et
er
 o
f 
in
hi
bi
tio
n 
(m
m
)
0
2
4
6
8
10
12
14
16
18
20
Parameter Value Std. Error
Maximum inhibition 11.2224 0.4258
Conc of inhib that gives half  Imax 0.1734 0.0312
Background 0.2474 0.3457
193 
The curve did show very potent inhibition on the growth of the bacteria at all the concentration 
of chlorhexidine. From Figure 6.11C above the Imax (mm) for chlorhexidine was 11.22±0.43 
mM/min, and the inhibition IC50 of chlorhexidine was 0.17±0.03 mM. This compares to in 
vitro results (see Section 6.2.4). 
The fifth largest S-value (-36.7435) from MOE prediction as an inhibitor on E.coli
DNA ligase LigA was for Bestatin. Figure 6.12A shows a Mueller-Hinton agar plate with three 
concentrations 4, 10 and 20 mM of Bestatin. The agar plate shows five disks: negative control 
(just H2O), 5 mg/ml Ampicillin as a positive control, 3 is 4 mM Bestatin, 4 is 10 mM Bestatin 
and 5 is 20 mM of Bestatin. This agar plate shows there is no inhibition zone of Bestatin. 
Figure 6.12B shows the data of the inhibition zones by measuring the diameter of the zone 
around the disk for all the concentrations of Bestatin. Figure 6.12C shows a curve of IC50
inhibition of Bestatin. The curve did not show any inhibition on the growth of the bacteria at 
4, 10 and 20 mM concentration of Bestatin.  From Figure 6.12C the flat line did not shows any 
inhibition or effect on the growth of E.coli at any concentration of Bestatin. This the same to 
in vitro results (see Section 6.2.5), which showed the Bestatin did not inhibit LigA enzyme.
The sixth largest S-value (-36.1202) from MOE prediction as an inhibitor on E.coli
DNA ligase LigA was for 2-(Aminometyl) Imidazole. Figure 6.13A shows a Mueller-Hinton 
agar plate with three concentrations 100, 150, and 200 mM of 2-(Aminometyl) Imidazole. This 
agar plate shows there is no inhibition zone of 2-(Aminometyl) Imidazole. 
Figure 6.13B shows the data of the inhibition zones by measuring the diameter of the 
zone around the disk for all the concentrations of 2-(Aminometyl) Imidazole. Figure 6.13C
shows a curve of IC50 inhibition of 2-(Aminometyl) Imidazole. The curve did not show any 
inhibition on the growth of the bacteria at 100, 150 and 200 mM concentration of 2-
(Aminometyl) Imidazole. From Figure 6.13C the flat line did not shows any inhibition or 
effect on the growth of E.coli at any concentration of 2-(Aminometyl) Imidazole.  
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Figure 6.12. The in vivo Inhibition of Bestatin on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of Bestatin were used in this plate: 4, 10 and 20 mM. The agar plate shows 
five disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a negative control just H2O, 
3 is 4 mM of Bestatin, 2 is 10 mM of Bestatin and 5 is 20 mM of Bestatin. Panel B) shows the data of 
the inhibition zones (diameter) for different concentrations of 5-Azacytidine. The data were fit to a 
Michaelis-Menten kinetics fit using Grafit software, and the Vmax and Km modified to Imax and IC50. 
Panel C) shows a curve of IC50 inhibition of Bestatin. The diameter data of Bestatin concentrations 
from Panel B was put in Grafit software along with the Bestatin concentration and an inhibition (IC50) 
fit added to the data using an IC50 inhibition equation. The curve did not show any inhibition on the 
growth of the bacteria at 4, 10 and 20 mM concentration of Bestatin. 
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Figure 6.13. The in vivo Inhibition of 2-(Aminometyl) Imidazole on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of 2-(Aminometyl) Imidazole were used in this plate: 100, 150 and 200 
mM. The agar plate shows five disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a 
negative control just H2O, 3 is 100 mM of 2-(Aminometyl) Imidazole, 2 is 150 mM of 2-
(Aminometyl) Imidazole and 5 is 200 mM of 2-(Aminometyl) Imidazole. Panel B) shows the data 
of the inhibition zones (diameter) for different concentrations of 2-(Aminometyl) Imidazole. The data 
were used a Michaelis-Menten kinetics fit using Grafit software, and the Vmax and Km modified to Imax
and IC50. Panel C) shows a curve of IC50 inhibition of 2-(Aminometyl) Imidazole. The diameter data 
of 2-(Aminometyl) Imidazole concentrations from Panel B was put in Grafit software along with the
2-(Aminometyl) Imidazole concentration and an inhibition (IC50) fit added to the data using an IC50 
inhibition equation. The curve did not show any inhibition on the growth of the bacteria at 100, 150 and 
200 mM concentration of 2-(Aminometyl) Imidazole. 
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The seventh largest S-value (-35.1460) from MOE prediction as an inhibitor on E.coli DNA 
ligase LigA was for an Imidazolidinyl Urea. 
Figure 6.14A shows a Mueller-Hinton agar plate with three concentrations 100, 150 
and 200 mM of Imidazolidinyl Urea as one example of three Mueller-Hinton agar plates. 
Another two agar plates that corresponding to this experiment are shown in Appendix 6.11. 
This agar plate shows good inhibition zone with all three concentrations. Figure 6.14B shows 
the data of the inhibition zones by measuring the diameter of the zone around the disk for all 
the concentrations of Imidazolidinyl Urea. Figure 6.14C shows a curve of IC50 inhibition of 
Imidazolidinyl Urea. The curve did show very good inhibition on the growth of the bacteria at 
the three concentration, but not with1, 2, 4, 20, 40 mM. From Figure 6.14C the Imax for 
Imidazolidinyl Urea was 20.21±7.35 mM/min, and the inhibition IC50 of Imidazolidinyl Urea 
was 233.25±143.35 mM. This compares to in vitro results (see Section 6.2.7), which showed 
that the Imidazolidinyl Urea did inhibit LigA enzyme as well. 
The seventh largest S-value (-29.5067) from MOE prediction as an inhibitor on E.coli
DNA ligase LigA was for Imidazo [1,2-a] pyridine-7-carboxylic acid.  
Figure 6.15A shows a Mueller-Hinton agar plate with three concentrations at 200 mM 
of Imidazo [1,2-a] pyridine-7-carboxylic acid. The agar plate shows five disks: negative control 
(just H2O), 5 mg/ml Ampicillin as a positive control and 3, 4 and 5 are 200 mM of Imidazo 
[1,2-a] pyridine-7-carboxylic acid. The figure did not show any inhibition or effect on the 
growth of E.coli at 200 mM concentration of Imidazo [1,2-a] pyridine-7-carboxylic acid with 
three repeats.  
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Figure 6.14. The in vivo Inhibition of Imidazolidinyl Urea on the growth of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of the agar 
plate. Three concentrations of Imidazolidinyl Urea were used in this plate: 100, 150 and 200 mM. 
The agar plate shows five disks were applied: 1 is 5 mg/ml Ampicillin as a positive control, 2 is a 
negative control just H2O, 3 is 100 mM of Imidazolidinyl Urea, 4 is 150 mM of Imidazolidinyl Urea 
and 5 is 200 mM of Imidazolidinyl Urea. Panel B) shows the data of the inhibition zones (diameter) 
for different concentrations of Imidazolidinyl Urea using ImageJ. The data were fit to a Michaelis-
Menten kinetics fit using Grafit software, and the Vmax and Km modified to Imax and IC50. Panel C)
shows a curve of IC50 inhibition of Imidazolidinyl Urea. The diameter data of Imidazolidinyl Urea 
concentrations from Panel B was put in Grafit software along with the Imidazolidinyl Urea 
concentration and an inhibition (IC50) fit added to the data using an IC50 inhibition equation. The curve 
did show very potent inhibition on the growth of the bacteria at all the concentrations of Imidazolidinyl 
Urea. The Imax for Imidazolidinyl Urea was 20.21±7.35 mM/min, and the inhibition IC50 of 
Imidazolidinyl Urea was 233.25±143.35 mM. 
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Figure 6.15. The in vivo Inhibition of Imidazo [1,2-a] pyridine-7-carboxylic acid on the growth 
of E.coli.
Panel A) a Mueller-Hinton agar plate with wild type of E.coli that streaked on the surface of 
the agar plate. The concentration of Imidazo [1,2-a] pyridine-7-carboxylic acid was used in this plate 
just 200 mM, but repeated three times. The agar plate shows five disks were applied: 1 is 5 mg/ml 
Ampicillin as a positive control, 2 is a negative control just H2O, 3, 4 and 5 is 200 mM of Imidazo [1,2-
a] pyridine-7-carboxylic acid. The plate did show any inhibition or effect on the growth of E.coli at 200 
mM concentration of Imidazo [1,2-a] pyridine-7-carboxylic acid with three repeats. 
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6.4. Discussion.  
In this chapter we described the various experiments in vitro and in vivo (denaturing gel and 
Kirby-Bauer) that were utilized to research if these different compounds or inhibitors that had 
a high negative S-value (MOE in Chapter 5) can interact or bind to LigA and inhibit its 
activity. This is the second and third stage of a combination of in silico, in vitro and in vivo 
techniques. A list of LigA binding compounds was identified (in silico), based on their ability 
to bind the enzyme in one of four sites (Figure 5.4 in Chapter 5). These different compounds 
were: Glutathione disulphide (#49740 Sigma), 5-Azacytidine (#A2385 Sigma), Geneticin 
(G418) (#A1270 Sigma), Chlorhexidine (#282227 Aldrich), Bestatin/Ubenimex (#482609 
Aldrich), 2-(Aminometyl) imidazole (#738840 Aldrich), Imidazolidinyl Urea (#I5133 
Aldrich), and Imidazo[1,2-a]pyridine-7-carboxylic acid (#CDD017300 Aldrich). In this 
chapter, these compounds or inhibitors were examined in vitro, at different concentrations to 
check their ability to inhibit the nick-sealing ability of LigA. They were all then tested for cell 
toxicity using the Kirby-Bauer plating technique (in vivo). 
Table 6.1 shows a summary of the results for all the compounds, listing their S-values, 
the sites of MOE, the IC50 in vitro and IC50 in vivo. Each of these compounds will be discussed 
individually. The first compound (Glutathione disulphide), had the largest negative S-value 
from MOE and docked in Site 3, meaning that it docked very well in silico. However, both the 
in vitro and in vivo experiment did not show any inhibition of LigA. This shows that although 
a compound may be predicted in MOE, but it maybe not affect the protein in vitro and in vivo.    
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Compound Name S-value MOE 
Site 
IC50
(in vitro inhibition) 
IC50
(in vivo inhibition)
1 Glutathione 
disulphide 
-47.76 2 No inhibition No inhibition
2 5-Azacytidine -43.43 3 10.34±4.14 µM No inhibition
3 Geneticin -40.10 1 45.31±13.81 µM 0.63± 0.17 mM
4 Chlorhexidine -39.06 1 20.66±6.11 µM 0.17±0.03 mM
5 Bestatin/Ubeni
mex 
-36.74 4 No inhibition No inhibition
6 2-(Aminometyl) 
imidazole 
-36.12 4 - No inhibition
7 Imidazolidinyl 
Urea 
-35.14 2 7.56±14.48 µM 233.25±143.35 mM
8 Imidazo[1,2-a] 
pyridine-7-
carboxylic acid 
-29.50 3 - No inhibition
Table 6.1. Shows a summary of the results for all the compounds, listing their S-values, the 
sites of MOE, the IC50 in vitro and IC50 in vivo.
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The second compound was 5-Azacytidine, with S-value -43.43,  was predicted to form 
hydrogen bond interactions with several residues including Lys 115 using MOE (Chapter 5), 
which is the active and essential side chain in LigA protein to form the covalent intermediate 
bound (protein-AMP). We predicted to see high inhibition by in vitro and in vivo studies. As 
shown in table 6.1, 5-Azacytidinewas successfully did give inhibition of LigA by in vitro
studies (IC50 10.34±4.14 µM), but failed to inhibit the growth of bacteria by in vivo (Kirby-
Bauer experiments). This is an example of MOE prediction was correct and did give in vitro 
inhibition. So this compound definitely interacts with nicked DNA-LigA complex, but the 
mechanism is not known. The reason for failing the 5-Azacytidine compound to inhibit the 
growth of bacteria (in vivo) may be due to poor permeability of the outer membrane of the 
bacteria or the disability of 5-Azacytidine to interact or bind with LigA protein inside the cell.  
The third compound was Geneticin (G418), with S-value -43.43, this inhibitor was 
identified from docking Site 1 of LigA by using MOE, and was in the OB domain, which is 
responsible for adenylating the nicked DNA in the Step 2 in the clamping mechanism of the 
enzyme. As shown in table 6.1, Geneticin (G418) successfully did give inhibition of LigA by 
in vitro (IC50 45.31±13.81 µM) and as well by in vivo (IC50 0.63± 0.17mM) studies (Kirby-
Bauer experiments).  
The fourth compound was Chlorhexidine molecule, with S-value -39.0645, this 
inhibitor was identified from docking Site 1 of LigA by using MOE, and was in the OB domain. 
Chlorhexidine molecule was forming interactions with residues Asp 326 and Asp 398. This 
bound in a similar way to Geneticin, which is responsible for adenylating the nicked DNA in 
the Step 2 in the clamping mechanism of the enzyme.  
 As shown in table 6.1, Chlorhexidine successfully did give inhibition of LigA by in 
vitro (IC50 20.66±6.11 µM) and by in vivo (IC50 0.17±0.03 mM.) studies (Kirby-Bauer 
experiments). This is again an example of MOE prediction was correct and did give in vitro
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and in vivo inhibition. So this compound definitely interacts with nicked DNA-LigA complex 
in vitro and inhibit the protein, and may be as well in vivo, but the mechanism is not known. 
Unfortunately, the fifth, sixth and eighth compounds (Bestatin, 2-(Aminometyl) 
imidazole, Imidazolidinyl Urea and Imidazo [1,2-a]pyridine-7-carboxylic acid) in Site 4 and 3 
(NTase and Ia domain) of LigA by using MOE with S-value -36.74, -36.12 and -29.50, 
respectively did not show any inhibition on LigA (in vitro and in vivo).  As shown in table 6.1, 
these compounds show that although a compound may be predicted in MOE, but not affect the 
protein in vitro and in vivo technique.  The reason for the disability for inhibit the LigA protein 
with these compounds that had a higher S-value using MOE technique may be return to many 
reasons. One of these reasons was may be these compounds did not attach or bind to the 
essential amino acid of LigA protein when the nicked DNA was fixed by the protein.   
The seventh compound Imidazolidinyl urea, which had a higher S-value (-35.1460) in 
Site 2 (NTase domain) was forming interaction and displacement with residue Arg 487 that 
considers one of the essential amino acid that penetrates the minor groove at the outer edge of 
3-OH side of the nick in HhH domain and contact to the nuclotidyltransferase domain, which 
involved with DNA binding (Wang et al., 2008). This is again an example of MOE prediction 
was correct and did give in vitro (IC50 7.56±14.48 µM) and in vivo inhibition (IC50
233.25±143.35 mM). So this compound definitely interacts with nicked DNA-LigA complex 
in vitro and inhibit the protein, and may be as well in vivo. The missing data of the in vitro
experiment analysis (Section 6.2) of the 2-(Aminometyl) imidazole and Imidazo [1,2-a] 
pyridine-7-carboxylic acid compounds (See table 6.1) would be the basis of future 
experiments.  
The overall of this chapter was four out of eight compounds did inhibit the activity of 
LigA in vitro (5-Azacytidine, Geneticin (G418), Chlorhexidine and Imidazolidinyl with IC50
10.34±4.14, 45.31±13.81, 20.66±6.11 and 7.56±14.48 µM, respectively. They confirmed that 
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were work and active against E.coli DNA ligase in vitro, which is increased the chance for 
being future antibiotic (See 5.6 in Chapter 5).  Especially for Geneticin as we know its biology 
activity, if scientist can link the eukaryotic cells with neoR gen that has resistance against 
Geneticin via using gene editing technique (Harvey, et al., 2013).  
Three of the eight compounds: Geneticin (G418), Chlorhexidine and Imidazolidinyl, 
did inhibit the growth of the bacteria (in vivo) with IC50 0.63± 0.17, 0.17±0.03 and 
233.25±143.35 mM, respectively. They had success in all three areas of study (in silico, in vitro 
and in vivo) and make them a suitable candidates and increase the chance for being future drug 
development studies as a promising drug target for bacteria. Site 1 and 2 (HhH and OB domain) 
of E.coli DNA ligase LigA protein using MOE technique had the success rate of compounds 
to inhibit the enzyme in three technique in silico, in vitro an in vivo. These indicates its potential 
as a key site in further MOE docking runs and opens the possibilities for further structural 
studies to inhibit LigA activity. More discussion with other data was added in the final 
discussion in Chapter 7. 
204 
Chapter 7: Final Discussion 
DNA Ligases play a crucial role in repairing damaged DNA as well as other crucial DNA 
metabolism processes as replication and recombination (Lehman, 1974; Mills et al., 2011). 
They are also a promising antibacterial drug target. The overall aim of my work was to bring 
together a series of experiments on these two known DNA ligases from E.coli LigA and LigB, 
comparing their properties and functions under a range of experimental conditions. The main 
findings of this thesis can be divided into four main areas. The first plan was to clone, express 
and purify native LigA and LigB. The second finding was to compare the kinetics and DNA 
binding studies of native LigA and native LigB.  
The third was to use in silico molecular docking (MOE programme) to find new 
compounds (inhibitors) that would inhibit DNA LigA. The fourth finding was to test eight of 
the new compounds found by using MOE, using both in vitro (time-courses on purified 
enzyme) and in vivo (Kirby-Bauer) to use them as new antibiotic or inhibitors in the future. In 
E.coli, there are in fact two DNA ligases: LigA (already solved the crystal structure, 2OWO) 
(Shuman et al., 2007) and a second ligase (LigB) that has a different DNA and protein sequence 
(Sriskanda & Shuman, 2001), but has no solved 3D structure.  
The main aim of Chapter 3 was to clone, express and purify native LigA and LigB, 
which are two of the key repair enzymes in E. coli. The challenge was to determine how best 
to induce and purify the two native enzymes, using different chromatography techniques. The 
key role of this was the decision not to use a His-tagged version of each protein, since this 
positively-charged group can interfere with DNA binding properties (Chant et al. 2005). 
However, Sriskanda and Shuman in 2001 successfully purified E.coli LigB protein as a second 
DNA ligase using His-tagged version.   
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In this study the expression of native LigA in competent cell E. coli BL21 (DE3) by 
adding 1 mM IPTG gave very high amount of expressed LigA and has shown to be mostly 
soluble in buffer. However, the expression for native LigB was shown to be completely 
insoluble which led us to use a different way. The key features of LigB purification are listed 
in Chapter 3 (see Section 3.4.2). The solubility of expressed native LigB protein in NaCl and 
TritonX-100, or refolding native LigB protein and using His-tagged version did not give or 
show any soluble LigB. This is in contrast to Sriskanda and Shuman in 2001 who did obtain 
soluble His-tag LigB. Finally, using different condition and buffer during the expression of 
native LigB protein as I mentioned in the main introduction in Chapter 3 (see Section 3.4.2) 
small amount of native LigB was successfully purified and active. 
During purification, native LigA and LigB proteins were tested by a functional assay 
to look for ligation activity. Proteins that have approximately the correct size on SDS-PAGE 
gels were tested for ligase activity and by mass spectrometry to check their molecular mass. 
 The overall aim of Chapter 4 in this study was to bring together a series kinetic and 
binding experiments on these two DNA ligases, comparing their properties and functions under 
a range of experimental conditions. These were important building blocks towards potential 
future studies that could then explore and exploit small-molecule chemical libraries for 
compounds by using MOE technique (Chapter 5) that affect these basic kinetic parameters in 
vitro and in vivo to kill the bacteria and making them a promising antibiotic target in the future 
(Chapter 6). 
 Chapter 4 was to determine the kinetics and binding experiments of the native (no-tag) 
LigA and LigB proteins. This included finding the Vmax and Km for kinetics and Bmax and Kd
for binding experiments for these enzymes under many different reaction conditions. For 
kinetic experiments the variables tested were [DNA], [NAD+], temperature for both native 
LigA and LigB (~30 nM for both enzymes).and [NH4SO4] and [NMN] only for LigA. For 
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binding experiments gel-shift studies in EDTA-containing buffers (no Mg2+ added) was carried 
out for both enzymes. The Km values for all the parameters above of native LigA and LigB 
were determined using the Michalis-Menten fit (steady-state study). One of the important 
parameters which affect the enzyme activity is [DNA] substrate and [NAD+] cofactor. The Vmax
of native LigA and LigB for singly-nicked DNA substrate concentration in this study were 
62.10±8.56 nM and 9.73±0.58 nM, respectively. Therefore, native LigA was 6.4-fold faster 
than native LigB. The kcat for LigA and LigB for single-nicked [DNA] substrate were 2.07 min-
1 and 0.32-1, respectively.  
In a different study (single-turnover study) Sriskanda & Shuman 2001, obtained the 
initial rate for nick joining by LigB E.coli DNA ligase adenylate (0.026 s-1) which was about 
8.5-fold slower than LigA E.coli DNA ligase (0.22 s-1). The Km values for LigA and LigB (how 
tightly they bound the nicked DNA) for singly-nicked DNA substrate were 12.22±6.42 and 
3.50±1.34 nM, respectively, which is different to the Km value for Staphylococcus aureus DNA 
ligase LigA that achieved in a similar study (stead-state) by Gul et al, 2006 who characterised 
the Km value for acridinium-ester-labelled DNA substrate (2.5±0.2 nM)  (Gul et al, 2006).  
 The Km value that obtained for NAD+ for E.coli LigA in this study was 1.55±0.33 µM 
which was quite similar to the Km value for NAD+ cofactor for S. aureus LigA (2.75±0.1 µM) 
that obtained by Gul et al, 2006. This result was slightly different with Sriskanda et al., 1999, 
they found the Km value for NAD+ of the wild-type E.coli DNA ligase LigA 3 µM. 
In 2004, Gong and his group stated that Mycobacterium tuberculosis encodes an NAD+-
dependent DNA ligase (LigA) plus three distinct ATP-dependent ligase homologs (LigB, 
LigC, and LigD). They reported that NAD+-dependent DNA ligase (LigA) is essential enzyme 
for ligation and growth of M. tuberculosis, whereas ATP-dependent ligase LigB is 
distinguished for nick joining the DNA, but is not essential for the growth of M. tuberculosis 
bacteria. The Km value for NAD+ cofactor for NAD+-dependent DNA ligase LigA of M. 
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tuberculosis was 1 µM which was about 1.5-fold tight than the Km value for NAD+ for E.coli
DNA LigA (1.55±0.33 µM) in this study, and the Km value for NAD+ cofactor for ATP-
dependent ligase LigB of M. tuberculosis was 0.34 mM which was much less tight than the Km
value for NAD+ for E.coli DNA LigB (0.16±0.03 µM) in this study (Gong et al.,, 2004).  
However, Hua et al., 2008 identified that Deinococcus radiodurans (DR) encoded an 
NAD+-dependent DNA ligase (DRLigA) and an ATP-dependent DNA ligase (DRLigB) 
(which totally different to E.coli NAD+-dependent of LigB) in the genome of this extremely 
radioresistant bacterium. Their results showed that DRLigB displayed higher activity than 
DRLigA at sticky and blunt ended joining of DNA, indicating that DRLigB is a key DNA 
ligase of D. radiodurans in DNA recombination and double-strand break repair. 
Temperature is one of the important parameters which affect enzyme activity, as the 
enzyme will not function properly at a temperature which is too high or low.  This study showed 
that native E.coli DNA ligases LigA and LigB enzymes had a slightly different optimum 
temperature for activity. For LigA this the optimum temperature was ~20°C as shown in Figure 
4.8, and for LigB approximately the optimum temperature was 16°C as shown in Figure 4.9. 
Most DNA ligases are used at 16ºC or room temperature and can be denatured by heat (Lohman 
et al., 2011B). Also, we found LigA if left at room temperature overnight lost almost its 
activity. In this thesis the temperature used in every ligase reaction (kinetics study) was 16ºC, 
which was close to the optimum temperature for each enzyme. Different reaction temperatures 
have been used in the literature. For example, Wilkinson et al. in 2005, the reaction of the 
ligase activity of E.coli DNA ligase LigA was incubated at 25ºC. As well Gul et al, 2006 used 
room temperature for incubating Staphylococcus aureus DNA ligase LigA for all their kinetic 
experiments. 
To the extent of our knowledge this is the first study which has replicated and 
subsequently confirmed by Dugaiczyk et al., 1975 findings that the optimum temperature for 
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ligating cohesive ends by LigA is in the range of 10-15°C. However contrary to Dugaiczyks 
findings, which stated that increasing the temperature from 0-10°C increased rate of reaction 
but an increase of up to 15°C did not further increase the rate, here in this study we found that 
the optimum temperature for native LigA was ~20°C and  ~16ºC for LigB.  
Otherwise, the optimal temperature of NAD+-dependent DNA ligase (LigA) and an 
ATP-dependent DNA ligase (LigB) of Deinococcus radiodurans were 60ºC as Hua et al., 2008 
reported. 
In comparative gel-shift studies in EDTA-containing buffers (no Mg2+ added) showed 
that LigA bound the 50 bp single nicked DNA with a Kd of 661.15±142.22 nM and LigB 
4,566.30±1146.70 nM in this study. The error bars are quite large so further points are needed. 
The main purpose of the initial gel-shift experiments in this thesis was to test if native LigA 
and LigB are different enzymes in the way they bind the nick DNA. These results confirm 
previous work by Wilkinson et al, 2005, when they did gel-mobility shift experiments for E.coli
NAD+-dependent DNA ligase LigA: approximately 50% of the protein was complexed to DNA 
at a 4:1 ratio of protein:DNA and the Kd for the complex was ~5 µM, which was about 7.5-
fold less tighter than native LigA in this study, but was similar to native LigB.
In 1999, Doherty & Wigley stated that the ATP-dependent DNA ligase from 
bacteriophage T7 contains two domains: large domain (adenylation) and small domain (oligo-
binding (OB)). The larger domain (adenylation or ligation domain) was able to band shift both 
single and double-stranded DNA, while the smaller domain (OB domain) was only able to bind 
to double-stranded DNA.  
Depending on the results finding for three parameters using kinetics experiments for 
native LigA and LigB showed that the Vmax for varying DNA substrate and varying NAD+
cofactor for LigA were faster than LigB, but the Km for both parameters for LigA were less 
tighter than LigB. These results together show that two enzymes do the same reaction may 
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have different roles in the cell, such as replication or repair. The overall comparison of E.coli
DNA ligase native LigA and LigB in this study is LigA encoded for all eubacteria cell and 
essential enzyme for their growth and ligation, but not for LigB 
Our conclusion of native LigB suggest that the lack of BRCT C-terminus domain and 
two of the four Zn-binding cysteines of the protein that are present in LigA made the reaction 
activity of the native LigB protein slower than LigA. Sriskanda & Shuman 2001, reported that 
LigB is less active than LigA on their nicked DNA substrate, and they confirmed that the slow 
activity of LigB is too weak to seal the Okazaki fragments generated during the replication. 
Sriskanda in 1999, found that NAD+-dependent E.coli ligase LigA can support the growth and 
functionally substitute for the essential DNA ligase (ATP) in yeast Saccharomyces 
cerevisiae called Cdc9 ligase, Whereas LigB cannot do that in Cdc9 (Sriskanda, et al., 1999). 
As well,  Wilkinson and his group in 2005, compared the ligation activity (in vitro) of 
the full-length protein of E.coli DNA ligase LigA and the deletion of the BRCT domain from 
LigA, and they found that the ligation activity of the protein reduced by 3-fold and also reduced 
DNA binding by gel-shift experiment (Wilkinson et al, 2005). Furthermore, in 2004 Feng 
group, they found the mutation of Thermus species AK16D LigA BRCT domain (G671I 
mutant) showed a low ligation activity and lack of accumulation of the AMP-DNA 
intermediate (Feng, et al., 2004). 
As we know that E.coli DNA ligases are very important and essential enzymes inside 
the cell into two pathways: replication and repair. In 2017, Bodine with his group reported that 
E.coli LigB play a potential role in the base excision repair pathway or the mismatch repair 
pathway by deletion of LigB gene study (Bodine at al., 2017). Our suggestion in this study 
(depending of previous data of native LigA or LigB in this study and previous papers) is that 
LigA is essential enzyme in replication steps, whereas LigB is important enzyme for repairing 
the damage. Another idea is LigA is the main ligase for both replication and repair and LigB 
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is either a back-up ligase or support and help LigA protein to do its work or does not play a 
major role in the cell. 
Returning to the kinetic experiment in Chapter 4 for the remaining two parameters 
[NMN] and [NH4SO4] were only studied for LigA. Data for LigB were not obtained because 
the difficult and limited solubility of LigB prep. The interesting result for NMN was that it 
inhibited the reaction of LigA. The Yrange for [NMN] was 13.89±0.56 µM/min, and the 
inhibition IC50 was 31.34±1.56 µM, which was exactly near to the concentration of NAD+ in the 
standard study of ligation (25 µM) in this thesis. As seen in the previous kinetics experiments 
in Chapter 4, the ligation catalysed by LigA or LigB does not go to completion even at ideal 
reaction conditions. We hypothesised that the NMN, which is released during ligation as a by-
product, could somehow be involved in slowing down this ligation. These finding are in 
alignment with Cheng and Roths theory (1995) that NMN accumulation could potentially 
inhibit the activity of Ligase in bacteria.
The ammonium sulphate experiment on LigA in this study showed a distinctive 
stimulation on the rate of ligation reaction, and the Km for [NH4SO4] was 37.64±40.64 µM. 
This result confirms previous papers (Modrich & Lehman, 1973) that have reported the steady-
state rate of sealing by EcoLigA was increased up to 20-fold by low concentrations of 
ammonium ion, whereas sealing by ATP-dependent T4 DNA ligase was unaffected by NH4+. 
Chauleau & Shuman, 2016 found that 10 mM ammonium sulphate elicited a 48-fold increase 
in the rate of DNA adenylation (Step 2 in the mechanism process of LigA, Figure 1.7) and a 
16-fold increase in the rate of phosphodiester synthesis (Step 3 in the mechanism process of 
LigA). Furthermore,  Hayashi group in 1985 established that the DNA ligase (LigA) from 
E.coli was stimulated by high salt concentrations at 200 mM NaCl or 300 mM KCl (mono-
divalent cations) in 10% (w/v) PEG solutions (Hayashi, et al., 1985).  
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As described in Chapter 1 (section 1.7.4) the β-sliding clamp protein is an important 
component of the DNA replication fork, which forms a sliding clamp around duplex DNA, 
interacts with DNA polymerase and enables this enzyme to synthesize DNA processively 
(Levin et al., 1997). In this study we attempted to check and confirm if the E.coli β-sliding 
clamp protein interacted with E.coli DNA ligase LigA or not. There is increasing attention to 
the β-sliding clamp as a therapeutic drug target (Kukshal, et al., 2012). To do this we used an 
in vitro timecourse study (denaturing gel). We found here that the E.coli sliding β-clamp 
protein did not affect or increase the ligation activity of E.coli DNA LigA.  A similar result by 
Kukshal group in 2012 reported that M. tuberculosis β- sliding clamp does not interact directly 
with the NAD+-dependent DNA ligase. In contrast, Yang & LiCata, 2018 established that the 
PolI DNA polymerases from E.coli can significantly stimulate complementary intermolecular 
end-joining ligations by E.coli DNA ligase when the polymerases are present at concentrations 
lower than that of the DNA substrates; high polymerase concentrations relative to the DNA 
substrates inhibit the intermolecular ligation activity of DNA ligase. In human DNA ligase 
ATP-dependent have been reported and confirmed to associate with PCNA sliding-clamp 
(Levin et al, 1997). 
In Chapter 5 in this study, the Molecular Operating Environment (MOE) software was 
very important for identifying compounds that used for docking the native E.coli DNA ligase 
LigA. It is a powerful software package and had the ability to perform and find potential new 
inhibitors. Four potential docking sites of LigA protein were chosen by MOE. Sites were 
selected based on four factors: accessibility, pocket size, proximity to essential amino acids 
and sites of structural interest. Into each of the four chosen docking sites (Table 5.2 in Chapter 
5) was docked putative inhibitor molecules from a ZINC library of 800 compounds, which had 
3995 different structural conformations. These compounds were: Glutathione disulphide 
(#49740 Sigma), 5-Azacytidine (#A2385 Sigma), Geneticin (G418) (#A1270 Sigma), 
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Chlorhexidine (#282227 Aldrich), Bestatin/Ubenimex (#482609 Aldrich), 2-(Aminometyl) 
imidazole (#738840 Aldrich), Imidazolidinyl Urea (#I5133 Aldrich), and Imidazo [1,2-
a]pyridine-7-carboxylic acid (#CDD017300 Aldrich). 
However, with sufficient computational power, a far larger database of compounds 
could be screened, increasing the possibility of finding a compound that inhibits LigA activity 
specifically. Only four sites were selected for docking runs for this study, and the limitation for 
choosing just the first two larger and more negative S-value out of 800 compounds in each site 
decrease the probability of finding useful compounds. Again, the limitations are computational 
power and the time needed to leave the software running uninterrupted, a docking run of 30,000 
compounds would take several weeks to complete. 
In 2010, Singh & Somvanshi used the software AutoDock 3.0.5 for docking various 
drug to Mycobacterium tuberculosis LigA structure determined by homology modelling. They 
found four potent drugs (Chloroquine, Hydroxychloroquine, Putrienscine and Adriamycin) to 
inhibit M. tuberculosis LigA through the binding affinity between protein-drug interactions. A 
high-throughput screening (HTS) campaign was carried out by Mills et al., 2011 to identify the 
inhibitors of Haemophilus influenzae LigA by using an AstraZeneca corporate library. After 
comparing of IC50 against H. influenzae LigA and compound filtering based on 
physicochemical properties, 517 compounds were selected for testing for selectivity and 
spectrum of inhibition. Five substituted adenosine analogous were chosen as an inhibitor 
against H. influenzae LigA. 
In Chapter 6 in this study, we identified four out of eight compounds inhibited 
(disrupted) the ligation of E.coli DNA LigA in in vitro experiments. These inhibitors were 5-
Azacytidine, Geneticin (G418), Chlorhexidine and Imidazolidinyl with IC50 10.34±4.14, 
45.31±13.81, 20.66±6.11 and 7.56±14.48 µM, respectively. As well three of the these four 
compounds (Geneticin (G418), Chlorhexidine and Imidazolidinyl) with IC50 0.63± 0.17, 
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0.17±0.03 and 233.25±143.35 mM, respectively did inhibit the growth of the bacteria (in vivo) 
and had success in all three areas of study (in silico, in vitro and in vivo) and make them a 
suitable candidates for future drug development studies as a promising drug target for bacteria.  
In 2012, Podos et al., reported pyridochromanone inhibitor as a potent inhibition on 
NAD+-dependent DNA ligase Staphylococcus aureus (LigA) as an antibacterial target using 
full-length LigA with IC50 of 28 nM. Otherwise, Gong et al., 2004 found that 
pyridochromanone compound inhibited nick joining by E.coli DNA LigA in the presence of 5 
µM NAD+ with an IC50 of 0.6 µM. Dwivedi et al., 2008, established that Quinacrine (9-
aminoacridine), which bind to the nicked DNA, as a potent inhibitor of the E.coli DNA ligase 
with IC50 of 1.5±0.2 µM. As well they found fagaronine chloride and nitidine chloride had very 
potent ligation-inhibitory activity against human ligase I with IC50 27 and 69 µM, respectively.
Mills et al., 2011, identified several adenosine analogs as inhibitor to inhibit the 
function of LigA (in vitro) by using high-throughput screening (HTS), and all the compounds 
were chosen from AstraZeneca corporate library. One of these compounds had an IC50 of 0.5 
and 1.27 µM against Haemophilus influenzae and E.coli LigA, respectively. Novel compounds 
pyridopyrimidines and naphthyridines were identified as potent inhibitors of bacterial NAD+-
dependent E.coli DNA ligase LigA. This study depending the key interaction with the ligase 
enzyme, specifically residues Glu114, Lys291, and Leu117 guided by molecular modelling 
and X-ray crystallography. They found that pyridopyrimidines and naphthyridines compounds 
had an IC50 of 0.077 and 0.23 µM against E.coli LigA. 
 Several derivatives of Dispiro-cycloalkanone specifically inhibited the nick-closing and 
cohesive-end ligation activities of the NAD+-dependent DNA ligase of the Wolbachia
symbiont of Brugia malayi (wBm-LigA) without inhibiting human or T4 DNA ligase. The 
active site of the target enzyme showed interaction with these compounds by using Docking 
studies. The adverse effects of these inhibitors were observed on wBm-LigA in vitro. One of 
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these derivatives of Dispiro-cycloalkanone called compound 2 (as they mentioned) had the best 
inhibition with lowest IC50 1.2 µM (Shrivastava, et al., 2015). Meier et al., 2008 identified a 
compound (2,4-diamino-7-dimethylamino-pyrimido[4,5-d]pyrimidine) with the ability to 
specifically disrupt the function of the Streptococcus pneumoniae LigA enzyme in vitro and in 
vivo but does not disrupt the function of ATP-dependent enzymes. 
In 2015, collaborative work between research groups in the United States and Germany 
announced that they had found and isolated a new class of antibiotic that killed some groups 
of Gram-positive bacteria (Staphylococcus aureus and Mycobacterium tuberculosis) without 
detectable resistance. This new antibiotic was called Teixobactin and was discovered in a 
screen of uncultured soil bacteria (Ling et al., 2015; Lewis, 2015). It is a peptide (secondary 
metabolism) of some species of bacteria found in soil, and it appears to harm bacteria by 
binding to lipid groups in the cell wall which lead to inhibition of cell wall synthesis and kill 
the bacteria (Denise, 2015).  
Recently, in 2018, a group of researchers from Rockefeller University discovered a new 
novel antibiotic that was able to kill several bacteria (Gram-positive bacteria) called 
Malacidins. They are a class of compound made by bacteria found in soil and their activity 
appears to be dependent on calcium ions. Calcium-dependent antibiotics family contain a 
conserved Asp-X-Asp-Gly motif that is thought to facilitate calcium binding (Hover, 2018; 
Bunkoczi, 2005). Malacidins appear to be active after they bind to calcium; the calcium-bound 
molecule then shows to bind to the lipid, and the cell wall of the bacterial produce molecular 
that lead to destruction of the cell wall and death of the bacteria (Hover, 2018).  
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Appendix Figure 2.1.  DNA sequence of GeneArt LigA (5-3).
CGTGACTGATCATATGGAATCAATCGAACAACAACTGACAGAACTGCGAACGACGCTTCGCCATC 
ATGAATATCTTTATCATGTGATGGATGCGCCGGAAATTCCCGACGCTGAATACGACAGGCTGATG 
CGCGAACTGCGCGAGCTGGAAACCAAACATCCAGAACTGATTACGCCTGATTCGCCTACTCAACG 
TGTAGGCGCTGCGCCGCTGGCGGCTTTCAGCCAGATACGCCATGAAGTACCAATGCTGTCACTGG 
ATAACGTTTTTGATGAAGAAAGCTTTCTTGCTTTCAACAAACGTGTGCAGGACCGTCTGAAAAAC 
AACGAGAAAGTCACCTGGTGCTGTGAGCTGAAGCTGGATGGTCTTGCCGTCAGTATTCTGTATGA 
AAATGGCGTTTTAGTCAGTGCCGCGACCCGTGGCGATGGCACCACCGGGGAAGATATCACGTCTA 
ATGTGCGTACTATTCGCGCCATTCCGCTGAAGCTGCACGGAGAGAATATCCCGGCGCGTCTGGAA 
GTGCGTGGTGAAGTGTTCCTGCCGCAGGCGGGGTTCGAAAAGATTAACGAAGATGCGCGACGCAC 
GGGCGGGAAAGTGTTTGCTAACCCACGTAATGCGGCAGCTGGTTCACTGCGTCAGCTTGATCCGC 
GTATTACAGCGAAGCGACCGCTCACTTTTTTCTGCTATGGCGTTGGTGTTCTGGAAGGTGGCGAG 
CTGCCGGATACTCATCTTGGCCGTTTACTGCAATTTAAAAAGTGGGGGTTGCCGGTCAGCGATCG 
GGTAACGCTTTGTGAATCGGCGGAAGAAGTGCTGGCGTTCTATCACAAAGTGGAAGAAGACCGCC 
CGACGCTGGGCTTTGATATCGACGGCGTGGTGATTAAGGTCAACTCACTGGCACAGCAGGAGCAG 
CTTGGCTTTGTCGCGCGTGCCCCGCGCTGGGCGGTAGCGTTTAAATTCCCGGCGCAGGAGCAGAT 
GACCTTTGTGCGTGACGTCGAGTTTCAGGTTGGGCGTACTGGCGCGATTACGCCTGTTGCGCGTC 
TGGAACCTGTCCATGTTGCAGGCGTGCTGGTGAGTAACGCAACCTTACACAATGCGGATGAAATC 
GAACGTCTTGGTTTACGCATTGGCGATAAAGTGGTGATTCGCCGCGCTGGCGACGTGATCCCGCA 
GGTGGTTAACGTCGTGCTTTCTGAACGCCCGGAAGATACCCGTGAGGTTGTATTCCCGACGCATT 
GTCCGGTATGTGGTTCTGACGTTGAGCGTGTGGAAGGTGAAGCGGTTGCCCGCTGTACCGGTGGC 
CTGATTTGCGGTGCGCAGCGTAAAGAGTCGCTGAAACACTTTGTTTCCCGCCGTGCGATGGATGT 
TGACGGAATGGGCGACAAAATCATCGATCAGCTGGTTGAAAAAGAATATGTCCATACTCCGGCAG 
ATCTGTTCAAACTCACCGCAGGCAAACTGACCGGACTGGAGCGTATGGGGCCAAAATCGGCACAA 
AACGTGGTTAACGCGCTGGAAAAAGCGAAAGAAACCACCTTTGCTCGCTTCCTCTATGCACTTGG 
CATCCGTGAAGTCGGCGAGGCCACCGCAGCAGGTCTGGCGGCATATTTCGGCACGCTGGAAGCGC 
TGGAAGCCGCTTCGATTGAAGAGCTGCAAAAGGTGCCTGATGTTGGCATTGTCGTTGCATCCCAC 
GTTCACAACTTCTTTGCCGAAGAAAGCAACCGCAATGTCATCAGCGAGCTGTTGGCGGAAGGTGT 
TCACTGGCCTGCGCCGATCGTTATCAACGCGGAAGAGATTGACAGCCCGTTTGCTGGTAAAACCG 
TGGTGCTTACGGGCAGCTTAAGCCAGATGTCGCGTGATGACGCTAAAGCTCGACTGGTCGAACTG 
GGCGCGAAAGTCGCGGGCAGCGTGTCGAAGAAAACCGATCTGGTGATAGCGGGTGAAGCTGCAGG 
ATCTAAACTGGCGAAGGCGCAGGAACTGGGCATTGAAGTCATCGACGAAGCGGAAATGCTGCGTT 
TGCTGGGTAGCTGACATATGCGTGACTGAT 
Appendix Figure 2.2.  Protein sequence of LigA (N-C terminal). 
671 amino acids 
Mw = 73605.8594 Da 
Estimated pI = 5.55 
Molar extinction (ε) at A280 = 34760 M-1cm-1 (or 0.4722 (mg/ml)-1cm-1) 
MESIEQQLTELRTTLRHHEYLYHVMDAPEIPDAEYDRLMRELRELETKHPELITPDSPTQRVG
AAPLAAFSQIRHEVPMLSLDNVFDEESFLAFNKRVQDRLKNNEKVTWCCELKLDGLAVSILY
ENGVLVSAATRGDGTTGEDITSNVRTIRAIPLKLHGENIPARLEVRGEVFLPQAGFEKINEDAR
RTGGKVFANPRNAAAGSLRQLDPRITAKRPLTFFCYGVGVLEGGELPDTHLGRLLQFKKWG
LPVSDRVTLCESAEEVLAFYHKVEEDRPTLGFDIDGVVIKVNSLAQQEQLGFVARAPRWAVA
FKFPAQEQMTFVRDVEFQVGRTGAITPVARLEPVHVAGVLVSNATLHNADEIERLGLRIGDK
VVIRRAGDVIPQVVNVVLSERPEDTREVVFPTHCPVCGSDVERVEGEAVARCTGGLICGAQR
KESLKHFVSRRAMDVDGMGDKIIDQLVEKEYVHTPADLFKLTAGKLTGLERMGPKSAQNVV
NALEKAKETTFARFLYALGIREVGEATAAGLAAYFGTLEALEAASIEELQKVPDVGIVVASH
VHNFFAEESNRNVISELLAEGVHWPAPIVINAEEIDSPFAGKTVVLTGSLSQMSRDDAKARLV
ELGAKVAGSVSKKTDLVIAGEAAGSKLAKAQELGIEVIDEAEMLRLLGS 
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Appendix Figure 2.3.  DNA sequence of GeneArt LigB (5-3). 
CGTGACTGATCATATGAAAGTATGGATGGCGATATTAATAGGTATCTTGTGCTGGCAATCATCTG 
TGTGGGCGGTCTGTCCGGCCTGGTCGCCAGCCAGAGCACAGGAAGAAATTTCCCGCCTGCAACAG 
CAAATAAAACAGTGGGACGATGACTACTGGAAGGAAGGAAAAAGTGAGGTGGAAGACGGTGTTTA 
CGATCAGTTAAGCGCCCGTCTTACGCAGTGGCAACGCTGCTTTGGGAGCGAGCCCCGCGACGTGA 
TGATGCCGCCTTTAAATGGTGCGGTTATGCATCCGGTTGCCCATACGGGTGTACGCAAAATGGTG 
GATAAAAACGCATTAAGTCTGTGGATGCGAGAACGTAGCGATCTTTGGGTGCAGCCAAAAGTTGA 
TGGCGTTGCGGTAACCCTGGTTTATCGGGACGGGAAACTGAACAAAGCAATCAGTCGCGGTAATG 
GCCTGAAAGGCGAGGACTGGACGCAGAAAGTTAGCTTAATTTCCGCTGTGCCGCAAACCGTTAGC 
GGGCCTTTAGCCAACAGTACGCTTCAGGGGGAAATATTTCTCCAGCGCGAGGGGCATATCCAACA 
ACAAATGGGGGGAATAAATGCCCGCGCAAAAGTTGCTGGCTTGATGATGCGCCAGGACGATAGCG 
ACACGCTGAATTCTCTGGGCGTTTTTGTCTGGGCATGGCCGGATGGACCGCAGTTAATGTCTGAT 
CGTTTAAAAGAGCTGGCTACCGCAGGTTTTACTCTAACGCAGACGTATACCCGTGCGGTGAAAAA 
TGCTGATGAAGTTGCGCGCGTACGCAATGAGTGGTGGAAAGCGGAATTACCCTTCGTCACCGATG 
GCGTAGTTGTACGAGCGGCGAAAGAGCCAGAATCCCGCCATTGGCTACCGGGCCAGGCAGAGTGG 
CTGGTGGCCTGGAAATATCAACCTGTAGCTCAGGTTGCCGAAGTGAAGGCAATTCAGTTTGCGGT 
GGGTAAGAGCGGTAAAATATCGGTGGTTGCGTCACTCGCACCTGTCATGCTGGATGATAAAAAAG 
TCCAGCGGGTGAATATTGGTTCCGTCAGGCGCTGGCAGGAGTGGGATATTGCGCCTGGTGATCAG 
ATTCTCGTCAGCCTTGCCGGTCAGGGTATTCCTCGCATTGATGATGTGGTGTGGCGCGGTGCAGA 
ACGTACAAAACCGACACCGCCAGAAAACCGCTTTAACTCGTTGACCTGCTACTTTGCTTCTGATG 
TTTGTCAGGAACAGTTCATTTCACGCTTAGTCTGGCTGGGGGCAAAACAGGTTCTTGGGCTGGAT 
GGCATTGGTGAGGCCGGTTGGCGCGCGCTGCATCAGACTCATCGCTTTGAACATATCTTTTCCTG 
GCTTTTATTAACGCCAGAGCAATTACAGAACACGCCGGGGATCGCGAAAAGTAAAAGTGCGCAGC 
TATGGCATCAGTTTAATCTGGCTCGTAAGCAGCCTTTTACTCGCTGGGTGATGGCAATGGGAATA 
CCGCTAACCCGGGCGGCGCTTAATGCCAGTGATGAACGGTCCTGGTCGCAACTTTTATTTAGCAC 
GGAGCAGTTCTGGCAGCAGCTGCCGGGGACTGGATCGGGACGCGCCAGACAGGTTATTGAATGGA 
AGGAAAATGCGCAAATCAAGAAGCTGGGCAGTTGGCTGGCTGCCCAGCAGATCACAGGTTTTGAA 
CCTTAGCATATGCGTGACTGAT 
Appendix Figure 2.4.  Protein sequence of LigB (N-C terminal). 
560 amino acids 
Mw = 63179.3 Da 
Estimated pI = 9.11 
Molar extinction (ε) at A280 = 168690 M-1cm-1
MKVWMAILIGILCWQSSVWAVCPAWSPARAQEEISRLQQQIKQWDDDYWKEGKSEVEDGV
YDQLSARLTQWQRCFGSEPRDVMMPPLNGAVMHPVAHTGVRKMVDKNALSLWMRERSDL
WVQPKVDGVAVTLVYRDGKLNKAISRGNGLKGEDWTQKVSLISAVPQTVSGPLANSTLQGE
IFLQREGHIQQQMGGINARAKVAGLMMRQDDSDTLNSLGVFVWAWPDGPQLMSDRLKELA
TAGFTLTQTYTRAVKNADEVARVRNEWWKAELPFVTDGVVVRAAKEPESRHWLPGQAEW
LVAWKYQPVAQVAEVKAIQFAVGKSGKISVVASLAPVMLDDKKVQRVNIGSVRRWQEWDI
APGDQILVSLAGQGIPRIDDVVWRGAERTKPTPPENRFNSLTCYFASDVCQEQFISRLVWLGA
KQVLGLDGIGEAGWRALHQTHRFEHIFSWLLLTPEQLQNTPGIAKSKSAQLWHQFNLARKQP
FTRWVMAMGIPLTRAALNASDERSWSQLLFSTEQFWQQLPGTGSGRARQVIEWKENAQIKK
LGSWLAAQQITGFEP 
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Appendix Figure 2.5.  DNA sequence map of pET29c expression vector (5-3).
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTAT
GCTAGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATC
TCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCGGATCCA
CAGATATCCCATGGAACCGCGTGGCACCAGGGTACCCAGATCTGGGCTGTCCATGTGCTGGCGTTCGA
ATTTAGCAGCAGCGGTTTCTTTCATATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAG
GGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCGATC
TCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTA
TATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCG
TGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTT
GCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGG
AGAGCGTCGAGATCCCGGACACCATCGAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCG
GAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGG
TGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAA
AAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAA
CAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGC
GATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCG
AAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCG
CTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGT
CTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGC
ATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGT
CTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGG
CGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTG
CGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGC
GTTGGTGCGGACATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCCGTT
AACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTC
AGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCG
CCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTC
CCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGA
TCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTAT
CGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGG
TCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGA
ATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGC
CATTATCGCCGGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAG
GCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGC
TGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCT
GGAAACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTAC
CCTGTGGAACACCTACATCTGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCC
CGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGT
AACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTT
ACACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAG
ACATTAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCT
TCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCT
GACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGT
CAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGG
AGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATATGCGGTGT
GAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGA
CTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT
CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGT
AAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCC
TCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGC
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGG
CTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
234 
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTAT
GTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGG
TATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAA
CCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTT
GGTCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAA
CGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATG
GGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAG
AGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAAC
TGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTT
ACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAA
ATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTT
AACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAG
TGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGC
CATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGG
AAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCT
ATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATA
ATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATTAATTCATGAG
CGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCA
TTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAA
AAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGG
TGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGC
GAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGG
TCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
T7 promoter region 
Lac operator binding site (for lac repressor) 
RBS (ribosome binding sequence 
NdeI site (catatg) 
pET29C-seqTOP 5- TGATGCCGGCCACGATGCGTCCGGCGTAGA  30mer 
pET29C-seqBOT 5- GGTACCCAGATCTGGGCTGTCCATGTGCTG  30mer 
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Appendix Figure 2.6. DNA sequence map of pET28b expression vector (5-3).
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTAT
GCTAGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATC
TCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCGGATCCC
GACCCATTTGCTGTCCACCAGTCATGCTAGCCATATGGCTGCCGCGCGGCACCAGGCCGCTGCTGTGA
TGATGATGATGATGGCTGCTGCCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAG
GGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCTCGA
TCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATC
GCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGG
TATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCGG
CGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGGAGAG
CGTCGAGATCCCGGACACCATCGAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAG
AGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTC
TCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGT
GGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGT
CGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATT
AAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGC
CTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGG
ATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCT
GACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGCATCT
GGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGC
GTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCGAC
TGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGAT
GCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTG
GTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACC
ACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGG
CCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCA
ATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGA
CTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGATCTC
GACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTC
GCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCAT
TTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCT
TGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATT
ATCGCCGGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTG
GCGGGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCT
GCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAA
ACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTG
TGGAACACCTACATCTGTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCC
GCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGTAACC
CGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACAC
GGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACAT
TAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCAC
GACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACA
CATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGG
GCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTG
TATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATATGCGGTGTGAAA
TACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCG
CTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAA
AGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
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CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGT
GTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCC
GGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAG
GCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATC
TGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCAC
CGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAG
ATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTC
ATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGG
AAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCT
CGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTT
GTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGC
TGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTC
ACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATAT
TGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACA
GCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGAT
TTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATT
CTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAAT
TAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGG
AACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCC
TGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATTAATTCATGAGCGGA
TACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCC
ACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTT
TTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGT
GTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAAC
CGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCC
GTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAAC
GTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCAC
GCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
T7 promoter region 
Lac operator binding site (for lac repressor) 
RBS (ribosome binding sequence 
NdeI site (5-CATATG-3)
pET28b-seqTOP 5- TGATGCCGGCCACGATGCGTCCGGCGTAGA  30mer 
pET28b-seqBOT 5- CTTGTCGACGGAGCTCGAATTCGGATCCCG  30mer 
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Appendix 3 
Appendix Figure 3.1. Native LigA protein coverage with peptide by Mass 
Spectrometry.  
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Appendix Figure 3.2. Native LigB protein coverage with peptide by Mass 
Spectrometry .
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Appendix 4 
All the gels for Chapter 4 are copied as high-resolution .tif files on the attached CD. Shown below as 
an example are all the gels for the LigA and LigB experiments on DNA. Each has a short description 
by the panel letter (A-D), with brief details of the reaction timecourse below. 
Appendix Figure 4.1. LigA with varying [DNA]. Panels A-D, reaction conditions described in 
Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 and 180 min
A LigA + 5 nM DNA B LigA + 5 nM DNA
C LigA + 10 nM DNA D LigA + 10 nM DNA
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Appendix Figure 4.2. LigA with varying [DNA]. 
Panels A-D, reaction conditions described in Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 
and 180 min 
A LigA + 30 nM DNA B LigA + 30 nM DNA
C LigA + 60 nM DNA D LigA + 60 nM DNA
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Appendix Figure 4.3. LigA with varying [DNA]. 
Panels A-D, reaction conditions described in Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 
and 180 min. 
A LigA + 80 nM DNA B LigA + 80 nM DNA
C LigA + 100 nM DNA D LigA + 100 nM DNA
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Appendix Figure 4.4. LigB with varying [DNA]. 
Panels A-D, reaction conditions described in Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 
and 180 min. 
A LigB + 5 nM DNA B LigB + 5 nM DNA
D LigB + 10 nM DNA C LigB + 10 nM DNA
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Appendix Figure 4.5. LigB with varying [DNA]. 
Panels A-D, reaction conditions described in Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 
and 180 min. 
A LigB + 30 nM DNA B LigB + 30 nM DNA
D LigB + 60 nM DNA C LigB + 60 nM DNA
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Appendix Figure 4.6. LigB with varying [DNA]. 
Panels A-D, reaction conditions described in Chapter 4.3.1. Timepoints were 0, 0.5, 1. 3, 5, 10, 20, 60 
and 180 min. 
A LigB + 80 nM DNA B LigB + 80 nM DNA
D LigB + 100 nM DNA C LigB + 100 nM DNA
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Appendix 6. 
Appendix Figure 6.1. The Inhibition of LigA with Varying Glutathione Disulphide 
Concentrations.  
In vitro Glutathione Disulphide,
at 0, 0.04, 0.4, 4 nM (left to right).
In vitro Glutathione Disulphide,
at 0.4, 4 and 0 µM (left to right).
In vitro Glutathione Disulphide, at 
0, 0.2 and 1, and 2 µM (left to right).
In vitro Glutathione Disulphide, at 
20, 50, 200 and 400 µM (left to right).
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Appendix Figure 6.2. The Inhibition of LigA with Varying 5-Azacytidine Concentrations. 
Appendix Figure 6.3. The Inhibition of LigA with Varying Geneticin/G418 Concentrations. 
In vitro 5-Azacytidine, at 0, 0.04, 
0.4 and 4 µM (left to right).
In vitro 5-Azacytidine, at 10, 50, 
100 and 400 µM (left to right).
In vitro Geneticin, at 0, 0.04 and 
4 µM (left to right). 
In vitro Geneticin, at 0.4, 10, 20 
and 50 µM (left to right). 
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 Appendix Figure 6.4. The Inhibition of LigA with Varying Chlorhexidine Concentrations. 
In vitro    Chlorhexidine, at 0.04, 
0.4, 4 and 20 µM (left to right). 
In vitro    Chlorhexidine, at 50, 
100, 200 and 400 µM (left to right). 
In vitro Geneticin, at 0, 0.4 and 4, 
400 µM (left to right). 
In vitro Geneticin, at 100 and 200 
µM (left to right).
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Appendix Figure 6.5. The Inhibition of LigA with Varying Bestatin Concentrations.
In vitro    Bestatin, at 0.04 and 0.4 
µM (left to right). 
In vitro    Bestatin, at 0 and 4 µM 
(left to right). 
In vitro    Bestatin, at 10, 50, 100 
and 400 µM (left to right). 
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Appendix Figure 6.6. The Inhibition of LigA with Varying Imidazolidinyl Urea
Concentrations.
In vitro    Imidazolidinyl Urea, at
0.04, 0.4 and 4 µM (left to right). 
In vitro    Imidazolidinyl Urea, at
0.04µM (left to right). 
In vitro    Imidazolidinyl Urea, at
0.4 and 4 µM (left to right). 
In vitro    Imidazolidinyl Urea, at 10, 
50, 200 and 400 µM (left to right). 
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Appendix Figure 6.7.             Appendix Figure 6.8
Appendix Figure 6.9. 
In vivo glutathione disulphide. 1 is positive 
con, 2 is negative con., 3, 4 and 5 are 200 Mm.   
In vivo 5-Azacytidine. 1 and 3 are 100. 2 and 
4 are 200 mM.  
In vivo Geneticin. 1 is positive con, 2 is 
negative con. 3, 4 and 5 are 0.01, 0.05, 0.10 
Mm, respectively.  
In vivo Geneticin.  1 is positive con, 2 is 
negative con. 3, 4 and 5 are 0.40, 0.60, 0.80
Mm, respectively. 
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Appendix Figure 6.10.
Appendix Figure 6.11.
In vivo chlorohexidine. 1 is positive con, 2 is 
negative con. 3, 4 and 5 are at 0.01, 0.05, 0.10 
mM, respectively.
In vivo chlorohexidine. 1 is negative con, 2 is 
positive con. 3, 4 and 5 are 0.40, 0.60, 0.80 
mM, respectively.
In vivo Imidazolidinyl Urea. 1 is positive con, 
2 is negative con. 1, 2, 4 mM, respectively.  
In vivo Imidazolidinyl Urea. 1 is positive con, 
2 is negative con. 20, 40, 80 are mM, 
respectively.
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